{"cells":[{"cell_type":"code","metadata":{"deepnote_to_be_reexecuted":false,"source_hash":"d032561f","execution_millis":1,"cell_id":"00000-aa7a453a-5606-4cb8-9da4-af301105b5fe","execution_start":1611680936825,"deepnote_cell_type":"code"},"source":"import numpy as np\nimport pandas as pd\nimport matplotlib.pyplot as plt\nimport seaborn as sns\nimport sklearn\nfrom statsmodels.distributions.empirical_distribution import ECDF","execution_count":19,"outputs":[]},{"cell_type":"code","metadata":{"deepnote_to_be_reexecuted":false,"source_hash":"c709358b","execution_millis":11644,"cell_id":"00001-3e00e7df-c261-4021-b518-2fe1644c1661","execution_start":1611680818333,"deepnote_cell_type":"code"},"source":"df_prescript  = pd.read_csv('/work/amr-uti/data/all_prescriptions.csv')\ndf_uti_features = pd.read_csv('/work/amr-uti/data/all_uti_features.csv')\ndf_uti_resist_lab = pd.read_csv('/work/amr-uti/data/all_uti_resist_labels.csv')\ndata_dict = pd.read_csv('/work/amr-uti/data/data_dictionary.csv')\ntest_uncomp_resist_data =  pd.read_csv('/work/amr-uti/data//test_uncomp_resist_data.csv')\ntest_uncomp_uti_features =  pd.read_csv('/work/amr-uti/data//test_uncomp_uti_features.csv')\ntrain_uncomp_resist_data =  pd.read_csv('/work/amr-uti/data//train_uncomp_resist_data.csv')\ntrain_uncomp_uti_features =  pd.read_csv('/work/amr-uti/data//train_uncomp_uti_features.csv')\n","execution_count":4,"outputs":[]},{"cell_type":"code","metadata":{"tags":[],"cell_id":"00002-52b177da-48a0-49d6-9317-d9a105a10507","deepnote_to_be_reexecuted":false,"source_hash":"5f9d015c","execution_millis":30,"execution_start":1611680829982,"deepnote_cell_type":"code"},"source":"all_uncomp_uti_features = test_uncomp_uti_features.append(train_uncomp_uti_features)\nall_uncomp_uti_features.shape[0]\nprint('The size of the uncomp train set', test_uncomp_resist_data.shape[0])\nprint('The size of the uncomp train set', train_uncomp_resist_data.shape[0])\n","execution_count":5,"outputs":[{"name":"stdout","text":"The size of the uncomp train set 3941\nThe size of the uncomp train set 11865\n","output_type":"stream"}]},{"cell_type":"code","metadata":{"deepnote_to_be_reexecuted":false,"source_hash":"125ca1d3","cell_id":"00002-70414311-d556-46a3-acd4-13b6aa2f4a05","execution_millis":166,"execution_start":1611680831961,"deepnote_cell_type":"code"},"source":"\n# Find Feature Lists\n\nstarting = 'infection_site'\ndf_prescript.head()\nfeatures = [s for s in list(df_uti_features.isna().sum().index) if s.startswith(starting)]\nprint('\\n'.join(features))\nprint('Number of Features:', len(features))","execution_count":6,"outputs":[{"name":"stdout","text":"infection_sites - RESPIRATORY_TRACT\ninfection_sites - BLOOD\ninfection_sites - SKIN_SOFTTISSUE\ninfection_sites - ABSCESS_OR_FLUID_NOS\ninfection_sites - MUCOCUTANEOUS\ninfection_sites - GENITOURINARY\nNumber of Features: 6\n","output_type":"stream"}]},{"cell_type":"code","metadata":{"deepnote_to_be_reexecuted":false,"source_hash":"d744d4ce","cell_id":"00003-da3f4adc-db7e-4cd9-9b88-64e98c53811a","execution_millis":140,"execution_start":1611680832484,"deepnote_cell_type":"code"},"source":"# Training set demographic distribution\ncount = train_uncomp_uti_features[\"demographics - is_white\"].value_counts()\nsns.set_style('whitegrid')\ng = sns.barplot(x = count.index, y = count)\ng.set(ylabel='Number of Observations')\n_ = g.set(xticklabels=['Non-White', 'White'])","execution_count":7,"outputs":[{"data":{"text/plain":"<Figure size 432x288 with 1 Axes>","image/png":"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\n"},"metadata":{},"output_type":"display_data"}]},{"cell_type":"code","metadata":{"tags":[],"cell_id":"00005-c3a4340c-173b-4bb9-86f4-9ce130f23f15","deepnote_to_be_reexecuted":false,"source_hash":"b6d8476b","execution_millis":194,"execution_start":1611680833142,"deepnote_cell_type":"code"},"source":"sns.violinplot(x = 'demographics - is_white', y = 'demographics - age', data = train_uncomp_uti_features)\n","execution_count":8,"outputs":[{"output_type":"execute_result","execution_count":8,"data":{"text/plain":"<AxesSubplot:xlabel='demographics - is_white', ylabel='demographics - age'>"},"metadata":{}},{"data":{"text/plain":"<Figure size 432x288 with 1 Axes>","image/png":"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\n"},"metadata":{},"output_type":"display_data"}]},{"cell_type":"code","metadata":{"deepnote_to_be_reexecuted":false,"source_hash":"496ed48","cell_id":"00004-444ac0ad-ee63-4332-b63b-19e99ff22e66","execution_millis":117,"execution_start":1611680833521,"deepnote_cell_type":"code"},"source":"# Total set demographic distribution\ncount = all_uncomp_uti_features[\"demographics - is_white\"].value_counts()\nsns.set_style('whitegrid')\ng = sns.barplot(x = count.index, y = count)\ng.set(ylabel='Number of Observations')\n_ = g.set(xticklabels=['Non-White', 'White'])","execution_count":9,"outputs":[{"data":{"text/plain":"<Figure size 432x288 with 1 Axes>","image/png":"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\n"},"metadata":{},"output_type":"display_data"}]},{"cell_type":"code","metadata":{"deepnote_to_be_reexecuted":false,"source_hash":"6db285fa","cell_id":"00005-a3629705-08f8-4288-8687-339c7ecec2b9","execution_millis":311,"execution_start":1611680833885,"deepnote_cell_type":"code"},"source":"sns.violinplot(x = 'demographics - is_white', y = 'demographics - age', data = all_uncomp_uti_features)\n","execution_count":10,"outputs":[{"output_type":"execute_result","execution_count":10,"data":{"text/plain":"<AxesSubplot:xlabel='demographics - is_white', ylabel='demographics - age'>"},"metadata":{}},{"data":{"text/plain":"<Figure size 432x288 with 1 Axes>","image/png":"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\n"},"metadata":{},"output_type":"display_data"}]},{"cell_type":"code","metadata":{"deepnote_to_be_reexecuted":false,"source_hash":"36030bd","cell_id":"00008-20f6a13a-a4bf-4f8c-8e21-0d3c3a46cb54","execution_millis":457,"execution_start":1611680834301,"deepnote_cell_type":"code"},"source":"pie = pd.DataFrame({'count': [3, 4 , 144, 224, 81, 52, 36, 155, 74, 4, 6, 5]},\n                  index=['demographics', 'location_type', 'prior_abx_rest','prior_abx_exp_med', 'prior_abx_exp_class','prior_abx_exp_subclass', 'prior_infect_org', 'comorbidities','colonization_pressure', 'skilled_nursing', 'other_infection', 'prior_procedures' ])\nplot = pie.plot.pie(y='count', figsize=(5, 5))\nplot.set_title(\"Breakdown of Features Numbers\")\nplt.legend(bbox_to_anchor=(1.2, 1), loc='upper left')","execution_count":11,"outputs":[{"output_type":"execute_result","execution_count":11,"data":{"text/plain":"<matplotlib.legend.Legend at 0x7ffadf0441d0>"},"metadata":{}},{"data":{"text/plain":"<Figure size 360x360 with 1 Axes>","image/png":"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\n"},"metadata":{},"output_type":"display_data"}]},{"cell_type":"code","metadata":{"deepnote_to_be_reexecuted":false,"source_hash":"4a5cb3e0","cell_id":"00009-22c07acd-bfb7-4545-a530-a60f6599952f","execution_millis":358,"execution_start":1611680834850,"deepnote_cell_type":"code"},"source":"_  =  sns.heatmap(pie, annot=True, fmt=\"d\",  cmap=\"YlGnBu\", square = True)\n# fix for mpl bug that cuts off top/bottom of seaborn viz\nb, t = plt.ylim() # discover the values for bottom and top\nb += 0.5 # Add 0.5 to the bottom\nt -= 0.5 # Subtract 0.5 from the top\nplt.ylim(b, t) # update the ylim(bottom, top) values\nplt.show() # ta-da!","execution_count":12,"outputs":[{"data":{"text/plain":"<Figure size 432x288 with 2 Axes>","image/png":"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\n"},"metadata":{},"output_type":"display_data"}]},{"cell_type":"code","metadata":{"deepnote_to_be_reexecuted":false,"source_hash":"805cc6f","cell_id":"00010-3aa643b5-8572-43bf-890b-d9631408dc40","execution_millis":17,"execution_start":1611680835786,"deepnote_cell_type":"code"},"source":"df_uti_resist_lab.head()","execution_count":13,"outputs":[{"output_type":"execute_result","execution_count":13,"data":{"application/vnd.deepnote.dataframe.v2+json":{"row_count":5,"column_count":7,"columns":[{"name":"example_id","dtype":"int64","stats":{"unique_count":5,"nan_count":0,"min":0,"max":4,"histogram":[{"bin_start":0,"bin_end":0.4,"count":1},{"bin_start":0.4,"bin_end":0.8,"count":0},{"bin_start":0.8,"bin_end":1.2000000000000002,"count":1},{"bin_start":1.2000000000000002,"bin_end":1.6,"count":0},{"bin_start":1.6,"bin_end":2,"count":0},{"bin_start":2,"bin_end":2.4000000000000004,"count":1},{"bin_start":2.4000000000000004,"bin_end":2.8000000000000003,"count":0},{"bin_start":2.8000000000000003,"bin_end":3.2,"count":1},{"bin_start":3.2,"bin_end":3.6,"count":0},{"bin_start":3.6,"bin_end":4,"count":1}]}},{"name":"NIT","dtype":"float64","stats":{"unique_count":1,"nan_count":0,"min":0,"max":0,"histogram":[{"bin_start":-0.5,"bin_end":-0.4,"count":0},{"bin_start":-0.4,"bin_end":-0.3,"count":0},{"bin_start":-0.3,"bin_end":-0.19999999999999996,"count":0},{"bin_start":-0.19999999999999996,"bin_end":-0.09999999999999998,"count":0},{"bin_start":-0.09999999999999998,"bin_end":0,"count":0},{"bin_start":0,"bin_end":0.10000000000000009,"count":5},{"bin_start":0.10000000000000009,"bin_end":0.20000000000000007,"count":0},{"bin_start":0.20000000000000007,"bin_end":0.30000000000000004,"count":0},{"bin_start":0.30000000000000004,"bin_end":0.4,"count":0},{"bin_start":0.4,"bin_end":0.5,"count":0}]}},{"name":"SXT","dtype":"float64","stats":{"unique_count":1,"nan_count":0,"min":0,"max":0,"histogram":[{"bin_start":-0.5,"bin_end":-0.4,"count":0},{"bin_start":-0.4,"bin_end":-0.3,"count":0},{"bin_start":-0.3,"bin_end":-0.19999999999999996,"count":0},{"bin_start":-0.19999999999999996,"bin_end":-0.09999999999999998,"count":0},{"bin_start":-0.09999999999999998,"bin_end":0,"count":0},{"bin_start":0,"bin_end":0.10000000000000009,"count":5},{"bin_start":0.10000000000000009,"bin_end":0.20000000000000007,"count":0},{"bin_start":0.20000000000000007,"bin_end":0.30000000000000004,"count":0},{"bin_start":0.30000000000000004,"bin_end":0.4,"count":0},{"bin_start":0.4,"bin_end":0.5,"count":0}]}},{"name":"CIP","dtype":"float64","stats":{"unique_count":2,"nan_count":0,"min":0,"max":1,"histogram":[{"bin_start":0,"bin_end":0.1,"count":4},{"bin_start":0.1,"bin_end":0.2,"count":0},{"bin_start":0.2,"bin_end":0.30000000000000004,"count":0},{"bin_start":0.30000000000000004,"bin_end":0.4,"count":0},{"bin_start":0.4,"bin_end":0.5,"count":0},{"bin_start":0.5,"bin_end":0.6000000000000001,"count":0},{"bin_start":0.6000000000000001,"bin_end":0.7000000000000001,"count":0},{"bin_start":0.7000000000000001,"bin_end":0.8,"count":0},{"bin_start":0.8,"bin_end":0.9,"count":0},{"bin_start":0.9,"bin_end":1,"count":1}]}},{"name":"LVX","dtype":"float64","stats":{"unique_count":2,"nan_count":0,"min":0,"max":1,"histogram":[{"bin_start":0,"bin_end":0.1,"count":4},{"bin_start":0.1,"bin_end":0.2,"count":0},{"bin_start":0.2,"bin_end":0.30000000000000004,"count":0},{"bin_start":0.30000000000000004,"bin_end":0.4,"count":0},{"bin_start":0.4,"bin_end":0.5,"count":0},{"bin_start":0.5,"bin_end":0.6000000000000001,"count":0},{"bin_start":0.6000000000000001,"bin_end":0.7000000000000001,"count":0},{"bin_start":0.7000000000000001,"bin_end":0.8,"count":0},{"bin_start":0.8,"bin_end":0.9,"count":0},{"bin_start":0.9,"bin_end":1,"count":1}]}},{"name":"is_train","dtype":"int64","stats":{"unique_count":2,"nan_count":0,"min":0,"max":1,"histogram":[{"bin_start":0,"bin_end":0.1,"count":1},{"bin_start":0.1,"bin_end":0.2,"count":0},{"bin_start":0.2,"bin_end":0.30000000000000004,"count":0},{"bin_start":0.30000000000000004,"bin_end":0.4,"count":0},{"bin_start":0.4,"bin_end":0.5,"count":0},{"bin_start":0.5,"bin_end":0.6000000000000001,"count":0},{"bin_start":0.6000000000000001,"bin_end":0.7000000000000001,"count":0},{"bin_start":0.7000000000000001,"bin_end":0.8,"count":0},{"bin_start":0.8,"bin_end":0.9,"count":0},{"bin_start":0.9,"bin_end":1,"count":4}]}},{"name":"uncomplicated","dtype":"int64","stats":{"unique_count":2,"nan_count":0,"min":0,"max":1,"histogram":[{"bin_start":0,"bin_end":0.1,"count":4},{"bin_start":0.1,"bin_end":0.2,"count":0},{"bin_start":0.2,"bin_end":0.30000000000000004,"count":0},{"bin_start":0.30000000000000004,"bin_end":0.4,"count":0},{"bin_start":0.4,"bin_end":0.5,"count":0},{"bin_start":0.5,"bin_end":0.6000000000000001,"count":0},{"bin_start":0.6000000000000001,"bin_end":0.7000000000000001,"count":0},{"bin_start":0.7000000000000001,"bin_end":0.8,"count":0},{"bin_start":0.8,"bin_end":0.9,"count":0},{"bin_start":0.9,"bin_end":1,"count":1}]}},{"name":"_deepnote_index_column","dtype":"int64"}],"rows_top":[{"example_id":0,"NIT":0,"SXT":0,"CIP":0,"LVX":0,"is_train":0,"uncomplicated":0,"_deepnote_index_column":0},{"example_id":1,"NIT":0,"SXT":0,"CIP":0,"LVX":0,"is_train":1,"uncomplicated":0,"_deepnote_index_column":1},{"example_id":2,"NIT":0,"SXT":0,"CIP":1,"LVX":1,"is_train":1,"uncomplicated":0,"_deepnote_index_column":2},{"example_id":3,"NIT":0,"SXT":0,"CIP":0,"LVX":0,"is_train":1,"uncomplicated":0,"_deepnote_index_column":3},{"example_id":4,"NIT":0,"SXT":0,"CIP":0,"LVX":0,"is_train":1,"uncomplicated":1,"_deepnote_index_column":4}],"rows_bottom":null},"text/plain":"   example_id  NIT  SXT  CIP  LVX  is_train  uncomplicated\n0           0  0.0  0.0  0.0  0.0         0              0\n1           1  0.0  0.0  0.0  0.0         1              0\n2           2  0.0  0.0  1.0  1.0         1              0\n3           3  0.0  0.0  0.0  0.0         1              0\n4           4  0.0  0.0  0.0  0.0         1              1","text/html":"<div>\n<style scoped>\n    .dataframe tbody tr th:only-of-type {\n        vertical-align: middle;\n    }\n\n    .dataframe tbody tr th {\n        vertical-align: top;\n    }\n\n    .dataframe thead th {\n        text-align: right;\n    }\n</style>\n<table border=\"1\" class=\"dataframe\">\n  <thead>\n    <tr style=\"text-align: right;\">\n      <th></th>\n      <th>example_id</th>\n      <th>NIT</th>\n      <th>SXT</th>\n      <th>CIP</th>\n      <th>LVX</th>\n      <th>is_train</th>\n      <th>uncomplicated</th>\n    </tr>\n  </thead>\n  <tbody>\n    <tr>\n      <th>0</th>\n      <td>0</td>\n      <td>0.0</td>\n      <td>0.0</td>\n      <td>0.0</td>\n      <td>0.0</td>\n      <td>0</td>\n      <td>0</td>\n    </tr>\n    <tr>\n      <th>1</th>\n      <td>1</td>\n      <td>0.0</td>\n      <td>0.0</td>\n      <td>0.0</td>\n      <td>0.0</td>\n      <td>1</td>\n      <td>0</td>\n    </tr>\n    <tr>\n      <th>2</th>\n      <td>2</td>\n      <td>0.0</td>\n      <td>0.0</td>\n      <td>1.0</td>\n      <td>1.0</td>\n      <td>1</td>\n      <td>0</td>\n    </tr>\n    <tr>\n      <th>3</th>\n      <td>3</td>\n      <td>0.0</td>\n      <td>0.0</td>\n      <td>0.0</td>\n      <td>0.0</td>\n      <td>1</td>\n      <td>0</td>\n    </tr>\n    <tr>\n      <th>4</th>\n      <td>4</td>\n      <td>0.0</td>\n      <td>0.0</td>\n      <td>0.0</td>\n      <td>0.0</td>\n      <td>1</td>\n      <td>1</td>\n    </tr>\n  </tbody>\n</table>\n</div>"},"metadata":{}}]},{"cell_type":"code","metadata":{"deepnote_to_be_reexecuted":false,"source_hash":"aa02b055","cell_id":"00011-ece095a7-f4e5-4c9d-8515-57e1e7d817d2","execution_millis":0,"execution_start":1611680838114,"deepnote_cell_type":"code"},"source":"# Study only looked at uncomplicated UTI\n\ndf_uti_resist_lab.groupby(['is_train', 'uncomplicated']).size()","execution_count":14,"outputs":[{"output_type":"execute_result","execution_count":14,"data":{"text/plain":"is_train  uncomplicated\n0         0                31999\n          1                 3941\n1         0                69097\n          1                11865\ndtype: int64"},"metadata":{}}]},{"cell_type":"code","metadata":{"deepnote_to_be_reexecuted":false,"source_hash":"56d48fa9","cell_id":"00012-33dfac83-037d-4ac2-aa62-2d118c35ad1a","execution_millis":201,"execution_start":1611680841762,"deepnote_cell_type":"code"},"source":"pd.set_option('display.max_rows', None)\npd.set_option('display.max_columns', None)\ndata_dict","execution_count":15,"outputs":[{"output_type":"execute_result","execution_count":15,"data":{"application/vnd.deepnote.dataframe.v2+json":{"row_count":801,"column_count":5,"columns":[{"name":"file","dtype":"object","stats":{"unique_count":3,"nan_count":0,"categories":[{"name":"all_uti_features.csv","count":791},{"name":"all_uti_resist_labels.csv","count":7},{"name":"all_prescriptions.csv","count":3}]}},{"name":"column","dtype":"object","stats":{"unique_count":796,"nan_count":0,"categories":[{"name":"example_id","count":3},{"name":"is_train","count":3},{"name":"794 others","count":795}]}},{"name":"until","dtype":"float64","stats":{"unique_count":3,"nan_count":26,"min":0,"max":7,"histogram":[{"bin_start":0,"bin_end":0.7,"count":164},{"bin_start":0.7,"bin_end":1.4,"count":0},{"bin_start":1.4,"bin_end":2.0999999999999996,"count":357},{"bin_start":2.0999999999999996,"bin_end":2.8,"count":0},{"bin_start":2.8,"bin_end":3.5,"count":0},{"bin_start":3.5,"bin_end":4.199999999999999,"count":0},{"bin_start":4.199999999999999,"bin_end":4.8999999999999995,"count":0},{"bin_start":4.8999999999999995,"bin_end":5.6,"count":0},{"bin_start":5.6,"bin_end":6.3,"count":0},{"bin_start":6.3,"bin_end":7,"count":254}]}},{"name":"from","dtype":"object","stats":{"unique_count":10,"nan_count":26,"categories":[{"name":"90","count":183},{"name":"9 others","count":592},{"name":"Missing","count":26}]}},{"name":"description","dtype":"object","stats":{"unique_count":31,"nan_count":0,"categories":[{"name":"Prior antibiotic exposure (detailed names)","count":224},{"name":"Elixhauser Comorbidities","count":155},{"name":"29 others","count":422}]}},{"name":"_deepnote_index_column","dtype":"int64"}],"rows_top":[{"file":"all_uti_resist_labels.csv","column":"example_id","until":"nan","from":"nan","description":"Unique specimen ID used to link between files","_deepnote_index_column":0},{"file":"all_uti_resist_labels.csv","column":"NIT","until":"nan","from":"nan","description":"Indicator of resistance to nitrofurantoin","_deepnote_index_column":1},{"file":"all_uti_resist_labels.csv","column":"SXT","until":"nan","from":"nan","description":"Indicator of resistance to trimethoprim-sulfamethoxazole","_deepnote_index_column":2},{"file":"all_uti_resist_labels.csv","column":"CIP","until":"nan","from":"nan","description":"Indicator of resistance to ciprofloxacin","_deepnote_index_column":3},{"file":"all_uti_resist_labels.csv","column":"LVX","until":"nan","from":"nan","description":"Indicator of resistance to levofloxacin","_deepnote_index_column":4},{"file":"all_uti_resist_labels.csv","column":"is_train","until":"nan","from":"nan","description":"Used to denote membership in training set (2007-13)","_deepnote_index_column":5},{"file":"all_uti_resist_labels.csv","column":"uncomplicated","until":"nan","from":"nan","description":"Used to denote membership in uncomplicated UTI cohort","_deepnote_index_column":6},{"file":"all_prescriptions.csv","column":"example_id","until":"nan","from":"nan","description":"Unique specimen ID used to link between files","_deepnote_index_column":7},{"file":"all_prescriptions.csv","column":"prescription","until":"nan","from":"nan","description":"Observed empiric prescription (one of NIT, SXT, CIP, LVX)","_deepnote_index_column":8},{"file":"all_prescriptions.csv","column":"is_train","until":"nan","from":"nan","description":"Used to denote membership in training set (2007-13)","_deepnote_index_column":9},{"file":"all_uti_features.csv","column":"example_id","until":"nan","from":"nan","description":"Unique specimen ID used to link between files","_deepnote_index_column":10},{"file":"all_uti_features.csv","column":"demographics - age","until":"nan","from":"nan","description":"Age (years)","_deepnote_index_column":11},{"file":"all_uti_features.csv","column":"demographics - is_white","until":"nan","from":"nan","description":"Race (white)","_deepnote_index_column":12},{"file":"all_uti_features.csv","column":"demographics - is_veteran","until":"nan","from":"nan","description":"Veteran Status (true)","_deepnote_index_column":13},{"file":"all_uti_features.csv","column":"micro - prev resistance LVX 14","until":"7.0","from":"14.0","description":"Prior antibiotic resistance, see documentation for acronyms","_deepnote_index_column":14},{"file":"all_uti_features.csv","column":"micro - prev resistance AMP 14","until":"7.0","from":"14.0","description":"Prior antibiotic resistance, see documentation for acronyms","_deepnote_index_column":15},{"file":"all_uti_features.csv","column":"micro - prev resistance CFZ 14","until":"7.0","from":"14.0","description":"Prior antibiotic resistance, see documentation for acronyms","_deepnote_index_column":16},{"file":"all_uti_features.csv","column":"micro - prev resistance NIT 14","until":"7.0","from":"14.0","description":"Prior antibiotic resistance, see documentation for acronyms","_deepnote_index_column":17},{"file":"all_uti_features.csv","column":"micro - prev resistance GEN 14","until":"7.0","from":"14.0","description":"Prior antibiotic resistance, see documentation for acronyms","_deepnote_index_column":18},{"file":"all_uti_features.csv","column":"micro - prev resistance SXT 14","until":"7.0","from":"14.0","description":"Prior antibiotic resistance, see documentation for acronyms","_deepnote_index_column":19},{"file":"all_uti_features.csv","column":"micro - prev resistance TET 14","until":"7.0","from":"14.0","description":"Prior antibiotic resistance, see documentation for acronyms","_deepnote_index_column":20},{"file":"all_uti_features.csv","column":"micro - prev resistance AMC 14","until":"7.0","from":"14.0","description":"Prior antibiotic resistance, see documentation for acronyms","_deepnote_index_column":21},{"file":"all_uti_features.csv","column":"micro - prev resistance CIP 14","until":"7.0","from":"14.0","description":"Prior antibiotic resistance, see documentation for acronyms","_deepnote_index_column":22},{"file":"all_uti_features.csv","column":"micro - prev resistance SAM 14","until":"7.0","from":"14.0","description":"Prior antibiotic resistance, see documentation for acronyms","_deepnote_index_column":23},{"file":"all_uti_features.csv","column":"micro - prev resistance ERY 30","until":"7.0","from":"30.0","description":"Prior antibiotic resistance, see documentation for acronyms","_deepnote_index_column":24},{"file":"all_uti_features.csv","column":"micro - prev resistance OXA 30","until":"7.0","from":"30.0","description":"Prior antibiotic resistance, see documentation for acronyms","_deepnote_index_column":25},{"file":"all_uti_features.csv","column":"micro - prev resistance QUD 30","until":"7.0","from":"30.0","description":"Prior antibiotic resistance, see documentation for acronyms","_deepnote_index_column":26},{"file":"all_uti_features.csv","column":"micro - prev resistance RIF 30","until":"7.0","from":"30.0","description":"Prior antibiotic resistance, see documentation for acronyms","_deepnote_index_column":27},{"file":"all_uti_features.csv","column":"micro - prev resistance AMP 30","until":"7.0","from":"30.0","description":"Prior antibiotic resistance, see documentation for acronyms","_deepnote_index_column":28},{"file":"all_uti_features.csv","column":"micro - prev resistance CFZ 30","until":"7.0","from":"30.0","description":"Prior antibiotic resistance, see documentation for acronyms","_deepnote_index_column":29},{"file":"all_uti_features.csv","column":"micro - prev resistance PEN 30","until":"7.0","from":"30.0","description":"Prior antibiotic resistance, see documentation for acronyms","_deepnote_index_column":30},{"file":"all_uti_features.csv","column":"micro - prev resistance LVX 30","until":"7.0","from":"30.0","description":"Prior antibiotic resistance, see documentation for acronyms","_deepnote_index_column":31},{"file":"all_uti_features.csv","column":"micro - prev resistance CLI 30","until":"7.0","from":"30.0","description":"Prior antibiotic resistance, see documentation for acronyms","_deepnote_index_column":32},{"file":"all_uti_features.csv","column":"micro - prev resistance DOX 30","until":"7.0","from":"30.0","description":"Prior antibiotic resistance, see documentation for acronyms","_deepnote_index_column":33},{"file":"all_uti_features.csv","column":"micro - prev resistance NIT 30","until":"7.0","from":"30.0","description":"Prior antibiotic resistance, see documentation for acronyms","_deepnote_index_column":34},{"file":"all_uti_features.csv","column":"micro - prev resistance TET 30","until":"7.0","from":"30.0","description":"Prior antibiotic resistance, see documentation for acronyms","_deepnote_index_column":35},{"file":"all_uti_features.csv","column":"micro - prev resistance CIP 30","until":"7.0","from":"30.0","description":"Prior antibiotic resistance, see documentation for acronyms","_deepnote_index_column":36},{"file":"all_uti_features.csv","column":"micro - prev resistance CRO 30","until":"7.0","from":"30.0","description":"Prior antibiotic resistance, see documentation for acronyms","_deepnote_index_column":37},{"file":"all_uti_features.csv","column":"micro - prev resistance GEN 30","until":"7.0","from":"30.0","description":"Prior antibiotic resistance, see documentation for acronyms","_deepnote_index_column":38},{"file":"all_uti_features.csv","column":"micro - prev resistance SXT 30","until":"7.0","from":"30.0","description":"Prior antibiotic resistance, see documentation for acronyms","_deepnote_index_column":39},{"file":"all_uti_features.csv","column":"micro - prev resistance AMC 30","until":"7.0","from":"30.0","description":"Prior antibiotic resistance, see documentation for acronyms","_deepnote_index_column":40},{"file":"all_uti_features.csv","column":"micro - prev resistance ATM 30","until":"7.0","from":"30.0","description":"Prior antibiotic resistance, see documentation for acronyms","_deepnote_index_column":41},{"file":"all_uti_features.csv","column":"micro - prev resistance PIP 30","until":"7.0","from":"30.0","description":"Prior antibiotic resistance, see documentation for acronyms","_deepnote_index_column":42},{"file":"all_uti_features.csv","column":"micro - prev resistance TOB 30","until":"7.0","from":"30.0","description":"Prior antibiotic resistance, see documentation for acronyms","_deepnote_index_column":43},{"file":"all_uti_features.csv","column":"micro - prev resistance TZP 30","until":"7.0","from":"30.0","description":"Prior antibiotic resistance, see documentation for acronyms","_deepnote_index_column":44},{"file":"all_uti_features.csv","column":"micro - prev resistance SAM 30","until":"7.0","from":"30.0","description":"Prior antibiotic resistance, see documentation for acronyms","_deepnote_index_column":45},{"file":"all_uti_features.csv","column":"micro - prev resistance STRS 30","until":"7.0","from":"30.0","description":"Prior antibiotic resistance, see documentation for acronyms","_deepnote_index_column":46},{"file":"all_uti_features.csv","column":"micro - prev resistance MXF 30","until":"7.0","from":"30.0","description":"Prior antibiotic resistance, see documentation for acronyms","_deepnote_index_column":47},{"file":"all_uti_features.csv","column":"micro - prev resistance FOX 30","until":"7.0","from":"30.0","description":"Prior antibiotic resistance, see documentation for acronyms","_deepnote_index_column":48},{"file":"all_uti_features.csv","column":"micro - prev resistance AMC 90","until":"7.0","from":"90.0","description":"Prior antibiotic resistance, see documentation for acronyms","_deepnote_index_column":49},{"file":"all_uti_features.csv","column":"micro - prev resistance AMP 90","until":"7.0","from":"90.0","description":"Prior antibiotic resistance, see documentation for acronyms","_deepnote_index_column":50},{"file":"all_uti_features.csv","column":"micro - prev resistance ATM 90","until":"7.0","from":"90.0","description":"Prior antibiotic resistance, see documentation for acronyms","_deepnote_index_column":51},{"file":"all_uti_features.csv","column":"micro - prev resistance CAZ 90","until":"7.0","from":"90.0","description":"Prior antibiotic resistance, see documentation for acronyms","_deepnote_index_column":52},{"file":"all_uti_features.csv","column":"micro - prev resistance CIP 90","until":"7.0","from":"90.0","description":"Prior antibiotic resistance, see documentation for acronyms","_deepnote_index_column":53},{"file":"all_uti_features.csv","column":"micro - prev resistance CRO 90","until":"7.0","from":"90.0","description":"Prior antibiotic resistance, see documentation for acronyms","_deepnote_index_column":54},{"file":"all_uti_features.csv","column":"micro - prev resistance NAL 90","until":"7.0","from":"90.0","description":"Prior antibiotic resistance, see documentation for acronyms","_deepnote_index_column":55},{"file":"all_uti_features.csv","column":"micro - prev resistance PIP 90","until":"7.0","from":"90.0","description":"Prior antibiotic resistance, see documentation for acronyms","_deepnote_index_column":56},{"file":"all_uti_features.csv","column":"micro - prev resistance SXT 90","until":"7.0","from":"90.0","description":"Prior antibiotic resistance, see documentation for acronyms","_deepnote_index_column":57},{"file":"all_uti_features.csv","column":"micro - prev resistance TET 90","until":"7.0","from":"90.0","description":"Prior antibiotic resistance, see documentation for acronyms","_deepnote_index_column":58},{"file":"all_uti_features.csv","column":"micro - prev resistance CFZ 90","until":"7.0","from":"90.0","description":"Prior antibiotic resistance, see documentation for acronyms","_deepnote_index_column":59},{"file":"all_uti_features.csv","column":"micro - prev resistance LVX 90","until":"7.0","from":"90.0","description":"Prior antibiotic resistance, see documentation for acronyms","_deepnote_index_column":60},{"file":"all_uti_features.csv","column":"micro - prev resistance NIT 90","until":"7.0","from":"90.0","description":"Prior antibiotic resistance, see documentation for acronyms","_deepnote_index_column":61},{"file":"all_uti_features.csv","column":"micro - prev resistance OXA 90","until":"7.0","from":"90.0","description":"Prior antibiotic resistance, see documentation for acronyms","_deepnote_index_column":62},{"file":"all_uti_features.csv","column":"micro - prev resistance PEN 90","until":"7.0","from":"90.0","description":"Prior antibiotic resistance, see documentation for acronyms","_deepnote_index_column":63},{"file":"all_uti_features.csv","column":"micro - prev resistance ERY 90","until":"7.0","from":"90.0","description":"Prior antibiotic resistance, see documentation for acronyms","_deepnote_index_column":64},{"file":"all_uti_features.csv","column":"micro - prev resistance CHL 90","until":"7.0","from":"90.0","description":"Prior antibiotic resistance, see documentation for acronyms","_deepnote_index_column":65},{"file":"all_uti_features.csv","column":"micro - prev resistance QUD 90","until":"7.0","from":"90.0","description":"Prior antibiotic resistance, see documentation for acronyms","_deepnote_index_column":66},{"file":"all_uti_features.csv","column":"micro - prev resistance DOX 90","until":"7.0","from":"90.0","description":"Prior antibiotic resistance, see documentation for acronyms","_deepnote_index_column":67},{"file":"all_uti_features.csv","column":"micro - prev resistance RIF 90","until":"7.0","from":"90.0","description":"Prior antibiotic resistance, see documentation for acronyms","_deepnote_index_column":68},{"file":"all_uti_features.csv","column":"micro - prev resistance CLI 90","until":"7.0","from":"90.0","description":"Prior antibiotic resistance, see documentation for acronyms","_deepnote_index_column":69},{"file":"all_uti_features.csv","column":"micro - prev resistance GEN 90","until":"7.0","from":"90.0","description":"Prior antibiotic resistance, see documentation for acronyms","_deepnote_index_column":70},{"file":"all_uti_features.csv","column":"micro - prev resistance IPM 90","until":"7.0","from":"90.0","description":"Prior antibiotic resistance, see documentation for acronyms","_deepnote_index_column":71},{"file":"all_uti_features.csv","column":"micro - prev resistance TIC 90","until":"7.0","from":"90.0","description":"Prior antibiotic resistance, see documentation for acronyms","_deepnote_index_column":72},{"file":"all_uti_features.csv","column":"micro - prev resistance TOB 90","until":"7.0","from":"90.0","description":"Prior antibiotic resistance, see documentation for acronyms","_deepnote_index_column":73},{"file":"all_uti_features.csv","column":"micro - prev resistance CTT 90","until":"7.0","from":"90.0","description":"Prior antibiotic resistance, see documentation for acronyms","_deepnote_index_column":74},{"file":"all_uti_features.csv","column":"micro - prev resistance FEP 90","until":"7.0","from":"90.0","description":"Prior antibiotic resistance, see documentation for acronyms","_deepnote_index_column":75},{"file":"all_uti_features.csv","column":"micro - prev resistance TZP 90","until":"7.0","from":"90.0","description":"Prior antibiotic resistance, see documentation for acronyms","_deepnote_index_column":76},{"file":"all_uti_features.csv","column":"micro - prev resistance AMK 90","until":"7.0","from":"90.0","description":"Prior antibiotic resistance, see documentation for acronyms","_deepnote_index_column":77},{"file":"all_uti_features.csv","column":"micro - prev resistance LZD 90","until":"7.0","from":"90.0","description":"Prior antibiotic resistance, see documentation for acronyms","_deepnote_index_column":78},{"file":"all_uti_features.csv","column":"micro - prev resistance SAM 90","until":"7.0","from":"90.0","description":"Prior antibiotic resistance, see documentation for acronyms","_deepnote_index_column":79},{"file":"all_uti_features.csv","column":"micro - prev resistance STRS 90","until":"7.0","from":"90.0","description":"Prior antibiotic resistance, see documentation for acronyms","_deepnote_index_column":80},{"file":"all_uti_features.csv","column":"micro - prev resistance GENS 90","until":"7.0","from":"90.0","description":"Prior antibiotic resistance, see documentation for acronyms","_deepnote_index_column":81},{"file":"all_uti_features.csv","column":"micro - prev resistance MXF 90","until":"7.0","from":"90.0","description":"Prior antibiotic resistance, see documentation for acronyms","_deepnote_index_column":82},{"file":"all_uti_features.csv","column":"micro - prev resistance FOX 90","until":"7.0","from":"90.0","description":"Prior antibiotic resistance, see documentation for acronyms","_deepnote_index_column":83},{"file":"all_uti_features.csv","column":"micro - prev resistance LVX 180","until":"7.0","from":"180.0","description":"Prior antibiotic resistance, see documentation for acronyms","_deepnote_index_column":84},{"file":"all_uti_features.csv","column":"micro - prev resistance AMP 180","until":"7.0","from":"180.0","description":"Prior antibiotic resistance, see documentation for acronyms","_deepnote_index_column":85},{"file":"all_uti_features.csv","column":"micro - prev resistance CFZ 180","until":"7.0","from":"180.0","description":"Prior antibiotic resistance, see documentation for acronyms","_deepnote_index_column":86},{"file":"all_uti_features.csv","column":"micro - prev resistance CIP 180","until":"7.0","from":"180.0","description":"Prior antibiotic resistance, see documentation for acronyms","_deepnote_index_column":87},{"file":"all_uti_features.csv","column":"micro - prev resistance GEN 180","until":"7.0","from":"180.0","description":"Prior antibiotic resistance, see documentation for acronyms","_deepnote_index_column":88},{"file":"all_uti_features.csv","column":"micro - prev resistance PIP 180","until":"7.0","from":"180.0","description":"Prior antibiotic resistance, see documentation for acronyms","_deepnote_index_column":89},{"file":"all_uti_features.csv","column":"micro - prev resistance ATM 180","until":"7.0","from":"180.0","description":"Prior antibiotic resistance, see documentation for acronyms","_deepnote_index_column":90},{"file":"all_uti_features.csv","column":"micro - prev resistance IPM 180","until":"7.0","from":"180.0","description":"Prior antibiotic resistance, see documentation for acronyms","_deepnote_index_column":91},{"file":"all_uti_features.csv","column":"micro - prev resistance TIC 180","until":"7.0","from":"180.0","description":"Prior antibiotic resistance, see documentation for acronyms","_deepnote_index_column":92},{"file":"all_uti_features.csv","column":"micro - prev resistance TOB 180","until":"7.0","from":"180.0","description":"Prior antibiotic resistance, see documentation for acronyms","_deepnote_index_column":93},{"file":"all_uti_features.csv","column":"micro - prev resistance ERY 180","until":"7.0","from":"180.0","description":"Prior antibiotic resistance, see documentation for acronyms","_deepnote_index_column":94},{"file":"all_uti_features.csv","column":"micro - prev resistance OXA 180","until":"7.0","from":"180.0","description":"Prior antibiotic resistance, see documentation for acronyms","_deepnote_index_column":95},{"file":"all_uti_features.csv","column":"micro - prev resistance PEN 180","until":"7.0","from":"180.0","description":"Prior antibiotic resistance, see documentation for acronyms","_deepnote_index_column":96},{"file":"all_uti_features.csv","column":"micro - prev resistance CLI 180","until":"7.0","from":"180.0","description":"Prior antibiotic resistance, see documentation for acronyms","_deepnote_index_column":97},{"file":"all_uti_features.csv","column":"micro - prev resistance NAL 180","until":"7.0","from":"180.0","description":"Prior antibiotic resistance, see documentation for acronyms","_deepnote_index_column":98},{"file":"all_uti_features.csv","column":"micro - prev resistance DOX 180","until":"7.0","from":"180.0","description":"Prior antibiotic resistance, see documentation for acronyms","_deepnote_index_column":99}],"rows_bottom":[{"file":"all_uti_features.csv","column":"comorbidity 180 - PHTN","until":"0.0","from":"180","description":"Elixhauser Comorbidities","_deepnote_index_column":701},{"file":"all_uti_features.csv","column":"comorbidity 180 - Drugs","until":"0.0","from":"180","description":"Elixhauser Comorbidities","_deepnote_index_column":702},{"file":"all_uti_features.csv","column":"comorbidity 180 - Mets","until":"0.0","from":"180","description":"Elixhauser Comorbidities","_deepnote_index_column":703},{"file":"all_uti_features.csv","column":"comorbidity 180 - PUD","until":"0.0","from":"180","description":"Elixhauser Comorbidities","_deepnote_index_column":704},{"file":"all_uti_features.csv","column":"comorbidity 180 - HIV","until":"0.0","from":"180","description":"Elixhauser Comorbidities","_deepnote_index_column":705},{"file":"all_uti_features.csv","column":"procedure 180 - had cvc","until":"0.0","from":"180","description":"Prior central venous catheter (CVC)","_deepnote_index_column":706},{"file":"all_uti_features.csv","column":"procedure 180 - had surgery","until":"0.0","from":"180","description":"Prior surgical procedure","_deepnote_index_column":707},{"file":"all_uti_features.csv","column":"procedure 180 - had mechanical ventilation","until":"0.0","from":"180","description":"Prior mechanical ventilation","_deepnote_index_column":708},{"file":"all_uti_features.csv","column":"procedure 180 - had hemodialysis","until":"0.0","from":"180","description":"Prior hemodialysis","_deepnote_index_column":709},{"file":"all_uti_features.csv","column":"procedure 180 - had parenteral nutrition","until":"0.0","from":"180","description":"Prior parenteral nutrition","_deepnote_index_column":710},{"file":"all_uti_features.csv","column":"custom 7 - nursing home","until":"0.0","from":"7","description":"Prior visit to skilled nursing facility","_deepnote_index_column":711},{"file":"all_uti_features.csv","column":"custom 14 - nursing home","until":"0.0","from":"14","description":"Prior visit to skilled nursing facility","_deepnote_index_column":712},{"file":"all_uti_features.csv","column":"custom 30 - nursing home","until":"0.0","from":"30","description":"Prior visit to skilled nursing facility","_deepnote_index_column":713},{"file":"all_uti_features.csv","column":"custom 90 - nursing home","until":"0.0","from":"90","description":"Prior visit to skilled nursing facility","_deepnote_index_column":714},{"file":"all_uti_features.csv","column":"infection_sites - RESPIRATORY_TRACT","until":"nan","from":"nan","description":"Other infection sites","_deepnote_index_column":715},{"file":"all_uti_features.csv","column":"infection_sites - BLOOD","until":"nan","from":"nan","description":"Other infection sites","_deepnote_index_column":716},{"file":"all_uti_features.csv","column":"infection_sites - SKIN_SOFTTISSUE","until":"nan","from":"nan","description":"Other infection sites","_deepnote_index_column":717},{"file":"all_uti_features.csv","column":"infection_sites - ABSCESS_OR_FLUID_NOS","until":"nan","from":"nan","description":"Other infection sites","_deepnote_index_column":718},{"file":"all_uti_features.csv","column":"infection_sites - MUCOCUTANEOUS","until":"nan","from":"nan","description":"Other infection sites","_deepnote_index_column":719},{"file":"all_uti_features.csv","column":"infection_sites - GENITOURINARY","until":"nan","from":"nan","description":"Other infection sites","_deepnote_index_column":720},{"file":"all_uti_features.csv","column":"hosp ward - ER","until":"nan","from":"nan","description":"Specimen collected in Emergency Room","_deepnote_index_column":721},{"file":"all_uti_features.csv","column":"hosp ward - ICU","until":"nan","from":"nan","description":"Specimen collected in Intensive Care Unit","_deepnote_index_column":722},{"file":"all_uti_features.csv","column":"hosp ward - IP","until":"nan","from":"nan","description":"Specimen collected in inpatient setting","_deepnote_index_column":723},{"file":"all_uti_features.csv","column":"hosp ward - OP","until":"nan","from":"nan","description":"Specimen collected in outpatient setting","_deepnote_index_column":724},{"file":"all_uti_features.csv","column":"selected micro - colonization pressure AMC 90 - granular level","until":"7.0","from":"90","description":"Resistance rate at same floor/ward/clinic","_deepnote_index_column":725},{"file":"all_uti_features.csv","column":"selected micro - colonization pressure AMP 90 - granular level","until":"7.0","from":"90","description":"Resistance rate at same floor/ward/clinic","_deepnote_index_column":726},{"file":"all_uti_features.csv","column":"selected micro - colonization pressure ATM 90 - granular level","until":"7.0","from":"90","description":"Resistance rate at same floor/ward/clinic","_deepnote_index_column":727},{"file":"all_uti_features.csv","column":"selected micro - colonization pressure CAZ 90 - granular level","until":"7.0","from":"90","description":"Resistance rate at same floor/ward/clinic","_deepnote_index_column":728},{"file":"all_uti_features.csv","column":"selected micro - colonization pressure CIP 90 - granular level","until":"7.0","from":"90","description":"Resistance rate at same floor/ward/clinic","_deepnote_index_column":729},{"file":"all_uti_features.csv","column":"selected micro - colonization pressure CLI 90 - granular level","until":"7.0","from":"90","description":"Resistance rate at same floor/ward/clinic","_deepnote_index_column":730},{"file":"all_uti_features.csv","column":"selected micro - colonization pressure CRO 90 - granular level","until":"7.0","from":"90","description":"Resistance rate at same floor/ward/clinic","_deepnote_index_column":731},{"file":"all_uti_features.csv","column":"selected micro - colonization pressure DOX 90 - granular level","until":"7.0","from":"90","description":"Resistance rate at same floor/ward/clinic","_deepnote_index_column":732},{"file":"all_uti_features.csv","column":"selected micro - colonization pressure ERY 90 - granular level","until":"7.0","from":"90","description":"Resistance rate at same floor/ward/clinic","_deepnote_index_column":733},{"file":"all_uti_features.csv","column":"selected micro - colonization pressure FEP 90 - granular level","until":"7.0","from":"90","description":"Resistance rate at same floor/ward/clinic","_deepnote_index_column":734},{"file":"all_uti_features.csv","column":"selected micro - colonization pressure FOX 90 - granular level","until":"7.0","from":"90","description":"Resistance rate at same floor/ward/clinic","_deepnote_index_column":735},{"file":"all_uti_features.csv","column":"selected micro - colonization pressure GEN 90 - granular level","until":"7.0","from":"90","description":"Resistance rate at same floor/ward/clinic","_deepnote_index_column":736},{"file":"all_uti_features.csv","column":"selected micro - colonization pressure IPM 90 - granular level","until":"7.0","from":"90","description":"Resistance rate at same floor/ward/clinic","_deepnote_index_column":737},{"file":"all_uti_features.csv","column":"selected micro - colonization pressure LVX 90 - granular level","until":"7.0","from":"90","description":"Resistance rate at same floor/ward/clinic","_deepnote_index_column":738},{"file":"all_uti_features.csv","column":"selected micro - colonization pressure MEM 90 - granular level","until":"7.0","from":"90","description":"Resistance rate at same floor/ward/clinic","_deepnote_index_column":739},{"file":"all_uti_features.csv","column":"selected micro - colonization pressure MXF 90 - granular level","until":"7.0","from":"90","description":"Resistance rate at same floor/ward/clinic","_deepnote_index_column":740},{"file":"all_uti_features.csv","column":"selected micro - colonization pressure NIT 90 - granular level","until":"7.0","from":"90","description":"Resistance rate at same floor/ward/clinic","_deepnote_index_column":741},{"file":"all_uti_features.csv","column":"selected micro - colonization pressure OXA 90 - granular level","until":"7.0","from":"90","description":"Resistance rate at same floor/ward/clinic","_deepnote_index_column":742},{"file":"all_uti_features.csv","column":"selected micro - colonization pressure PEN 90 - granular level","until":"7.0","from":"90","description":"Resistance rate at same floor/ward/clinic","_deepnote_index_column":743},{"file":"all_uti_features.csv","column":"selected micro - colonization pressure SAM 90 - granular level","until":"7.0","from":"90","description":"Resistance rate at same floor/ward/clinic","_deepnote_index_column":744},{"file":"all_uti_features.csv","column":"selected micro - colonization pressure SXT 90 - granular level","until":"7.0","from":"90","description":"Resistance rate at same floor/ward/clinic","_deepnote_index_column":745},{"file":"all_uti_features.csv","column":"selected micro - colonization pressure TET 90 - granular level","until":"7.0","from":"90","description":"Resistance rate at same floor/ward/clinic","_deepnote_index_column":746},{"file":"all_uti_features.csv","column":"selected micro - colonization pressure TZP 90 - granular level","until":"7.0","from":"90","description":"Resistance rate at same floor/ward/clinic","_deepnote_index_column":747},{"file":"all_uti_features.csv","column":"selected micro - colonization pressure VAN 90 - granular level","until":"7.0","from":"90","description":"Resistance rate at same floor/ward/clinic","_deepnote_index_column":748},{"file":"all_uti_features.csv","column":"selected micro - colonization pressure AMC 90 - higher level","until":"7.0","from":"90","description":"Resistance rate at same hospital / department type","_deepnote_index_column":749},{"file":"all_uti_features.csv","column":"selected micro - colonization pressure AMP 90 - higher level","until":"7.0","from":"90","description":"Resistance rate at same hospital / department type","_deepnote_index_column":750},{"file":"all_uti_features.csv","column":"selected micro - colonization pressure ATM 90 - higher level","until":"7.0","from":"90","description":"Resistance rate at same hospital / department type","_deepnote_index_column":751},{"file":"all_uti_features.csv","column":"selected micro - colonization pressure CAZ 90 - higher level","until":"7.0","from":"90","description":"Resistance rate at same hospital / department type","_deepnote_index_column":752},{"file":"all_uti_features.csv","column":"selected micro - colonization pressure CIP 90 - higher level","until":"7.0","from":"90","description":"Resistance rate at same hospital / department type","_deepnote_index_column":753},{"file":"all_uti_features.csv","column":"selected micro - colonization pressure CLI 90 - higher level","until":"7.0","from":"90","description":"Resistance rate at same hospital / department type","_deepnote_index_column":754},{"file":"all_uti_features.csv","column":"selected micro - colonization pressure CRO 90 - higher level","until":"7.0","from":"90","description":"Resistance rate at same hospital / department type","_deepnote_index_column":755},{"file":"all_uti_features.csv","column":"selected micro - colonization pressure DOX 90 - higher level","until":"7.0","from":"90","description":"Resistance rate at same hospital / department type","_deepnote_index_column":756},{"file":"all_uti_features.csv","column":"selected micro - colonization pressure ERY 90 - higher level","until":"7.0","from":"90","description":"Resistance rate at same hospital / department type","_deepnote_index_column":757},{"file":"all_uti_features.csv","column":"selected micro - colonization pressure FEP 90 - higher level","until":"7.0","from":"90","description":"Resistance rate at same hospital / department type","_deepnote_index_column":758},{"file":"all_uti_features.csv","column":"selected micro - colonization pressure FOX 90 - higher level","until":"7.0","from":"90","description":"Resistance rate at same hospital / department type","_deepnote_index_column":759},{"file":"all_uti_features.csv","column":"selected micro - colonization pressure GEN 90 - higher level","until":"7.0","from":"90","description":"Resistance rate at same hospital / department type","_deepnote_index_column":760},{"file":"all_uti_features.csv","column":"selected micro - colonization pressure IPM 90 - higher level","until":"7.0","from":"90","description":"Resistance rate at same hospital / department type","_deepnote_index_column":761},{"file":"all_uti_features.csv","column":"selected micro - colonization pressure LVX 90 - higher level","until":"7.0","from":"90","description":"Resistance rate at same hospital / department type","_deepnote_index_column":762},{"file":"all_uti_features.csv","column":"selected micro - colonization pressure MEM 90 - higher level","until":"7.0","from":"90","description":"Resistance rate at same hospital / department type","_deepnote_index_column":763},{"file":"all_uti_features.csv","column":"selected micro - colonization pressure MIN 90 - higher level","until":"7.0","from":"90","description":"Resistance rate at same hospital / department type","_deepnote_index_column":764},{"file":"all_uti_features.csv","column":"selected micro - colonization pressure MXF 90 - higher level","until":"7.0","from":"90","description":"Resistance rate at same hospital / department type","_deepnote_index_column":765},{"file":"all_uti_features.csv","column":"selected micro - colonization pressure NIT 90 - higher level","until":"7.0","from":"90","description":"Resistance rate at same hospital / department type","_deepnote_index_column":766},{"file":"all_uti_features.csv","column":"selected micro - colonization pressure OXA 90 - higher level","until":"7.0","from":"90","description":"Resistance rate at same hospital / department type","_deepnote_index_column":767},{"file":"all_uti_features.csv","column":"selected micro - colonization pressure PEN 90 - higher level","until":"7.0","from":"90","description":"Resistance rate at same hospital / department type","_deepnote_index_column":768},{"file":"all_uti_features.csv","column":"selected micro - colonization pressure SAM 90 - higher level","until":"7.0","from":"90","description":"Resistance rate at same hospital / department type","_deepnote_index_column":769},{"file":"all_uti_features.csv","column":"selected micro - colonization pressure SXT 90 - higher level","until":"7.0","from":"90","description":"Resistance rate at same hospital / department type","_deepnote_index_column":770},{"file":"all_uti_features.csv","column":"selected micro - colonization pressure TET 90 - higher level","until":"7.0","from":"90","description":"Resistance rate at same hospital / department type","_deepnote_index_column":771},{"file":"all_uti_features.csv","column":"selected micro - colonization pressure TZP 90 - higher level","until":"7.0","from":"90","description":"Resistance rate at same hospital / department type","_deepnote_index_column":772},{"file":"all_uti_features.csv","column":"selected micro - colonization pressure VAN 90 - higher level","until":"7.0","from":"90","description":"Resistance rate at same hospital / department type","_deepnote_index_column":773},{"file":"all_uti_features.csv","column":"selected micro - colonization pressure AMC 90 - overall","until":"7.0","from":"90","description":"Resistance rate across all specimens","_deepnote_index_column":774},{"file":"all_uti_features.csv","column":"selected micro - colonization pressure AMP 90 - overall","until":"7.0","from":"90","description":"Resistance rate across all specimens","_deepnote_index_column":775},{"file":"all_uti_features.csv","column":"selected micro - colonization pressure ATM 90 - overall","until":"7.0","from":"90","description":"Resistance rate across all specimens","_deepnote_index_column":776},{"file":"all_uti_features.csv","column":"selected micro - colonization pressure CAZ 90 - overall","until":"7.0","from":"90","description":"Resistance rate across all specimens","_deepnote_index_column":777},{"file":"all_uti_features.csv","column":"selected micro - colonization pressure CIP 90 - overall","until":"7.0","from":"90","description":"Resistance rate across all specimens","_deepnote_index_column":778},{"file":"all_uti_features.csv","column":"selected micro - colonization pressure CLI 90 - overall","until":"7.0","from":"90","description":"Resistance rate across all specimens","_deepnote_index_column":779},{"file":"all_uti_features.csv","column":"selected micro - colonization pressure CRO 90 - overall","until":"7.0","from":"90","description":"Resistance rate across all specimens","_deepnote_index_column":780},{"file":"all_uti_features.csv","column":"selected micro - colonization pressure DOX 90 - overall","until":"7.0","from":"90","description":"Resistance rate across all specimens","_deepnote_index_column":781},{"file":"all_uti_features.csv","column":"selected micro - colonization pressure ERY 90 - overall","until":"7.0","from":"90","description":"Resistance rate across all specimens","_deepnote_index_column":782},{"file":"all_uti_features.csv","column":"selected micro - colonization pressure FEP 90 - overall","until":"7.0","from":"90","description":"Resistance rate across all specimens","_deepnote_index_column":783},{"file":"all_uti_features.csv","column":"selected micro - colonization pressure FOX 90 - overall","until":"7.0","from":"90","description":"Resistance rate across all specimens","_deepnote_index_column":784},{"file":"all_uti_features.csv","column":"selected micro - colonization pressure GEN 90 - overall","until":"7.0","from":"90","description":"Resistance rate across all specimens","_deepnote_index_column":785},{"file":"all_uti_features.csv","column":"selected micro - colonization pressure IPM 90 - overall","until":"7.0","from":"90","description":"Resistance rate across all specimens","_deepnote_index_column":786},{"file":"all_uti_features.csv","column":"selected micro - colonization pressure LVX 90 - overall","until":"7.0","from":"90","description":"Resistance rate across all specimens","_deepnote_index_column":787},{"file":"all_uti_features.csv","column":"selected micro - colonization pressure MEM 90 - overall","until":"7.0","from":"90","description":"Resistance rate across all specimens","_deepnote_index_column":788},{"file":"all_uti_features.csv","column":"selected micro - colonization pressure MIN 90 - overall","until":"7.0","from":"90","description":"Resistance rate across all specimens","_deepnote_index_column":789},{"file":"all_uti_features.csv","column":"selected micro - colonization pressure MXF 90 - overall","until":"7.0","from":"90","description":"Resistance rate across all specimens","_deepnote_index_column":790},{"file":"all_uti_features.csv","column":"selected micro - colonization pressure NIT 90 - overall","until":"7.0","from":"90","description":"Resistance rate across all specimens","_deepnote_index_column":791},{"file":"all_uti_features.csv","column":"selected micro - colonization pressure OXA 90 - overall","until":"7.0","from":"90","description":"Resistance rate across all specimens","_deepnote_index_column":792},{"file":"all_uti_features.csv","column":"selected micro - colonization pressure PEN 90 - overall","until":"7.0","from":"90","description":"Resistance rate across all specimens","_deepnote_index_column":793},{"file":"all_uti_features.csv","column":"selected micro - colonization pressure SAM 90 - overall","until":"7.0","from":"90","description":"Resistance rate across all specimens","_deepnote_index_column":794},{"file":"all_uti_features.csv","column":"selected micro - colonization pressure SXT 90 - overall","until":"7.0","from":"90","description":"Resistance rate across all specimens","_deepnote_index_column":795},{"file":"all_uti_features.csv","column":"selected micro - colonization pressure TET 90 - overall","until":"7.0","from":"90","description":"Resistance rate across all specimens","_deepnote_index_column":796},{"file":"all_uti_features.csv","column":"selected micro - colonization pressure TZP 90 - overall","until":"7.0","from":"90","description":"Resistance rate across all specimens","_deepnote_index_column":797},{"file":"all_uti_features.csv","column":"selected micro - colonization pressure VAN 90 - overall","until":"7.0","from":"90","description":"Resistance rate across all specimens","_deepnote_index_column":798},{"file":"all_uti_features.csv","column":"is_train","until":"nan","from":"nan","description":"Used to denote membership in training set (2007-13)","_deepnote_index_column":799},{"file":"all_uti_features.csv","column":"uncomplicated","until":"nan","from":"nan","description":"Used to denote membership in uncomplicated UTI cohort","_deepnote_index_column":800}]},"text/plain":"                          file  \\\n0    all_uti_resist_labels.csv   \n1    all_uti_resist_labels.csv   \n2    all_uti_resist_labels.csv   \n3    all_uti_resist_labels.csv   \n4    all_uti_resist_labels.csv   \n5    all_uti_resist_labels.csv   \n6    all_uti_resist_labels.csv   \n7        all_prescriptions.csv   \n8        all_prescriptions.csv   \n9        all_prescriptions.csv   \n10        all_uti_features.csv   \n11        all_uti_features.csv   \n12        all_uti_features.csv   \n13        all_uti_features.csv   \n14        all_uti_features.csv   \n15        all_uti_features.csv   \n16        all_uti_features.csv   \n17        all_uti_features.csv   \n18        all_uti_features.csv   \n19        all_uti_features.csv   \n20        all_uti_features.csv   \n21        all_uti_features.csv   \n22        all_uti_features.csv   \n23        all_uti_features.csv   \n24        all_uti_features.csv   \n25        all_uti_features.csv   \n26        all_uti_features.csv   \n27        all_uti_features.csv   \n28        all_uti_features.csv   \n29        all_uti_features.csv   \n30        all_uti_features.csv   \n31        all_uti_features.csv   \n32        all_uti_features.csv   \n33        all_uti_features.csv   \n34        all_uti_features.csv   \n35        all_uti_features.csv   \n36        all_uti_features.csv   \n37        all_uti_features.csv   \n38        all_uti_features.csv   \n39        all_uti_features.csv   \n40        all_uti_features.csv   \n41        all_uti_features.csv   \n42        all_uti_features.csv   \n43        all_uti_features.csv   \n44        all_uti_features.csv   \n45        all_uti_features.csv   \n46        all_uti_features.csv   \n47        all_uti_features.csv   \n48        all_uti_features.csv   \n49        all_uti_features.csv   \n50        all_uti_features.csv   \n51        all_uti_features.csv   \n52        all_uti_features.csv   \n53        all_uti_features.csv   \n54        all_uti_features.csv   \n55        all_uti_features.csv   \n56        all_uti_features.csv   \n57        all_uti_features.csv   \n58        all_uti_features.csv   \n59        all_uti_features.csv   \n60        all_uti_features.csv   \n61        all_uti_features.csv   \n62        all_uti_features.csv   \n63        all_uti_features.csv   \n64        all_uti_features.csv   \n65        all_uti_features.csv   \n66        all_uti_features.csv   \n67        all_uti_features.csv   \n68        all_uti_features.csv   \n69        all_uti_features.csv   \n70        all_uti_features.csv   \n71        all_uti_features.csv   \n72        all_uti_features.csv   \n73        all_uti_features.csv   \n74        all_uti_features.csv   \n75        all_uti_features.csv   \n76        all_uti_features.csv   \n77        all_uti_features.csv   \n78        all_uti_features.csv   \n79        all_uti_features.csv   \n80        all_uti_features.csv   \n81        all_uti_features.csv   \n82        all_uti_features.csv   \n83        all_uti_features.csv   \n84        all_uti_features.csv   \n85        all_uti_features.csv   \n86        all_uti_features.csv   \n87        all_uti_features.csv   \n88        all_uti_features.csv   \n89        all_uti_features.csv   \n90        all_uti_features.csv   \n91        all_uti_features.csv   \n92        all_uti_features.csv   \n93        all_uti_features.csv   \n94        all_uti_features.csv   \n95        all_uti_features.csv   \n96        all_uti_features.csv   \n97        all_uti_features.csv   \n98        all_uti_features.csv   \n99        all_uti_features.csv   \n100       all_uti_features.csv   \n101       all_uti_features.csv   \n102       all_uti_features.csv   \n103       all_uti_features.csv   \n104       all_uti_features.csv   \n105       all_uti_features.csv   \n106       all_uti_features.csv   \n107       all_uti_features.csv   \n108       all_uti_features.csv   \n109       all_uti_features.csv   \n110       all_uti_features.csv   \n111       all_uti_features.csv   \n112       all_uti_features.csv   \n113       all_uti_features.csv   \n114       all_uti_features.csv   \n115       all_uti_features.csv   \n116       all_uti_features.csv   \n117       all_uti_features.csv   \n118       all_uti_features.csv   \n119       all_uti_features.csv   \n120       all_uti_features.csv   \n121       all_uti_features.csv   \n122       all_uti_features.csv   \n123       all_uti_features.csv   \n124       all_uti_features.csv   \n125       all_uti_features.csv   \n126       all_uti_features.csv   \n127       all_uti_features.csv   \n128       all_uti_features.csv   \n129       all_uti_features.csv   \n130       all_uti_features.csv   \n131       all_uti_features.csv   \n132       all_uti_features.csv   \n133       all_uti_features.csv   \n134       all_uti_features.csv   \n135       all_uti_features.csv   \n136       all_uti_features.csv   \n137       all_uti_features.csv   \n138       all_uti_features.csv   \n139       all_uti_features.csv   \n140       all_uti_features.csv   \n141       all_uti_features.csv   \n142       all_uti_features.csv   \n143       all_uti_features.csv   \n144       all_uti_features.csv   \n145       all_uti_features.csv   \n146       all_uti_features.csv   \n147       all_uti_features.csv   \n148       all_uti_features.csv   \n149       all_uti_features.csv   \n150       all_uti_features.csv   \n151       all_uti_features.csv   \n152       all_uti_features.csv   \n153       all_uti_features.csv   \n154       all_uti_features.csv   \n155       all_uti_features.csv   \n156       all_uti_features.csv   \n157       all_uti_features.csv   \n158       all_uti_features.csv   \n159       all_uti_features.csv   \n160       all_uti_features.csv   \n161       all_uti_features.csv   \n162       all_uti_features.csv   \n163       all_uti_features.csv   \n164       all_uti_features.csv   \n165       all_uti_features.csv   \n166       all_uti_features.csv   \n167       all_uti_features.csv   \n168       all_uti_features.csv   \n169       all_uti_features.csv   \n170       all_uti_features.csv   \n171       all_uti_features.csv   \n172       all_uti_features.csv   \n173       all_uti_features.csv   \n174       all_uti_features.csv   \n175       all_uti_features.csv   \n176       all_uti_features.csv   \n177       all_uti_features.csv   \n178       all_uti_features.csv   \n179       all_uti_features.csv   \n180       all_uti_features.csv   \n181       all_uti_features.csv   \n182       all_uti_features.csv   \n183       all_uti_features.csv   \n184       all_uti_features.csv   \n185       all_uti_features.csv   \n186       all_uti_features.csv   \n187       all_uti_features.csv   \n188       all_uti_features.csv   \n189       all_uti_features.csv   \n190       all_uti_features.csv   \n191       all_uti_features.csv   \n192       all_uti_features.csv   \n193       all_uti_features.csv   \n194       all_uti_features.csv   \n195       all_uti_features.csv   \n196       all_uti_features.csv   \n197       all_uti_features.csv   \n198       all_uti_features.csv   \n199       all_uti_features.csv   \n200       all_uti_features.csv   \n201       all_uti_features.csv   \n202       all_uti_features.csv   \n203       all_uti_features.csv   \n204       all_uti_features.csv   \n205       all_uti_features.csv   \n206       all_uti_features.csv   \n207       all_uti_features.csv   \n208       all_uti_features.csv   \n209       all_uti_features.csv   \n210       all_uti_features.csv   \n211       all_uti_features.csv   \n212       all_uti_features.csv   \n213       all_uti_features.csv   \n214       all_uti_features.csv   \n215       all_uti_features.csv   \n216       all_uti_features.csv   \n217       all_uti_features.csv   \n218       all_uti_features.csv   \n219       all_uti_features.csv   \n220       all_uti_features.csv   \n221       all_uti_features.csv   \n222       all_uti_features.csv   \n223       all_uti_features.csv   \n224       all_uti_features.csv   \n225       all_uti_features.csv   \n226       all_uti_features.csv   \n227       all_uti_features.csv   \n228       all_uti_features.csv   \n229       all_uti_features.csv   \n230       all_uti_features.csv   \n231       all_uti_features.csv   \n232       all_uti_features.csv   \n233       all_uti_features.csv   \n234       all_uti_features.csv   \n235       all_uti_features.csv   \n236       all_uti_features.csv   \n237       all_uti_features.csv   \n238       all_uti_features.csv   \n239       all_uti_features.csv   \n240       all_uti_features.csv   \n241       all_uti_features.csv   \n242       all_uti_features.csv   \n243       all_uti_features.csv   \n244       all_uti_features.csv   \n245       all_uti_features.csv   \n246       all_uti_features.csv   \n247       all_uti_features.csv   \n248       all_uti_features.csv   \n249       all_uti_features.csv   \n250       all_uti_features.csv   \n251       all_uti_features.csv   \n252       all_uti_features.csv   \n253       all_uti_features.csv   \n254       all_uti_features.csv   \n255       all_uti_features.csv   \n256       all_uti_features.csv   \n257       all_uti_features.csv   \n258       all_uti_features.csv   \n259       all_uti_features.csv   \n260       all_uti_features.csv   \n261       all_uti_features.csv   \n262       all_uti_features.csv   \n263       all_uti_features.csv   \n264       all_uti_features.csv   \n265       all_uti_features.csv   \n266       all_uti_features.csv   \n267       all_uti_features.csv   \n268       all_uti_features.csv   \n269       all_uti_features.csv   \n270       all_uti_features.csv   \n271       all_uti_features.csv   \n272       all_uti_features.csv   \n273       all_uti_features.csv   \n274       all_uti_features.csv   \n275       all_uti_features.csv   \n276       all_uti_features.csv   \n277       all_uti_features.csv   \n278       all_uti_features.csv   \n279       all_uti_features.csv   \n280       all_uti_features.csv   \n281       all_uti_features.csv   \n282       all_uti_features.csv   \n283       all_uti_features.csv   \n284       all_uti_features.csv   \n285       all_uti_features.csv   \n286       all_uti_features.csv   \n287       all_uti_features.csv   \n288       all_uti_features.csv   \n289       all_uti_features.csv   \n290       all_uti_features.csv   \n291       all_uti_features.csv   \n292       all_uti_features.csv   \n293       all_uti_features.csv   \n294       all_uti_features.csv   \n295       all_uti_features.csv   \n296       all_uti_features.csv   \n297       all_uti_features.csv   \n298       all_uti_features.csv   \n299       all_uti_features.csv   \n300       all_uti_features.csv   \n301       all_uti_features.csv   \n302       all_uti_features.csv   \n303       all_uti_features.csv   \n304       all_uti_features.csv   \n305       all_uti_features.csv   \n306       all_uti_features.csv   \n307       all_uti_features.csv   \n308       all_uti_features.csv   \n309       all_uti_features.csv   \n310       all_uti_features.csv   \n311       all_uti_features.csv   \n312       all_uti_features.csv   \n313       all_uti_features.csv   \n314       all_uti_features.csv   \n315       all_uti_features.csv   \n316       all_uti_features.csv   \n317       all_uti_features.csv   \n318       all_uti_features.csv   \n319       all_uti_features.csv   \n320       all_uti_features.csv   \n321       all_uti_features.csv   \n322       all_uti_features.csv   \n323       all_uti_features.csv   \n324       all_uti_features.csv   \n325       all_uti_features.csv   \n326       all_uti_features.csv   \n327       all_uti_features.csv   \n328       all_uti_features.csv   \n329       all_uti_features.csv   \n330       all_uti_features.csv   \n331       all_uti_features.csv   \n332       all_uti_features.csv   \n333       all_uti_features.csv   \n334       all_uti_features.csv   \n335       all_uti_features.csv   \n336       all_uti_features.csv   \n337       all_uti_features.csv   \n338       all_uti_features.csv   \n339       all_uti_features.csv   \n340       all_uti_features.csv   \n341       all_uti_features.csv   \n342       all_uti_features.csv   \n343       all_uti_features.csv   \n344       all_uti_features.csv   \n345       all_uti_features.csv   \n346       all_uti_features.csv   \n347       all_uti_features.csv   \n348       all_uti_features.csv   \n349       all_uti_features.csv   \n350       all_uti_features.csv   \n351       all_uti_features.csv   \n352       all_uti_features.csv   \n353       all_uti_features.csv   \n354       all_uti_features.csv   \n355       all_uti_features.csv   \n356       all_uti_features.csv   \n357       all_uti_features.csv   \n358       all_uti_features.csv   \n359       all_uti_features.csv   \n360       all_uti_features.csv   \n361       all_uti_features.csv   \n362       all_uti_features.csv   \n363       all_uti_features.csv   \n364       all_uti_features.csv   \n365       all_uti_features.csv   \n366       all_uti_features.csv   \n367       all_uti_features.csv   \n368       all_uti_features.csv   \n369       all_uti_features.csv   \n370       all_uti_features.csv   \n371       all_uti_features.csv   \n372       all_uti_features.csv   \n373       all_uti_features.csv   \n374       all_uti_features.csv   \n375       all_uti_features.csv   \n376       all_uti_features.csv   \n377       all_uti_features.csv   \n378       all_uti_features.csv   \n379       all_uti_features.csv   \n380       all_uti_features.csv   \n381       all_uti_features.csv   \n382       all_uti_features.csv   \n383       all_uti_features.csv   \n384       all_uti_features.csv   \n385       all_uti_features.csv   \n386       all_uti_features.csv   \n387       all_uti_features.csv   \n388       all_uti_features.csv   \n389       all_uti_features.csv   \n390       all_uti_features.csv   \n391       all_uti_features.csv   \n392       all_uti_features.csv   \n393       all_uti_features.csv   \n394       all_uti_features.csv   \n395       all_uti_features.csv   \n396       all_uti_features.csv   \n397       all_uti_features.csv   \n398       all_uti_features.csv   \n399       all_uti_features.csv   \n400       all_uti_features.csv   \n401       all_uti_features.csv   \n402       all_uti_features.csv   \n403       all_uti_features.csv   \n404       all_uti_features.csv   \n405       all_uti_features.csv   \n406       all_uti_features.csv   \n407       all_uti_features.csv   \n408       all_uti_features.csv   \n409       all_uti_features.csv   \n410       all_uti_features.csv   \n411       all_uti_features.csv   \n412       all_uti_features.csv   \n413       all_uti_features.csv   \n414       all_uti_features.csv   \n415       all_uti_features.csv   \n416       all_uti_features.csv   \n417       all_uti_features.csv   \n418       all_uti_features.csv   \n419       all_uti_features.csv   \n420       all_uti_features.csv   \n421       all_uti_features.csv   \n422       all_uti_features.csv   \n423       all_uti_features.csv   \n424       all_uti_features.csv   \n425       all_uti_features.csv   \n426       all_uti_features.csv   \n427       all_uti_features.csv   \n428       all_uti_features.csv   \n429       all_uti_features.csv   \n430       all_uti_features.csv   \n431       all_uti_features.csv   \n432       all_uti_features.csv   \n433       all_uti_features.csv   \n434       all_uti_features.csv   \n435       all_uti_features.csv   \n436       all_uti_features.csv   \n437       all_uti_features.csv   \n438       all_uti_features.csv   \n439       all_uti_features.csv   \n440       all_uti_features.csv   \n441       all_uti_features.csv   \n442       all_uti_features.csv   \n443       all_uti_features.csv   \n444       all_uti_features.csv   \n445       all_uti_features.csv   \n446       all_uti_features.csv   \n447       all_uti_features.csv   \n448       all_uti_features.csv   \n449       all_uti_features.csv   \n450       all_uti_features.csv   \n451       all_uti_features.csv   \n452       all_uti_features.csv   \n453       all_uti_features.csv   \n454       all_uti_features.csv   \n455       all_uti_features.csv   \n456       all_uti_features.csv   \n457       all_uti_features.csv   \n458       all_uti_features.csv   \n459       all_uti_features.csv   \n460       all_uti_features.csv   \n461       all_uti_features.csv   \n462       all_uti_features.csv   \n463       all_uti_features.csv   \n464       all_uti_features.csv   \n465       all_uti_features.csv   \n466       all_uti_features.csv   \n467       all_uti_features.csv   \n468       all_uti_features.csv   \n469       all_uti_features.csv   \n470       all_uti_features.csv   \n471       all_uti_features.csv   \n472       all_uti_features.csv   \n473       all_uti_features.csv   \n474       all_uti_features.csv   \n475       all_uti_features.csv   \n476       all_uti_features.csv   \n477       all_uti_features.csv   \n478       all_uti_features.csv   \n479       all_uti_features.csv   \n480       all_uti_features.csv   \n481       all_uti_features.csv   \n482       all_uti_features.csv   \n483       all_uti_features.csv   \n484       all_uti_features.csv   \n485       all_uti_features.csv   \n486       all_uti_features.csv   \n487       all_uti_features.csv   \n488       all_uti_features.csv   \n489       all_uti_features.csv   \n490       all_uti_features.csv   \n491       all_uti_features.csv   \n492       all_uti_features.csv   \n493       all_uti_features.csv   \n494       all_uti_features.csv   \n495       all_uti_features.csv   \n496       all_uti_features.csv   \n497       all_uti_features.csv   \n498       all_uti_features.csv   \n499       all_uti_features.csv   \n500       all_uti_features.csv   \n501       all_uti_features.csv   \n502       all_uti_features.csv   \n503       all_uti_features.csv   \n504       all_uti_features.csv   \n505       all_uti_features.csv   \n506       all_uti_features.csv   \n507       all_uti_features.csv   \n508       all_uti_features.csv   \n509       all_uti_features.csv   \n510       all_uti_features.csv   \n511       all_uti_features.csv   \n512       all_uti_features.csv   \n513       all_uti_features.csv   \n514       all_uti_features.csv   \n515       all_uti_features.csv   \n516       all_uti_features.csv   \n517       all_uti_features.csv   \n518       all_uti_features.csv   \n519       all_uti_features.csv   \n520       all_uti_features.csv   \n521       all_uti_features.csv   \n522       all_uti_features.csv   \n523       all_uti_features.csv   \n524       all_uti_features.csv   \n525       all_uti_features.csv   \n526       all_uti_features.csv   \n527       all_uti_features.csv   \n528       all_uti_features.csv   \n529       all_uti_features.csv   \n530       all_uti_features.csv   \n531       all_uti_features.csv   \n532       all_uti_features.csv   \n533       all_uti_features.csv   \n534       all_uti_features.csv   \n535       all_uti_features.csv   \n536       all_uti_features.csv   \n537       all_uti_features.csv   \n538       all_uti_features.csv   \n539       all_uti_features.csv   \n540       all_uti_features.csv   \n541       all_uti_features.csv   \n542       all_uti_features.csv   \n543       all_uti_features.csv   \n544       all_uti_features.csv   \n545       all_uti_features.csv   \n546       all_uti_features.csv   \n547       all_uti_features.csv   \n548       all_uti_features.csv   \n549       all_uti_features.csv   \n550       all_uti_features.csv   \n551       all_uti_features.csv   \n552       all_uti_features.csv   \n553       all_uti_features.csv   \n554       all_uti_features.csv   \n555       all_uti_features.csv   \n556       all_uti_features.csv   \n557       all_uti_features.csv   \n558       all_uti_features.csv   \n559       all_uti_features.csv   \n560       all_uti_features.csv   \n561       all_uti_features.csv   \n562       all_uti_features.csv   \n563       all_uti_features.csv   \n564       all_uti_features.csv   \n565       all_uti_features.csv   \n566       all_uti_features.csv   \n567       all_uti_features.csv   \n568       all_uti_features.csv   \n569       all_uti_features.csv   \n570       all_uti_features.csv   \n571       all_uti_features.csv   \n572       all_uti_features.csv   \n573       all_uti_features.csv   \n574       all_uti_features.csv   \n575       all_uti_features.csv   \n576       all_uti_features.csv   \n577       all_uti_features.csv   \n578       all_uti_features.csv   \n579       all_uti_features.csv   \n580       all_uti_features.csv   \n581       all_uti_features.csv   \n582       all_uti_features.csv   \n583       all_uti_features.csv   \n584       all_uti_features.csv   \n585       all_uti_features.csv   \n586       all_uti_features.csv   \n587       all_uti_features.csv   \n588       all_uti_features.csv   \n589       all_uti_features.csv   \n590       all_uti_features.csv   \n591       all_uti_features.csv   \n592       all_uti_features.csv   \n593       all_uti_features.csv   \n594       all_uti_features.csv   \n595       all_uti_features.csv   \n596       all_uti_features.csv   \n597       all_uti_features.csv   \n598       all_uti_features.csv   \n599       all_uti_features.csv   \n600       all_uti_features.csv   \n601       all_uti_features.csv   \n602       all_uti_features.csv   \n603       all_uti_features.csv   \n604       all_uti_features.csv   \n605       all_uti_features.csv   \n606       all_uti_features.csv   \n607       all_uti_features.csv   \n608       all_uti_features.csv   \n609       all_uti_features.csv   \n610       all_uti_features.csv   \n611       all_uti_features.csv   \n612       all_uti_features.csv   \n613       all_uti_features.csv   \n614       all_uti_features.csv   \n615       all_uti_features.csv   \n616       all_uti_features.csv   \n617       all_uti_features.csv   \n618       all_uti_features.csv   \n619       all_uti_features.csv   \n620       all_uti_features.csv   \n621       all_uti_features.csv   \n622       all_uti_features.csv   \n623       all_uti_features.csv   \n624       all_uti_features.csv   \n625       all_uti_features.csv   \n626       all_uti_features.csv   \n627       all_uti_features.csv   \n628       all_uti_features.csv   \n629       all_uti_features.csv   \n630       all_uti_features.csv   \n631       all_uti_features.csv   \n632       all_uti_features.csv   \n633       all_uti_features.csv   \n634       all_uti_features.csv   \n635       all_uti_features.csv   \n636       all_uti_features.csv   \n637       all_uti_features.csv   \n638       all_uti_features.csv   \n639       all_uti_features.csv   \n640       all_uti_features.csv   \n641       all_uti_features.csv   \n642       all_uti_features.csv   \n643       all_uti_features.csv   \n644       all_uti_features.csv   \n645       all_uti_features.csv   \n646       all_uti_features.csv   \n647       all_uti_features.csv   \n648       all_uti_features.csv   \n649       all_uti_features.csv   \n650       all_uti_features.csv   \n651       all_uti_features.csv   \n652       all_uti_features.csv   \n653       all_uti_features.csv   \n654       all_uti_features.csv   \n655       all_uti_features.csv   \n656       all_uti_features.csv   \n657       all_uti_features.csv   \n658       all_uti_features.csv   \n659       all_uti_features.csv   \n660       all_uti_features.csv   \n661       all_uti_features.csv   \n662       all_uti_features.csv   \n663       all_uti_features.csv   \n664       all_uti_features.csv   \n665       all_uti_features.csv   \n666       all_uti_features.csv   \n667       all_uti_features.csv   \n668       all_uti_features.csv   \n669       all_uti_features.csv   \n670       all_uti_features.csv   \n671       all_uti_features.csv   \n672       all_uti_features.csv   \n673       all_uti_features.csv   \n674       all_uti_features.csv   \n675       all_uti_features.csv   \n676       all_uti_features.csv   \n677       all_uti_features.csv   \n678       all_uti_features.csv   \n679       all_uti_features.csv   \n680       all_uti_features.csv   \n681       all_uti_features.csv   \n682       all_uti_features.csv   \n683       all_uti_features.csv   \n684       all_uti_features.csv   \n685       all_uti_features.csv   \n686       all_uti_features.csv   \n687       all_uti_features.csv   \n688       all_uti_features.csv   \n689       all_uti_features.csv   \n690       all_uti_features.csv   \n691       all_uti_features.csv   \n692       all_uti_features.csv   \n693       all_uti_features.csv   \n694       all_uti_features.csv   \n695       all_uti_features.csv   \n696       all_uti_features.csv   \n697       all_uti_features.csv   \n698       all_uti_features.csv   \n699       all_uti_features.csv   \n700       all_uti_features.csv   \n701       all_uti_features.csv   \n702       all_uti_features.csv   \n703       all_uti_features.csv   \n704       all_uti_features.csv   \n705       all_uti_features.csv   \n706       all_uti_features.csv   \n707       all_uti_features.csv   \n708       all_uti_features.csv   \n709       all_uti_features.csv   \n710       all_uti_features.csv   \n711       all_uti_features.csv   \n712       all_uti_features.csv   \n713       all_uti_features.csv   \n714       all_uti_features.csv   \n715       all_uti_features.csv   \n716       all_uti_features.csv   \n717       all_uti_features.csv   \n718       all_uti_features.csv   \n719       all_uti_features.csv   \n720       all_uti_features.csv   \n721       all_uti_features.csv   \n722       all_uti_features.csv   \n723       all_uti_features.csv   \n724       all_uti_features.csv   \n725       all_uti_features.csv   \n726       all_uti_features.csv   \n727       all_uti_features.csv   \n728       all_uti_features.csv   \n729       all_uti_features.csv   \n730       all_uti_features.csv   \n731       all_uti_features.csv   \n732       all_uti_features.csv   \n733       all_uti_features.csv   \n734       all_uti_features.csv   \n735       all_uti_features.csv   \n736       all_uti_features.csv   \n737       all_uti_features.csv   \n738       all_uti_features.csv   \n739       all_uti_features.csv   \n740       all_uti_features.csv   \n741       all_uti_features.csv   \n742       all_uti_features.csv   \n743       all_uti_features.csv   \n744       all_uti_features.csv   \n745       all_uti_features.csv   \n746       all_uti_features.csv   \n747       all_uti_features.csv   \n748       all_uti_features.csv   \n749       all_uti_features.csv   \n750       all_uti_features.csv   \n751       all_uti_features.csv   \n752       all_uti_features.csv   \n753       all_uti_features.csv   \n754       all_uti_features.csv   \n755       all_uti_features.csv   \n756       all_uti_features.csv   \n757       all_uti_features.csv   \n758       all_uti_features.csv   \n759       all_uti_features.csv   \n760       all_uti_features.csv   \n761       all_uti_features.csv   \n762       all_uti_features.csv   \n763       all_uti_features.csv   \n764       all_uti_features.csv   \n765       all_uti_features.csv   \n766       all_uti_features.csv   \n767       all_uti_features.csv   \n768       all_uti_features.csv   \n769       all_uti_features.csv   \n770       all_uti_features.csv   \n771       all_uti_features.csv   \n772       all_uti_features.csv   \n773       all_uti_features.csv   \n774       all_uti_features.csv   \n775       all_uti_features.csv   \n776       all_uti_features.csv   \n777       all_uti_features.csv   \n778       all_uti_features.csv   \n779       all_uti_features.csv   \n780       all_uti_features.csv   \n781       all_uti_features.csv   \n782       all_uti_features.csv   \n783       all_uti_features.csv   \n784       all_uti_features.csv   \n785       all_uti_features.csv   \n786       all_uti_features.csv   \n787       all_uti_features.csv   \n788       all_uti_features.csv   \n789       all_uti_features.csv   \n790       all_uti_features.csv   \n791       all_uti_features.csv   \n792       all_uti_features.csv   \n793       all_uti_features.csv   \n794       all_uti_features.csv   \n795       all_uti_features.csv   \n796       all_uti_features.csv   \n797       all_uti_features.csv   \n798       all_uti_features.csv   \n799       all_uti_features.csv   \n800       all_uti_features.csv   \n\n                                                column  until   from  \\\n0                                           example_id    NaN    NaN   \n1                                                  NIT    NaN    NaN   \n2                                                  SXT    NaN    NaN   \n3                                                  CIP    NaN    NaN   \n4                                                  LVX    NaN    NaN   \n5                                             is_train    NaN    NaN   \n6                                        uncomplicated    NaN    NaN   \n7                                           example_id    NaN    NaN   \n8                                         prescription    NaN    NaN   \n9                                             is_train    NaN    NaN   \n10                                          example_id    NaN    NaN   \n11                                  demographics - age    NaN    NaN   \n12                             demographics - is_white    NaN    NaN   \n13                           demographics - is_veteran    NaN    NaN   \n14                      micro - prev resistance LVX 14    7.0   14.0   \n15                      micro - prev resistance AMP 14    7.0   14.0   \n16                      micro - prev resistance CFZ 14    7.0   14.0   \n17                      micro - prev resistance NIT 14    7.0   14.0   \n18                      micro - prev resistance GEN 14    7.0   14.0   \n19                      micro - prev resistance SXT 14    7.0   14.0   \n20                      micro - prev resistance TET 14    7.0   14.0   \n21                      micro - prev resistance AMC 14    7.0   14.0   \n22                      micro - prev resistance CIP 14    7.0   14.0   \n23                      micro - prev resistance SAM 14    7.0   14.0   \n24                      micro - prev resistance ERY 30    7.0   30.0   \n25                      micro - prev resistance OXA 30    7.0   30.0   \n26                      micro - prev resistance QUD 30    7.0   30.0   \n27                      micro - prev resistance RIF 30    7.0   30.0   \n28                      micro - prev resistance AMP 30    7.0   30.0   \n29                      micro - prev resistance CFZ 30    7.0   30.0   \n30                      micro - prev resistance PEN 30    7.0   30.0   \n31                      micro - prev resistance LVX 30    7.0   30.0   \n32                      micro - prev resistance CLI 30    7.0   30.0   \n33                      micro - prev resistance DOX 30    7.0   30.0   \n34                      micro - prev resistance NIT 30    7.0   30.0   \n35                      micro - prev resistance TET 30    7.0   30.0   \n36                      micro - prev resistance CIP 30    7.0   30.0   \n37                      micro - prev resistance CRO 30    7.0   30.0   \n38                      micro - prev resistance GEN 30    7.0   30.0   \n39                      micro - prev resistance SXT 30    7.0   30.0   \n40                      micro - prev resistance AMC 30    7.0   30.0   \n41                      micro - prev resistance ATM 30    7.0   30.0   \n42                      micro - prev resistance PIP 30    7.0   30.0   \n43                      micro - prev resistance TOB 30    7.0   30.0   \n44                      micro - prev resistance TZP 30    7.0   30.0   \n45                      micro - prev resistance SAM 30    7.0   30.0   \n46                     micro - prev resistance STRS 30    7.0   30.0   \n47                      micro - prev resistance MXF 30    7.0   30.0   \n48                      micro - prev resistance FOX 30    7.0   30.0   \n49                      micro - prev resistance AMC 90    7.0   90.0   \n50                      micro - prev resistance AMP 90    7.0   90.0   \n51                      micro - prev resistance ATM 90    7.0   90.0   \n52                      micro - prev resistance CAZ 90    7.0   90.0   \n53                      micro - prev resistance CIP 90    7.0   90.0   \n54                      micro - prev resistance CRO 90    7.0   90.0   \n55                      micro - prev resistance NAL 90    7.0   90.0   \n56                      micro - prev resistance PIP 90    7.0   90.0   \n57                      micro - prev resistance SXT 90    7.0   90.0   \n58                      micro - prev resistance TET 90    7.0   90.0   \n59                      micro - prev resistance CFZ 90    7.0   90.0   \n60                      micro - prev resistance LVX 90    7.0   90.0   \n61                      micro - prev resistance NIT 90    7.0   90.0   \n62                      micro - prev resistance OXA 90    7.0   90.0   \n63                      micro - prev resistance PEN 90    7.0   90.0   \n64                      micro - prev resistance ERY 90    7.0   90.0   \n65                      micro - prev resistance CHL 90    7.0   90.0   \n66                      micro - prev resistance QUD 90    7.0   90.0   \n67                      micro - prev resistance DOX 90    7.0   90.0   \n68                      micro - prev resistance RIF 90    7.0   90.0   \n69                      micro - prev resistance CLI 90    7.0   90.0   \n70                      micro - prev resistance GEN 90    7.0   90.0   \n71                      micro - prev resistance IPM 90    7.0   90.0   \n72                      micro - prev resistance TIC 90    7.0   90.0   \n73                      micro - prev resistance TOB 90    7.0   90.0   \n74                      micro - prev resistance CTT 90    7.0   90.0   \n75                      micro - prev resistance FEP 90    7.0   90.0   \n76                      micro - prev resistance TZP 90    7.0   90.0   \n77                      micro - prev resistance AMK 90    7.0   90.0   \n78                      micro - prev resistance LZD 90    7.0   90.0   \n79                      micro - prev resistance SAM 90    7.0   90.0   \n80                     micro - prev resistance STRS 90    7.0   90.0   \n81                     micro - prev resistance GENS 90    7.0   90.0   \n82                      micro - prev resistance MXF 90    7.0   90.0   \n83                      micro - prev resistance FOX 90    7.0   90.0   \n84                     micro - prev resistance LVX 180    7.0  180.0   \n85                     micro - prev resistance AMP 180    7.0  180.0   \n86                     micro - prev resistance CFZ 180    7.0  180.0   \n87                     micro - prev resistance CIP 180    7.0  180.0   \n88                     micro - prev resistance GEN 180    7.0  180.0   \n89                     micro - prev resistance PIP 180    7.0  180.0   \n90                     micro - prev resistance ATM 180    7.0  180.0   \n91                     micro - prev resistance IPM 180    7.0  180.0   \n92                     micro - prev resistance TIC 180    7.0  180.0   \n93                     micro - prev resistance TOB 180    7.0  180.0   \n94                     micro - prev resistance ERY 180    7.0  180.0   \n95                     micro - prev resistance OXA 180    7.0  180.0   \n96                     micro - prev resistance PEN 180    7.0  180.0   \n97                     micro - prev resistance CLI 180    7.0  180.0   \n98                     micro - prev resistance NAL 180    7.0  180.0   \n99                     micro - prev resistance DOX 180    7.0  180.0   \n100                    micro - prev resistance QUD 180    7.0  180.0   \n101                    micro - prev resistance RIF 180    7.0  180.0   \n102                    micro - prev resistance TET 180    7.0  180.0   \n103                    micro - prev resistance AMC 180    7.0  180.0   \n104                    micro - prev resistance AMK 180    7.0  180.0   \n105                    micro - prev resistance CAZ 180    7.0  180.0   \n106                    micro - prev resistance CHL 180    7.0  180.0   \n107                    micro - prev resistance CRO 180    7.0  180.0   \n108                    micro - prev resistance CTT 180    7.0  180.0   \n109                    micro - prev resistance FEP 180    7.0  180.0   \n110                    micro - prev resistance NIT 180    7.0  180.0   \n111                    micro - prev resistance SXT 180    7.0  180.0   \n112                    micro - prev resistance VAN 180    7.0  180.0   \n113                    micro - prev resistance TZP 180    7.0  180.0   \n114                    micro - prev resistance ERT 180    7.0  180.0   \n115                    micro - prev resistance LZD 180    7.0  180.0   \n116                    micro - prev resistance SAM 180    7.0  180.0   \n117                   micro - prev resistance STRS 180    7.0  180.0   \n118                   micro - prev resistance GENS 180    7.0  180.0   \n119                    micro - prev resistance MXF 180    7.0  180.0   \n120                    micro - prev resistance FOX 180    7.0  180.0   \n121                    micro - prev resistance CFZ ALL    7.0    ALL   \n122                    micro - prev resistance ERY ALL    7.0    ALL   \n123                    micro - prev resistance LVX ALL    7.0    ALL   \n124                    micro - prev resistance OXA ALL    7.0    ALL   \n125                    micro - prev resistance PEN ALL    7.0    ALL   \n126                    micro - prev resistance TET ALL    7.0    ALL   \n127                    micro - prev resistance AMP ALL    7.0    ALL   \n128                    micro - prev resistance CIP ALL    7.0    ALL   \n129                    micro - prev resistance SXT ALL    7.0    ALL   \n130                    micro - prev resistance DOX ALL    7.0    ALL   \n131                    micro - prev resistance RIF ALL    7.0    ALL   \n132                    micro - prev resistance NIT ALL    7.0    ALL   \n133                    micro - prev resistance VAN ALL    7.0    ALL   \n134                    micro - prev resistance QUD ALL    7.0    ALL   \n135                    micro - prev resistance CLI ALL    7.0    ALL   \n136                    micro - prev resistance AMC ALL    7.0    ALL   \n137                    micro - prev resistance ATM ALL    7.0    ALL   \n138                    micro - prev resistance CAZ ALL    7.0    ALL   \n139                    micro - prev resistance CRO ALL    7.0    ALL   \n140                    micro - prev resistance FEP ALL    7.0    ALL   \n141                    micro - prev resistance NAL ALL    7.0    ALL   \n142                    micro - prev resistance PIP ALL    7.0    ALL   \n143                    micro - prev resistance GEN ALL    7.0    ALL   \n144                    micro - prev resistance ERT ALL    7.0    ALL   \n145                    micro - prev resistance CHL ALL    7.0    ALL   \n146                    micro - prev resistance AMK ALL    7.0    ALL   \n147                    micro - prev resistance CTT ALL    7.0    ALL   \n148                    micro - prev resistance IPM ALL    7.0    ALL   \n149                    micro - prev resistance TOB ALL    7.0    ALL   \n150                    micro - prev resistance TIC ALL    7.0    ALL   \n151                    micro - prev resistance TZP ALL    7.0    ALL   \n152                    micro - prev resistance LZD ALL    7.0    ALL   \n153                    micro - prev resistance SAM ALL    7.0    ALL   \n154                   micro - prev resistance GENS ALL    7.0    ALL   \n155                   micro - prev resistance STRS ALL    7.0    ALL   \n156                    micro - prev resistance MXF ALL    7.0    ALL   \n157                    micro - prev resistance FOX ALL    7.0    ALL   \n158                       ab class 7 - fluoroquinolone    2.0      7   \n159                         ab class 7 - glycopeptides    2.0      7   \n160                        ab class 7 - nitroimidazole    2.0      7   \n161                 ab class 7 - macrolide_lincosamide    2.0      7   \n162                            ab class 7 - nitrofuran    2.0      7   \n163                      ab class 7 - folate_inhibitor    2.0      7   \n164                           ab class 7 - beta_lactam    2.0      7   \n165                            ab class 7 - antifungal    2.0      7   \n166                          ab class 7 - tetracycline    2.0      7   \n167                             ab class 7 - ansamycin    2.0      7   \n168                       medication 7 - ciprofloxacin    2.0      7   \n169                        medication 7 - levofloxacin    2.0      7   \n170                          medication 7 - vancomycin    2.0      7   \n171                       medication 7 - metronidazole    2.0      7   \n172                         medication 7 - clindamycin    2.0      7   \n173                        medication 7 - azithromycin    2.0      7   \n174                      medication 7 - nitrofurantoin    2.0      7   \n175       medication 7 - trimethoprim/sulfamethoxazole    2.0      7   \n176                         medication 7 - amoxicillin    2.0      7   \n177                          medication 7 - cephalexin    2.0      7   \n178                         medication 7 - fluconazole    2.0      7   \n179                          medication 7 - penicillin    2.0      7   \n180             medication 7 - amoxicillin/clavulanate    2.0      7   \n181                         medication 7 - ceftazidime    2.0      7   \n182                         medication 7 - doxycycline    2.0      7   \n183                         medication 7 - cefpodoxime    2.0      7   \n184                        medication 7 - tetracycline    2.0      7   \n185                       medication 7 - dicloxacillin    2.0      7   \n186                          medication 7 - cefuroxime    2.0      7   \n187                         medication 7 - minocycline    2.0      7   \n188                            medication 7 - rifampin    2.0      7   \n189                      medication 7 - clarithromycin    2.0      7   \n190                           medication 7 - nafcillin    2.0      7   \n191                        medication 7 - erythromycin    2.0      7   \n192                          medication 7 - cefadroxil    2.0      7   \n193                         ab subtype 7 - penicillins    2.0      7   \n194                  ab subtype 7 - cephalosporin_gen1    2.0      7   \n195                               ab subtype 7 - azole    2.0      7   \n196                   ab subtype 7 - beta_lactam_combo    2.0      7   \n197                  ab subtype 7 - cephalosporin_gen3    2.0      7   \n198                  ab subtype 7 - antistaphylococcal    2.0      7   \n199                  ab subtype 7 - cephalosporin_gen2    2.0      7   \n200                         ab class 14 - tetracycline    2.0     14   \n201                      ab class 14 - fluoroquinolone    2.0     14   \n202                           ab class 14 - nitrofuran    2.0     14   \n203                        ab class 14 - glycopeptides    2.0     14   \n204                       ab class 14 - nitroimidazole    2.0     14   \n205                ab class 14 - macrolide_lincosamide    2.0     14   \n206                     ab class 14 - folate_inhibitor    2.0     14   \n207                          ab class 14 - beta_lactam    2.0     14   \n208                           ab class 14 - antifungal    2.0     14   \n209                           ab class 14 - fosfomycin    2.0     14   \n210                            ab class 14 - ansamycin    2.0     14   \n211                       medication 14 - tetracycline    2.0     14   \n212                      medication 14 - ciprofloxacin    2.0     14   \n213                     medication 14 - nitrofurantoin    2.0     14   \n214                       medication 14 - levofloxacin    2.0     14   \n215                         medication 14 - vancomycin    2.0     14   \n216                      medication 14 - metronidazole    2.0     14   \n217                        medication 14 - clindamycin    2.0     14   \n218                       medication 14 - azithromycin    2.0     14   \n219                        medication 14 - doxycycline    2.0     14   \n220      medication 14 - trimethoprim/sulfamethoxazole    2.0     14   \n221            medication 14 - amoxicillin/clavulanate    2.0     14   \n222                        medication 14 - fluconazole    2.0     14   \n223                        medication 14 - amoxicillin    2.0     14   \n224                         medication 14 - cephalexin    2.0     14   \n225                      medication 14 - dicloxacillin    2.0     14   \n226                         medication 14 - penicillin    2.0     14   \n227                        medication 14 - ceftazidime    2.0     14   \n228                        medication 14 - cefpodoxime    2.0     14   \n229                       medication 14 - erythromycin    2.0     14   \n230                     medication 14 - clarithromycin    2.0     14   \n231                       medication 14 - moxifloxacin    2.0     14   \n232                          medication 14 - nafcillin    2.0     14   \n233                         medication 14 - fosfomycin    2.0     14   \n234                         medication 14 - cefuroxime    2.0     14   \n235                        medication 14 - minocycline    2.0     14   \n236                           medication 14 - rifampin    2.0     14   \n237                         medication 14 - cefadroxil    2.0     14   \n238                  ab subtype 14 - beta_lactam_combo    2.0     14   \n239                              ab subtype 14 - azole    2.0     14   \n240                        ab subtype 14 - penicillins    2.0     14   \n241                 ab subtype 14 - cephalosporin_gen1    2.0     14   \n242                 ab subtype 14 - antistaphylococcal    2.0     14   \n243                 ab subtype 14 - cephalosporin_gen3    2.0     14   \n244                 ab subtype 14 - cephalosporin_gen2    2.0     14   \n245                ab class 30 - macrolide_lincosamide    2.0     30   \n246                         ab class 30 - tetracycline    2.0     30   \n247                      ab class 30 - fluoroquinolone    2.0     30   \n248                           ab class 30 - nitrofuran    2.0     30   \n249                        ab class 30 - glycopeptides    2.0     30   \n250                       ab class 30 - nitroimidazole    2.0     30   \n251                          ab class 30 - beta_lactam    2.0     30   \n252                     ab class 30 - folate_inhibitor    2.0     30   \n253                           ab class 30 - antifungal    2.0     30   \n254                           ab class 30 - monobactam    2.0     30   \n255                       ab class 30 - aminoglycoside    2.0     30   \n256                           ab class 30 - fosfomycin    2.0     30   \n257                            ab class 30 - ansamycin    2.0     30   \n258                       medication 30 - azithromycin    2.0     30   \n259                       medication 30 - tetracycline    2.0     30   \n260                       medication 30 - moxifloxacin    2.0     30   \n261                      medication 30 - ciprofloxacin    2.0     30   \n262                     medication 30 - nitrofurantoin    2.0     30   \n263                       medication 30 - levofloxacin    2.0     30   \n264                         medication 30 - vancomycin    2.0     30   \n265                      medication 30 - metronidazole    2.0     30   \n266                     medication 30 - clarithromycin    2.0     30   \n267                        medication 30 - clindamycin    2.0     30   \n268                        medication 30 - doxycycline    2.0     30   \n269                          medication 30 - cefazolin    2.0     30   \n270      medication 30 - trimethoprim/sulfamethoxazole    2.0     30   \n271            medication 30 - amoxicillin/clavulanate    2.0     30   \n272                        medication 30 - amoxicillin    2.0     30   \n273                        medication 30 - fluconazole    2.0     30   \n274                          medication 30 - aztreonam    2.0     30   \n275                         medication 30 - cephalexin    2.0     30   \n276                      medication 30 - dicloxacillin    2.0     30   \n277                        medication 30 - ceftriaxone    2.0     30   \n278                          medication 30 - cefoxitin    2.0     30   \n279                        medication 30 - cefpodoxime    2.0     30   \n280                         medication 30 - penicillin    2.0     30   \n281                        medication 30 - ceftazidime    2.0     30   \n282               medication 30 - ampicillin/sulbactam    2.0     30   \n283                         medication 30 - fosfomycin    2.0     30   \n284                       medication 30 - erythromycin    2.0     30   \n285                         medication 30 - gentamicin    2.0     30   \n286                          medication 30 - nafcillin    2.0     30   \n287                         medication 30 - cefuroxime    2.0     30   \n288                        medication 30 - minocycline    2.0     30   \n289                           medication 30 - rifampin    2.0     30   \n290                         medication 30 - cefadroxil    2.0     30   \n291                 ab subtype 30 - cephalosporin_gen1    2.0     30   \n292                  ab subtype 30 - beta_lactam_combo    2.0     30   \n293                        ab subtype 30 - penicillins    2.0     30   \n294                              ab subtype 30 - azole    2.0     30   \n295                 ab subtype 30 - antistaphylococcal    2.0     30   \n296                 ab subtype 30 - cephalosporin_gen3    2.0     30   \n297                 ab subtype 30 - cephalosporin_gen2    2.0     30   \n298                ab class 90 - macrolide_lincosamide    2.0     90   \n299                      ab class 90 - fluoroquinolone    2.0     90   \n300                         ab class 90 - tetracycline    2.0     90   \n301                           ab class 90 - nitrofuran    2.0     90   \n302                          ab class 90 - beta_lactam    2.0     90   \n303                        ab class 90 - glycopeptides    2.0     90   \n304                       ab class 90 - nitroimidazole    2.0     90   \n305                     ab class 90 - folate_inhibitor    2.0     90   \n306                           ab class 90 - antifungal    2.0     90   \n307                           ab class 90 - fosfomycin    2.0     90   \n308                           ab class 90 - monobactam    2.0     90   \n309                       ab class 90 - aminoglycoside    2.0     90   \n310                       ab class 90 - oxazolidinones    2.0     90   \n311                                ab class 90 - mixed    2.0     90   \n312                            ab class 90 - ansamycin    2.0     90   \n313                       medication 90 - azithromycin    2.0     90   \n314                      medication 90 - ciprofloxacin    2.0     90   \n315                       medication 90 - tetracycline    2.0     90   \n316                       medication 90 - moxifloxacin    2.0     90   \n317                       medication 90 - levofloxacin    2.0     90   \n318                     medication 90 - nitrofurantoin    2.0     90   \n319            medication 90 - amoxicillin/clavulanate    2.0     90   \n320                         medication 90 - vancomycin    2.0     90   \n321                           medication 90 - cefepime    2.0     90   \n322                      medication 90 - metronidazole    2.0     90   \n323      medication 90 - trimethoprim/sulfamethoxazole    2.0     90   \n324                        medication 90 - clindamycin    2.0     90   \n325                        medication 90 - cefpodoxime    2.0     90   \n326                        medication 90 - fluconazole    2.0     90   \n327                     medication 90 - clarithromycin    2.0     90   \n328                        medication 90 - ceftriaxone    2.0     90   \n329                        medication 90 - doxycycline    2.0     90   \n330                         medication 90 - cephalexin    2.0     90   \n331                          medication 90 - cefazolin    2.0     90   \n332                       medication 90 - trimethoprim    2.0     90   \n333                        medication 90 - amoxicillin    2.0     90   \n334                         medication 90 - fosfomycin    2.0     90   \n335                          medication 90 - aztreonam    2.0     90   \n336                          medication 90 - cefotetan    2.0     90   \n337                         medication 90 - penicillin    2.0     90   \n338                      medication 90 - dicloxacillin    2.0     90   \n339                        medication 90 - ceftazidime    2.0     90   \n340                          medication 90 - linezolid    2.0     90   \n341                         medication 90 - gentamicin    2.0     90   \n342                           medication 90 - cefixime    2.0     90   \n343                         medication 90 - cefuroxime    2.0     90   \n344               medication 90 - ampicillin/sulbactam    2.0     90   \n345                          medication 90 - cefoxitin    2.0     90   \n346                          medication 90 - ertapenem    2.0     90   \n347                       medication 90 - erythromycin    2.0     90   \n348                          medication 90 - cefprozil    2.0     90   \n349                           medication 90 - cefaclor    2.0     90   \n350                         medication 90 - cefadroxil    2.0     90   \n351                          medication 90 - nafcillin    2.0     90   \n352         medication 90 - amoxicillin_clarithromycin    2.0     90   \n353                        medication 90 - minocycline    2.0     90   \n354                           medication 90 - rifampin    2.0     90   \n355                  ab subtype 90 - beta_lactam_combo    2.0     90   \n356                 ab subtype 90 - cephalosporin_gen4    2.0     90   \n357                         ab subtype 90 - carbapenem    2.0     90   \n358                 ab subtype 90 - cephalosporin_gen3    2.0     90   \n359                              ab subtype 90 - azole    2.0     90   \n360                 ab subtype 90 - cephalosporin_gen1    2.0     90   \n361                        ab subtype 90 - penicillins    2.0     90   \n362                 ab subtype 90 - cephalosporin_gen2    2.0     90   \n363                 ab subtype 90 - antistaphylococcal    2.0     90   \n364                    ab class 180 - folate_inhibitor    2.0    180   \n365               ab class 180 - macrolide_lincosamide    2.0    180   \n366                     ab class 180 - fluoroquinolone    2.0    180   \n367                        ab class 180 - tetracycline    2.0    180   \n368                          ab class 180 - nitrofuran    2.0    180   \n369                         ab class 180 - beta_lactam    2.0    180   \n370                          ab class 180 - antifungal    2.0    180   \n371                       ab class 180 - glycopeptides    2.0    180   \n372                      ab class 180 - nitroimidazole    2.0    180   \n373                      ab class 180 - aminoglycoside    2.0    180   \n374                          ab class 180 - fosfomycin    2.0    180   \n375                          ab class 180 - monobactam    2.0    180   \n376                      ab class 180 - oxazolidinones    2.0    180   \n377                           ab class 180 - polymyxin    2.0    180   \n378                           ab class 180 - ansamycin    2.0    180   \n379                               ab class 180 - mixed    2.0    180   \n380     medication 180 - trimethoprim/sulfamethoxazole    2.0    180   \n381                      medication 180 - azithromycin    2.0    180   \n382                     medication 180 - ciprofloxacin    2.0    180   \n383                      medication 180 - tetracycline    2.0    180   \n384                    medication 180 - nitrofurantoin    2.0    180   \n385                      medication 180 - moxifloxacin    2.0    180   \n386                      medication 180 - levofloxacin    2.0    180   \n387           medication 180 - amoxicillin/clavulanate    2.0    180   \n388                       medication 180 - fluconazole    2.0    180   \n389                         medication 180 - meropenem    2.0    180   \n390                        medication 180 - vancomycin    2.0    180   \n391                          medication 180 - cefepime    2.0    180   \n392                        medication 180 - micafungin    2.0    180   \n393                     medication 180 - metronidazole    2.0    180   \n394                       medication 180 - clindamycin    2.0    180   \n395                       medication 180 - doxycycline    2.0    180   \n396                         medication 180 - ofloxacin    2.0    180   \n397                       medication 180 - cefpodoxime    2.0    180   \n398                    medication 180 - clarithromycin    2.0    180   \n399                       medication 180 - ceftriaxone    2.0    180   \n400                          medication 180 - amikacin    2.0    180   \n401                        medication 180 - cephalexin    2.0    180   \n402                         medication 180 - cefazolin    2.0    180   \n403                          medication 180 - cefixime    2.0    180   \n404                      medication 180 - trimethoprim    2.0    180   \n405                       medication 180 - amoxicillin    2.0    180   \n406                        medication 180 - fosfomycin    2.0    180   \n407                         medication 180 - aztreonam    2.0    180   \n408                         medication 180 - cefotetan    2.0    180   \n409                        medication 180 - penicillin    2.0    180   \n410                     medication 180 - dicloxacillin    2.0    180   \n411                       medication 180 - ceftazidime    2.0    180   \n412                         medication 180 - linezolid    2.0    180   \n413                        medication 180 - gentamicin    2.0    180   \n414                        medication 180 - cefuroxime    2.0    180   \n415                          medication 180 - cefaclor    2.0    180   \n416              medication 180 - ampicillin/sulbactam    2.0    180   \n417                         medication 180 - cefoxitin    2.0    180   \n418                         medication 180 - ertapenem    2.0    180   \n419                    medication 180 - amphotericin_b    2.0    180   \n420                      medication 180 - erythromycin    2.0    180   \n421                        medication 180 - cefadroxil    2.0    180   \n422                         medication 180 - cefprozil    2.0    180   \n423                          medication 180 - rifampin    2.0    180   \n424        medication 180 - amoxicillin_clarithromycin    2.0    180   \n425                         medication 180 - nafcillin    2.0    180   \n426                       medication 180 - minocycline    2.0    180   \n427                       medication 180 - polymyxin_b    2.0    180   \n428                 ab subtype 180 - beta_lactam_combo    2.0    180   \n429                             ab subtype 180 - azole    2.0    180   \n430                        ab subtype 180 - carbapenem    2.0    180   \n431                ab subtype 180 - cephalosporin_gen4    2.0    180   \n432                      ab subtype 180 - echinocandin    2.0    180   \n433                ab subtype 180 - cephalosporin_gen3    2.0    180   \n434                ab subtype 180 - cephalosporin_gen1    2.0    180   \n435                       ab subtype 180 - penicillins    2.0    180   \n436                ab subtype 180 - cephalosporin_gen2    2.0    180   \n437                ab subtype 180 - antistaphylococcal    2.0    180   \n438                           ab subtype 180 - polyene    2.0    180   \n439                     ab class ALL - fluoroquinolone    2.0    ALL   \n440                       ab class ALL - glycopeptides    2.0    ALL   \n441               ab class ALL - macrolide_lincosamide    2.0    ALL   \n442                    ab class ALL - folate_inhibitor    2.0    ALL   \n443                          ab class ALL - nitrofuran    2.0    ALL   \n444                        ab class ALL - tetracycline    2.0    ALL   \n445                          ab class ALL - antifungal    2.0    ALL   \n446                         ab class ALL - beta_lactam    2.0    ALL   \n447                      ab class ALL - nitroimidazole    2.0    ALL   \n448                      ab class ALL - aminoglycoside    2.0    ALL   \n449                          ab class ALL - fosfomycin    2.0    ALL   \n450                          ab class ALL - monobactam    2.0    ALL   \n451                           ab class ALL - ansamycin    2.0    ALL   \n452                      ab class ALL - oxazolidinones    2.0    ALL   \n453                           ab class ALL - polymyxin    2.0    ALL   \n454                               ab class ALL - mixed    2.0    ALL   \n455                      medication ALL - levofloxacin    2.0    ALL   \n456                        medication ALL - vancomycin    2.0    ALL   \n457                     medication ALL - ciprofloxacin    2.0    ALL   \n458                      medication ALL - azithromycin    2.0    ALL   \n459     medication ALL - trimethoprim/sulfamethoxazole    2.0    ALL   \n460                    medication ALL - nitrofurantoin    2.0    ALL   \n461                      medication ALL - tetracycline    2.0    ALL   \n462                      medication ALL - moxifloxacin    2.0    ALL   \n463                       medication ALL - fluconazole    2.0    ALL   \n464                       medication ALL - amoxicillin    2.0    ALL   \n465                        medication ALL - cephalexin    2.0    ALL   \n466                       medication ALL - cefpodoxime    2.0    ALL   \n467                       medication ALL - doxycycline    2.0    ALL   \n468                          medication ALL - cefixime    2.0    ALL   \n469                       medication ALL - ceftriaxone    2.0    ALL   \n470           medication ALL - amoxicillin/clavulanate    2.0    ALL   \n471                     medication ALL - dicloxacillin    2.0    ALL   \n472                         medication ALL - meropenem    2.0    ALL   \n473                          medication ALL - cefepime    2.0    ALL   \n474                        medication ALL - micafungin    2.0    ALL   \n475                     medication ALL - metronidazole    2.0    ALL   \n476                       medication ALL - clindamycin    2.0    ALL   \n477                         medication ALL - ofloxacin    2.0    ALL   \n478                        medication ALL - gentamicin    2.0    ALL   \n479                       medication ALL - minocycline    2.0    ALL   \n480                    medication ALL - clarithromycin    2.0    ALL   \n481                          medication ALL - amikacin    2.0    ALL   \n482                         medication ALL - ertapenem    2.0    ALL   \n483                        medication ALL - cefuroxime    2.0    ALL   \n484                         medication ALL - cefazolin    2.0    ALL   \n485                      medication ALL - trimethoprim    2.0    ALL   \n486                        medication ALL - fosfomycin    2.0    ALL   \n487              medication ALL - ampicillin/sulbactam    2.0    ALL   \n488                        medication ALL - penicillin    2.0    ALL   \n489                         medication ALL - aztreonam    2.0    ALL   \n490                         medication ALL - cefotetan    2.0    ALL   \n491                          medication ALL - rifampin    2.0    ALL   \n492                         medication ALL - nafcillin    2.0    ALL   \n493                       medication ALL - ceftazidime    2.0    ALL   \n494                         medication ALL - linezolid    2.0    ALL   \n495                      medication ALL - erythromycin    2.0    ALL   \n496                          medication ALL - cefaclor    2.0    ALL   \n497                       medication ALL - caspofungin    2.0    ALL   \n498                         medication ALL - cefoxitin    2.0    ALL   \n499                       medication ALL - polymyxin_b    2.0    ALL   \n500                    medication ALL - amphotericin_b    2.0    ALL   \n501                        medication ALL - cefadroxil    2.0    ALL   \n502                         medication ALL - cefprozil    2.0    ALL   \n503        medication ALL - amoxicillin_clarithromycin    2.0    ALL   \n504                             ab subtype ALL - azole    2.0    ALL   \n505                       ab subtype ALL - penicillins    2.0    ALL   \n506                ab subtype ALL - cephalosporin_gen1    2.0    ALL   \n507                ab subtype ALL - cephalosporin_gen3    2.0    ALL   \n508                 ab subtype ALL - beta_lactam_combo    2.0    ALL   \n509                ab subtype ALL - antistaphylococcal    2.0    ALL   \n510                        ab subtype ALL - carbapenem    2.0    ALL   \n511                ab subtype ALL - cephalosporin_gen4    2.0    ALL   \n512                      ab subtype ALL - echinocandin    2.0    ALL   \n513                ab subtype ALL - cephalosporin_gen2    2.0    ALL   \n514                           ab subtype ALL - polyene    2.0    ALL   \n515               micro - prev organism Escherichia 14    7.0     14   \n516                micro - prev organism Klebsiella 14    7.0     14   \n517              micro - prev organism Enterococcus 30    7.0     30   \n518               micro - prev organism Escherichia 30    7.0     30   \n519            micro - prev organism Staphylococcus 30    7.0     30   \n520                micro - prev organism Klebsiella 30    7.0     30   \n521                   micro - prev organism Proteus 30    7.0     30   \n522            micro - prev organism Staph_coag_neg 30    7.0     30   \n523              micro - prev organism Enterobacter 30    7.0     30   \n524               micro - prev organism Citrobacter 30    7.0     30   \n525             micro - prev organism Streptococcus 30    7.0     30   \n526                micro - prev organism Klebsiella 90    7.0     90   \n527             micro - prev organism Streptococcus 90    7.0     90   \n528               micro - prev organism Escherichia 90    7.0     90   \n529            micro - prev organism Staph_coag_neg 90    7.0     90   \n530              micro - prev organism Enterobacter 90    7.0     90   \n531            micro - prev organism Staphylococcus 90    7.0     90   \n532                   micro - prev organism Proteus 90    7.0     90   \n533              micro - prev organism Enterococcus 90    7.0     90   \n534               micro - prev organism Pseudomonas 90    7.0     90   \n535               micro - prev organism Citrobacter 90    7.0     90   \n536             micro - prev organism Acinetobacter 90    7.0     90   \n537              micro - prev organism Pseudomonas 180    7.0    180   \n538              micro - prev organism Escherichia 180    7.0    180   \n539           micro - prev organism Staphylococcus 180    7.0    180   \n540             micro - prev organism Enterococcus 180    7.0    180   \n541             micro - prev organism Enterobacter 180    7.0    180   \n542              micro - prev organism Providencia 180    7.0    180   \n543           micro - prev organism Staph_coag_neg 180    7.0    180   \n544            micro - prev organism Streptococcus 180    7.0    180   \n545            micro - prev organism Acinetobacter 180    7.0    180   \n546              micro - prev organism Citrobacter 180    7.0    180   \n547               micro - prev organism Klebsiella 180    7.0    180   \n548                  micro - prev organism Proteus 180    7.0    180   \n549                 micro - prev organism Serratia 180    7.0    180   \n550               micro - prev organism Morganella 180    7.0    180   \n551                         comorbidity 7 - Arrhythmia    0.0      7   \n552                                comorbidity 7 - HTN    0.0      7   \n553                        comorbidity 7 - Hypothyroid    0.0      7   \n554                          comorbidity 7 - Pulmonary    0.0      7   \n555                        comorbidity 7 - FluidsLytes    0.0      7   \n556                           comorbidity 7 - Lymphoma    0.0      7   \n557                                comorbidity 7 - CHF    0.0      7   \n558                            comorbidity 7 - Obesity    0.0      7   \n559                                comorbidity 7 - PVD    0.0      7   \n560                          comorbidity 7 - Rheumatic    0.0      7   \n561                          comorbidity 7 - BloodLoss    0.0      7   \n562                                 comorbidity 7 - DM    0.0      7   \n563                              comorbidity 7 - Renal    0.0      7   \n564                         comorbidity 7 - Depression    0.0      7   \n565                         comorbidity 7 - NeuroOther    0.0      7   \n566                          comorbidity 7 - Paralysis    0.0      7   \n567                           comorbidity 7 - Valvular    0.0      7   \n568                       comorbidity 7 - Coagulopathy    0.0      7   \n569                             comorbidity 7 - Anemia    0.0      7   \n570                            comorbidity 7 - Alcohol    0.0      7   \n571                              comorbidity 7 - HTNcx    0.0      7   \n572                              comorbidity 7 - Tumor    0.0      7   \n573                         comorbidity 7 - WeightLoss    0.0      7   \n574                              comorbidity 7 - Liver    0.0      7   \n575                          comorbidity 7 - Psychoses    0.0      7   \n576                               comorbidity 7 - DMcx    0.0      7   \n577                              comorbidity 7 - Drugs    0.0      7   \n578                               comorbidity 7 - Mets    0.0      7   \n579                                comorbidity 7 - PUD    0.0      7   \n580                               comorbidity 7 - PHTN    0.0      7   \n581                                comorbidity 7 - HIV    0.0      7   \n582                        comorbidity 14 - Arrhythmia    0.0     14   \n583                               comorbidity 14 - HTN    0.0     14   \n584                       comorbidity 14 - Hypothyroid    0.0     14   \n585                         comorbidity 14 - Pulmonary    0.0     14   \n586                               comorbidity 14 - CHF    0.0     14   \n587                       comorbidity 14 - FluidsLytes    0.0     14   \n588                          comorbidity 14 - Lymphoma    0.0     14   \n589                           comorbidity 14 - Obesity    0.0     14   \n590                               comorbidity 14 - PVD    0.0     14   \n591                         comorbidity 14 - Rheumatic    0.0     14   \n592                         comorbidity 14 - BloodLoss    0.0     14   \n593                                comorbidity 14 - DM    0.0     14   \n594                             comorbidity 14 - Renal    0.0     14   \n595                        comorbidity 14 - Depression    0.0     14   \n596                        comorbidity 14 - NeuroOther    0.0     14   \n597                         comorbidity 14 - Paralysis    0.0     14   \n598                          comorbidity 14 - Valvular    0.0     14   \n599                      comorbidity 14 - Coagulopathy    0.0     14   \n600                              comorbidity 14 - DMcx    0.0     14   \n601                            comorbidity 14 - Anemia    0.0     14   \n602                           comorbidity 14 - Alcohol    0.0     14   \n603                             comorbidity 14 - HTNcx    0.0     14   \n604                             comorbidity 14 - Tumor    0.0     14   \n605                         comorbidity 14 - Psychoses    0.0     14   \n606                        comorbidity 14 - WeightLoss    0.0     14   \n607                             comorbidity 14 - Liver    0.0     14   \n608                              comorbidity 14 - PHTN    0.0     14   \n609                             comorbidity 14 - Drugs    0.0     14   \n610                              comorbidity 14 - Mets    0.0     14   \n611                               comorbidity 14 - PUD    0.0     14   \n612                               comorbidity 14 - HIV    0.0     14   \n613                        comorbidity 30 - Arrhythmia    0.0     30   \n614                               comorbidity 30 - HTN    0.0     30   \n615                       comorbidity 30 - Hypothyroid    0.0     30   \n616                         comorbidity 30 - Pulmonary    0.0     30   \n617                               comorbidity 30 - CHF    0.0     30   \n618                       comorbidity 30 - FluidsLytes    0.0     30   \n619                          comorbidity 30 - Lymphoma    0.0     30   \n620                           comorbidity 30 - Obesity    0.0     30   \n621                               comorbidity 30 - PVD    0.0     30   \n622                         comorbidity 30 - Rheumatic    0.0     30   \n623                         comorbidity 30 - BloodLoss    0.0     30   \n624                                comorbidity 30 - DM    0.0     30   \n625                             comorbidity 30 - Renal    0.0     30   \n626                        comorbidity 30 - Depression    0.0     30   \n627                        comorbidity 30 - NeuroOther    0.0     30   \n628                         comorbidity 30 - Paralysis    0.0     30   \n629                          comorbidity 30 - Valvular    0.0     30   \n630                      comorbidity 30 - Coagulopathy    0.0     30   \n631                              comorbidity 30 - DMcx    0.0     30   \n632                            comorbidity 30 - Anemia    0.0     30   \n633                           comorbidity 30 - Alcohol    0.0     30   \n634                             comorbidity 30 - HTNcx    0.0     30   \n635                             comorbidity 30 - Tumor    0.0     30   \n636                         comorbidity 30 - Psychoses    0.0     30   \n637                        comorbidity 30 - WeightLoss    0.0     30   \n638                             comorbidity 30 - Liver    0.0     30   \n639                              comorbidity 30 - PHTN    0.0     30   \n640                             comorbidity 30 - Drugs    0.0     30   \n641                              comorbidity 30 - Mets    0.0     30   \n642                               comorbidity 30 - PUD    0.0     30   \n643                               comorbidity 30 - HIV    0.0     30   \n644                        comorbidity 90 - Arrhythmia    0.0     90   \n645                               comorbidity 90 - HTN    0.0     90   \n646                       comorbidity 90 - Hypothyroid    0.0     90   \n647                         comorbidity 90 - Pulmonary    0.0     90   \n648                               comorbidity 90 - CHF    0.0     90   \n649                       comorbidity 90 - FluidsLytes    0.0     90   \n650                          comorbidity 90 - Lymphoma    0.0     90   \n651                           comorbidity 90 - Obesity    0.0     90   \n652                                comorbidity 90 - DM    0.0     90   \n653                               comorbidity 90 - PVD    0.0     90   \n654                         comorbidity 90 - Rheumatic    0.0     90   \n655                         comorbidity 90 - BloodLoss    0.0     90   \n656                        comorbidity 90 - Depression    0.0     90   \n657                             comorbidity 90 - Renal    0.0     90   \n658                         comorbidity 90 - Paralysis    0.0     90   \n659                        comorbidity 90 - NeuroOther    0.0     90   \n660                          comorbidity 90 - Valvular    0.0     90   \n661                             comorbidity 90 - HTNcx    0.0     90   \n662                      comorbidity 90 - Coagulopathy    0.0     90   \n663                              comorbidity 90 - DMcx    0.0     90   \n664                            comorbidity 90 - Anemia    0.0     90   \n665                           comorbidity 90 - Alcohol    0.0     90   \n666                             comorbidity 90 - Tumor    0.0     90   \n667                         comorbidity 90 - Psychoses    0.0     90   \n668                        comorbidity 90 - WeightLoss    0.0     90   \n669                             comorbidity 90 - Liver    0.0     90   \n670                              comorbidity 90 - PHTN    0.0     90   \n671                             comorbidity 90 - Drugs    0.0     90   \n672                              comorbidity 90 - Mets    0.0     90   \n673                               comorbidity 90 - PUD    0.0     90   \n674                               comorbidity 90 - HIV    0.0     90   \n675                       comorbidity 180 - Arrhythmia    0.0    180   \n676                              comorbidity 180 - HTN    0.0    180   \n677                      comorbidity 180 - Hypothyroid    0.0    180   \n678                        comorbidity 180 - Pulmonary    0.0    180   \n679                       comorbidity 180 - Depression    0.0    180   \n680                              comorbidity 180 - CHF    0.0    180   \n681                      comorbidity 180 - FluidsLytes    0.0    180   \n682                         comorbidity 180 - Lymphoma    0.0    180   \n683                          comorbidity 180 - Obesity    0.0    180   \n684                               comorbidity 180 - DM    0.0    180   \n685                              comorbidity 180 - PVD    0.0    180   \n686                        comorbidity 180 - Rheumatic    0.0    180   \n687                           comorbidity 180 - Anemia    0.0    180   \n688                        comorbidity 180 - BloodLoss    0.0    180   \n689                            comorbidity 180 - Renal    0.0    180   \n690                        comorbidity 180 - Paralysis    0.0    180   \n691                       comorbidity 180 - NeuroOther    0.0    180   \n692                         comorbidity 180 - Valvular    0.0    180   \n693                            comorbidity 180 - HTNcx    0.0    180   \n694                     comorbidity 180 - Coagulopathy    0.0    180   \n695                             comorbidity 180 - DMcx    0.0    180   \n696                          comorbidity 180 - Alcohol    0.0    180   \n697                            comorbidity 180 - Tumor    0.0    180   \n698                        comorbidity 180 - Psychoses    0.0    180   \n699                       comorbidity 180 - WeightLoss    0.0    180   \n700                            comorbidity 180 - Liver    0.0    180   \n701                             comorbidity 180 - PHTN    0.0    180   \n702                            comorbidity 180 - Drugs    0.0    180   \n703                             comorbidity 180 - Mets    0.0    180   \n704                              comorbidity 180 - PUD    0.0    180   \n705                              comorbidity 180 - HIV    0.0    180   \n706                            procedure 180 - had cvc    0.0    180   \n707                        procedure 180 - had surgery    0.0    180   \n708         procedure 180 - had mechanical ventilation    0.0    180   \n709                   procedure 180 - had hemodialysis    0.0    180   \n710           procedure 180 - had parenteral nutrition    0.0    180   \n711                            custom 7 - nursing home    0.0      7   \n712                           custom 14 - nursing home    0.0     14   \n713                           custom 30 - nursing home    0.0     30   \n714                           custom 90 - nursing home    0.0     90   \n715                infection_sites - RESPIRATORY_TRACT    NaN    NaN   \n716                            infection_sites - BLOOD    NaN    NaN   \n717                  infection_sites - SKIN_SOFTTISSUE    NaN    NaN   \n718             infection_sites - ABSCESS_OR_FLUID_NOS    NaN    NaN   \n719                    infection_sites - MUCOCUTANEOUS    NaN    NaN   \n720                    infection_sites - GENITOURINARY    NaN    NaN   \n721                                     hosp ward - ER    NaN    NaN   \n722                                    hosp ward - ICU    NaN    NaN   \n723                                     hosp ward - IP    NaN    NaN   \n724                                     hosp ward - OP    NaN    NaN   \n725  selected micro - colonization pressure AMC 90 ...    7.0     90   \n726  selected micro - colonization pressure AMP 90 ...    7.0     90   \n727  selected micro - colonization pressure ATM 90 ...    7.0     90   \n728  selected micro - colonization pressure CAZ 90 ...    7.0     90   \n729  selected micro - colonization pressure CIP 90 ...    7.0     90   \n730  selected micro - colonization pressure CLI 90 ...    7.0     90   \n731  selected micro - colonization pressure CRO 90 ...    7.0     90   \n732  selected micro - colonization pressure DOX 90 ...    7.0     90   \n733  selected micro - colonization pressure ERY 90 ...    7.0     90   \n734  selected micro - colonization pressure FEP 90 ...    7.0     90   \n735  selected micro - colonization pressure FOX 90 ...    7.0     90   \n736  selected micro - colonization pressure GEN 90 ...    7.0     90   \n737  selected micro - colonization pressure IPM 90 ...    7.0     90   \n738  selected micro - colonization pressure LVX 90 ...    7.0     90   \n739  selected micro - colonization pressure MEM 90 ...    7.0     90   \n740  selected micro - colonization pressure MXF 90 ...    7.0     90   \n741  selected micro - colonization pressure NIT 90 ...    7.0     90   \n742  selected micro - colonization pressure OXA 90 ...    7.0     90   \n743  selected micro - colonization pressure PEN 90 ...    7.0     90   \n744  selected micro - colonization pressure SAM 90 ...    7.0     90   \n745  selected micro - colonization pressure SXT 90 ...    7.0     90   \n746  selected micro - colonization pressure TET 90 ...    7.0     90   \n747  selected micro - colonization pressure TZP 90 ...    7.0     90   \n748  selected micro - colonization pressure VAN 90 ...    7.0     90   \n749  selected micro - colonization pressure AMC 90 ...    7.0     90   \n750  selected micro - colonization pressure AMP 90 ...    7.0     90   \n751  selected micro - colonization pressure ATM 90 ...    7.0     90   \n752  selected micro - colonization pressure CAZ 90 ...    7.0     90   \n753  selected micro - colonization pressure CIP 90 ...    7.0     90   \n754  selected micro - colonization pressure CLI 90 ...    7.0     90   \n755  selected micro - colonization pressure CRO 90 ...    7.0     90   \n756  selected micro - colonization pressure DOX 90 ...    7.0     90   \n757  selected micro - colonization pressure ERY 90 ...    7.0     90   \n758  selected micro - colonization pressure FEP 90 ...    7.0     90   \n759  selected micro - colonization pressure FOX 90 ...    7.0     90   \n760  selected micro - colonization pressure GEN 90 ...    7.0     90   \n761  selected micro - colonization pressure IPM 90 ...    7.0     90   \n762  selected micro - colonization pressure LVX 90 ...    7.0     90   \n763  selected micro - colonization pressure MEM 90 ...    7.0     90   \n764  selected micro - colonization pressure MIN 90 ...    7.0     90   \n765  selected micro - colonization pressure MXF 90 ...    7.0     90   \n766  selected micro - colonization pressure NIT 90 ...    7.0     90   \n767  selected micro - colonization pressure OXA 90 ...    7.0     90   \n768  selected micro - colonization pressure PEN 90 ...    7.0     90   \n769  selected micro - colonization pressure SAM 90 ...    7.0     90   \n770  selected micro - colonization pressure SXT 90 ...    7.0     90   \n771  selected micro - colonization pressure TET 90 ...    7.0     90   \n772  selected micro - colonization pressure TZP 90 ...    7.0     90   \n773  selected micro - colonization pressure VAN 90 ...    7.0     90   \n774  selected micro - colonization pressure AMC 90 ...    7.0     90   \n775  selected micro - colonization pressure AMP 90 ...    7.0     90   \n776  selected micro - colonization pressure ATM 90 ...    7.0     90   \n777  selected micro - colonization pressure CAZ 90 ...    7.0     90   \n778  selected micro - colonization pressure CIP 90 ...    7.0     90   \n779  selected micro - colonization pressure CLI 90 ...    7.0     90   \n780  selected micro - colonization pressure CRO 90 ...    7.0     90   \n781  selected micro - colonization pressure DOX 90 ...    7.0     90   \n782  selected micro - colonization pressure ERY 90 ...    7.0     90   \n783  selected micro - colonization pressure FEP 90 ...    7.0     90   \n784  selected micro - colonization pressure FOX 90 ...    7.0     90   \n785  selected micro - colonization pressure GEN 90 ...    7.0     90   \n786  selected micro - colonization pressure IPM 90 ...    7.0     90   \n787  selected micro - colonization pressure LVX 90 ...    7.0     90   \n788  selected micro - colonization pressure MEM 90 ...    7.0     90   \n789  selected micro - colonization pressure MIN 90 ...    7.0     90   \n790  selected micro - colonization pressure MXF 90 ...    7.0     90   \n791  selected micro - colonization pressure NIT 90 ...    7.0     90   \n792  selected micro - colonization pressure OXA 90 ...    7.0     90   \n793  selected micro - colonization pressure PEN 90 ...    7.0     90   \n794  selected micro - colonization pressure SAM 90 ...    7.0     90   \n795  selected micro - colonization pressure SXT 90 ...    7.0     90   \n796  selected micro - colonization pressure TET 90 ...    7.0     90   \n797  selected micro - colonization pressure TZP 90 ...    7.0     90   \n798  selected micro - colonization pressure VAN 90 ...    7.0     90   \n799                                           is_train    NaN    NaN   \n800                                      uncomplicated    NaN    NaN   \n\n                                           description  \n0        Unique specimen ID used to link between files  \n1            Indicator of resistance to nitrofurantoin  \n2    Indicator of resistance to trimethoprim-sulfam...  \n3             Indicator of resistance to ciprofloxacin  \n4              Indicator of resistance to levofloxacin  \n5    Used to denote membership in training set (200...  \n6    Used to denote membership in uncomplicated UTI...  \n7        Unique specimen ID used to link between files  \n8    Observed empiric prescription (one of NIT, SXT...  \n9    Used to denote membership in training set (200...  \n10       Unique specimen ID used to link between files  \n11                                         Age (years)  \n12                                        Race (white)  \n13                               Veteran Status (true)  \n14   Prior antibiotic resistance, see documentation...  \n15   Prior antibiotic resistance, see documentation...  \n16   Prior antibiotic resistance, see documentation...  \n17   Prior antibiotic resistance, see documentation...  \n18   Prior antibiotic resistance, see documentation...  \n19   Prior antibiotic resistance, see documentation...  \n20   Prior antibiotic resistance, see documentation...  \n21   Prior antibiotic resistance, see documentation...  \n22   Prior antibiotic resistance, see documentation...  \n23   Prior antibiotic resistance, see documentation...  \n24   Prior antibiotic resistance, see documentation...  \n25   Prior antibiotic resistance, see documentation...  \n26   Prior antibiotic resistance, see documentation...  \n27   Prior antibiotic resistance, see documentation...  \n28   Prior antibiotic resistance, see documentation...  \n29   Prior antibiotic resistance, see documentation...  \n30   Prior antibiotic resistance, see documentation...  \n31   Prior antibiotic resistance, see documentation...  \n32   Prior antibiotic resistance, see documentation...  \n33   Prior antibiotic resistance, see documentation...  \n34   Prior antibiotic resistance, see documentation...  \n35   Prior antibiotic resistance, see documentation...  \n36   Prior antibiotic resistance, see documentation...  \n37   Prior antibiotic resistance, see documentation...  \n38   Prior antibiotic resistance, see documentation...  \n39   Prior antibiotic resistance, see documentation...  \n40   Prior antibiotic resistance, see documentation...  \n41   Prior antibiotic resistance, see documentation...  \n42   Prior antibiotic resistance, see documentation...  \n43   Prior antibiotic resistance, see documentation...  \n44   Prior antibiotic resistance, see documentation...  \n45   Prior antibiotic resistance, see documentation...  \n46   Prior antibiotic resistance, see documentation...  \n47   Prior antibiotic resistance, see documentation...  \n48   Prior antibiotic resistance, see documentation...  \n49   Prior antibiotic resistance, see documentation...  \n50   Prior antibiotic resistance, see documentation...  \n51   Prior antibiotic resistance, see documentation...  \n52   Prior antibiotic resistance, see documentation...  \n53   Prior antibiotic resistance, see documentation...  \n54   Prior antibiotic resistance, see documentation...  \n55   Prior antibiotic resistance, see documentation...  \n56   Prior antibiotic resistance, see documentation...  \n57   Prior antibiotic resistance, see documentation...  \n58   Prior antibiotic resistance, see documentation...  \n59   Prior antibiotic resistance, see documentation...  \n60   Prior antibiotic resistance, see documentation...  \n61   Prior antibiotic resistance, see documentation...  \n62   Prior antibiotic resistance, see documentation...  \n63   Prior antibiotic resistance, see documentation...  \n64   Prior antibiotic resistance, see documentation...  \n65   Prior antibiotic resistance, see documentation...  \n66   Prior antibiotic resistance, see documentation...  \n67   Prior antibiotic resistance, see documentation...  \n68   Prior antibiotic resistance, see documentation...  \n69   Prior antibiotic resistance, see documentation...  \n70   Prior antibiotic resistance, see documentation...  \n71   Prior antibiotic resistance, see documentation...  \n72   Prior antibiotic resistance, see documentation...  \n73   Prior antibiotic resistance, see documentation...  \n74   Prior antibiotic resistance, see documentation...  \n75   Prior antibiotic resistance, see documentation...  \n76   Prior antibiotic resistance, see documentation...  \n77   Prior antibiotic resistance, see documentation...  \n78   Prior antibiotic resistance, see documentation...  \n79   Prior antibiotic resistance, see documentation...  \n80   Prior antibiotic resistance, see documentation...  \n81   Prior antibiotic resistance, see documentation...  \n82   Prior antibiotic resistance, see documentation...  \n83   Prior antibiotic resistance, see documentation...  \n84   Prior antibiotic resistance, see documentation...  \n85   Prior antibiotic resistance, see documentation...  \n86   Prior antibiotic resistance, see documentation...  \n87   Prior antibiotic resistance, see documentation...  \n88   Prior antibiotic resistance, see documentation...  \n89   Prior antibiotic resistance, see documentation...  \n90   Prior antibiotic resistance, see documentation...  \n91   Prior antibiotic resistance, see documentation...  \n92   Prior antibiotic resistance, see documentation...  \n93   Prior antibiotic resistance, see documentation...  \n94   Prior antibiotic resistance, see documentation...  \n95   Prior antibiotic resistance, see documentation...  \n96   Prior antibiotic resistance, see documentation...  \n97   Prior antibiotic resistance, see documentation...  \n98   Prior antibiotic resistance, see documentation...  \n99   Prior antibiotic resistance, see documentation...  \n100  Prior antibiotic resistance, see documentation...  \n101  Prior antibiotic resistance, see documentation...  \n102  Prior antibiotic resistance, see documentation...  \n103  Prior antibiotic resistance, see documentation...  \n104  Prior antibiotic resistance, see documentation...  \n105  Prior antibiotic resistance, see documentation...  \n106  Prior antibiotic resistance, see documentation...  \n107  Prior antibiotic resistance, see documentation...  \n108  Prior antibiotic resistance, see documentation...  \n109  Prior antibiotic resistance, see documentation...  \n110  Prior antibiotic resistance, see documentation...  \n111  Prior antibiotic resistance, see documentation...  \n112  Prior antibiotic resistance, see documentation...  \n113  Prior antibiotic resistance, see documentation...  \n114  Prior antibiotic resistance, see documentation...  \n115  Prior antibiotic resistance, see documentation...  \n116  Prior antibiotic resistance, see documentation...  \n117  Prior antibiotic resistance, see documentation...  \n118  Prior antibiotic resistance, see documentation...  \n119  Prior antibiotic resistance, see documentation...  \n120  Prior antibiotic resistance, see documentation...  \n121  Prior antibiotic resistance, see documentation...  \n122  Prior antibiotic resistance, see documentation...  \n123  Prior antibiotic resistance, see documentation...  \n124  Prior antibiotic resistance, see documentation...  \n125  Prior antibiotic resistance, see documentation...  \n126  Prior antibiotic resistance, see documentation...  \n127  Prior antibiotic resistance, see documentation...  \n128  Prior antibiotic resistance, see documentation...  \n129  Prior antibiotic resistance, see documentation...  \n130  Prior antibiotic resistance, see documentation...  \n131  Prior antibiotic resistance, see documentation...  \n132  Prior antibiotic resistance, see documentation...  \n133  Prior antibiotic resistance, see documentation...  \n134  Prior antibiotic resistance, see documentation...  \n135  Prior antibiotic resistance, see documentation...  \n136  Prior antibiotic resistance, see documentation...  \n137  Prior antibiotic resistance, see documentation...  \n138  Prior antibiotic resistance, see documentation...  \n139  Prior antibiotic resistance, see documentation...  \n140  Prior antibiotic resistance, see documentation...  \n141  Prior antibiotic resistance, see documentation...  \n142  Prior antibiotic resistance, see documentation...  \n143  Prior antibiotic resistance, see documentation...  \n144  Prior antibiotic resistance, see documentation...  \n145  Prior antibiotic resistance, see documentation...  \n146  Prior antibiotic resistance, see documentation...  \n147  Prior antibiotic resistance, see documentation...  \n148  Prior antibiotic resistance, see documentation...  \n149  Prior antibiotic resistance, see documentation...  \n150  Prior antibiotic resistance, see documentation...  \n151  Prior antibiotic resistance, see documentation...  \n152  Prior antibiotic resistance, see documentation...  \n153  Prior antibiotic resistance, see documentation...  \n154  Prior antibiotic resistance, see documentation...  \n155  Prior antibiotic resistance, see documentation...  \n156  Prior antibiotic resistance, see documentation...  \n157  Prior antibiotic resistance, see documentation...  \n158                  Prior antibiotic exposure (class)  \n159                  Prior antibiotic exposure (class)  \n160                  Prior antibiotic exposure (class)  \n161                  Prior antibiotic exposure (class)  \n162                  Prior antibiotic exposure (class)  \n163                  Prior antibiotic exposure (class)  \n164                  Prior antibiotic exposure (class)  \n165                  Prior antibiotic exposure (class)  \n166                  Prior antibiotic exposure (class)  \n167                  Prior antibiotic exposure (class)  \n168         Prior antibiotic exposure (detailed names)  \n169         Prior antibiotic exposure (detailed names)  \n170         Prior antibiotic exposure (detailed names)  \n171         Prior antibiotic exposure (detailed names)  \n172         Prior antibiotic exposure (detailed names)  \n173         Prior antibiotic exposure (detailed names)  \n174         Prior antibiotic exposure (detailed names)  \n175         Prior antibiotic exposure (detailed names)  \n176         Prior antibiotic exposure (detailed names)  \n177         Prior antibiotic exposure (detailed names)  \n178         Prior antibiotic exposure (detailed names)  \n179         Prior antibiotic exposure (detailed names)  \n180         Prior antibiotic exposure (detailed names)  \n181         Prior antibiotic exposure (detailed names)  \n182         Prior antibiotic exposure (detailed names)  \n183         Prior antibiotic exposure (detailed names)  \n184         Prior antibiotic exposure (detailed names)  \n185         Prior antibiotic exposure (detailed names)  \n186         Prior antibiotic exposure (detailed names)  \n187         Prior antibiotic exposure (detailed names)  \n188         Prior antibiotic exposure (detailed names)  \n189         Prior antibiotic exposure (detailed names)  \n190         Prior antibiotic exposure (detailed names)  \n191         Prior antibiotic exposure (detailed names)  \n192         Prior antibiotic exposure (detailed names)  \n193               Prior antibiotic exposure (subclass)  \n194               Prior antibiotic exposure (subclass)  \n195               Prior antibiotic exposure (subclass)  \n196               Prior antibiotic exposure (subclass)  \n197               Prior antibiotic exposure (subclass)  \n198               Prior antibiotic exposure (subclass)  \n199               Prior antibiotic exposure (subclass)  \n200                  Prior antibiotic exposure (class)  \n201                  Prior antibiotic exposure (class)  \n202                  Prior antibiotic exposure (class)  \n203                  Prior antibiotic exposure (class)  \n204                  Prior antibiotic exposure (class)  \n205                  Prior antibiotic exposure (class)  \n206                  Prior antibiotic exposure (class)  \n207                  Prior antibiotic exposure (class)  \n208                  Prior antibiotic exposure (class)  \n209                  Prior antibiotic exposure (class)  \n210                  Prior antibiotic exposure (class)  \n211         Prior antibiotic exposure (detailed names)  \n212         Prior antibiotic exposure (detailed names)  \n213         Prior antibiotic exposure (detailed names)  \n214         Prior antibiotic exposure (detailed names)  \n215         Prior antibiotic exposure (detailed names)  \n216         Prior antibiotic exposure (detailed names)  \n217         Prior antibiotic exposure (detailed names)  \n218         Prior antibiotic exposure (detailed names)  \n219         Prior antibiotic exposure (detailed names)  \n220         Prior antibiotic exposure (detailed names)  \n221         Prior antibiotic exposure (detailed names)  \n222         Prior antibiotic exposure (detailed names)  \n223         Prior antibiotic exposure (detailed names)  \n224         Prior antibiotic exposure (detailed names)  \n225         Prior antibiotic exposure (detailed names)  \n226         Prior antibiotic exposure (detailed names)  \n227         Prior antibiotic exposure (detailed names)  \n228         Prior antibiotic exposure (detailed names)  \n229         Prior antibiotic exposure (detailed names)  \n230         Prior antibiotic exposure (detailed names)  \n231         Prior antibiotic exposure (detailed names)  \n232         Prior antibiotic exposure (detailed names)  \n233         Prior antibiotic exposure (detailed names)  \n234         Prior antibiotic exposure (detailed names)  \n235         Prior antibiotic exposure (detailed names)  \n236         Prior antibiotic exposure (detailed names)  \n237         Prior antibiotic exposure (detailed names)  \n238               Prior antibiotic exposure (subclass)  \n239               Prior antibiotic exposure (subclass)  \n240               Prior antibiotic exposure (subclass)  \n241               Prior antibiotic exposure (subclass)  \n242               Prior antibiotic exposure (subclass)  \n243               Prior antibiotic exposure (subclass)  \n244               Prior antibiotic exposure (subclass)  \n245                  Prior antibiotic exposure (class)  \n246                  Prior antibiotic exposure (class)  \n247                  Prior antibiotic exposure (class)  \n248                  Prior antibiotic exposure (class)  \n249                  Prior antibiotic exposure (class)  \n250                  Prior antibiotic exposure (class)  \n251                  Prior antibiotic exposure (class)  \n252                  Prior antibiotic exposure (class)  \n253                  Prior antibiotic exposure (class)  \n254                  Prior antibiotic exposure (class)  \n255                  Prior antibiotic exposure (class)  \n256                  Prior antibiotic exposure (class)  \n257                  Prior antibiotic exposure (class)  \n258         Prior antibiotic exposure (detailed names)  \n259         Prior antibiotic exposure (detailed names)  \n260         Prior antibiotic exposure (detailed names)  \n261         Prior antibiotic exposure (detailed names)  \n262         Prior antibiotic exposure (detailed names)  \n263         Prior antibiotic exposure (detailed names)  \n264         Prior antibiotic exposure (detailed names)  \n265         Prior antibiotic exposure (detailed names)  \n266         Prior antibiotic exposure (detailed names)  \n267         Prior antibiotic exposure (detailed names)  \n268         Prior antibiotic exposure (detailed names)  \n269         Prior antibiotic exposure (detailed names)  \n270         Prior antibiotic exposure (detailed names)  \n271         Prior antibiotic exposure (detailed names)  \n272         Prior antibiotic exposure (detailed names)  \n273         Prior antibiotic exposure (detailed names)  \n274         Prior antibiotic exposure (detailed names)  \n275         Prior antibiotic exposure (detailed names)  \n276         Prior antibiotic exposure (detailed names)  \n277         Prior antibiotic exposure (detailed names)  \n278         Prior antibiotic exposure (detailed names)  \n279         Prior antibiotic exposure (detailed names)  \n280         Prior antibiotic exposure (detailed names)  \n281         Prior antibiotic exposure (detailed names)  \n282         Prior antibiotic exposure (detailed names)  \n283         Prior antibiotic exposure (detailed names)  \n284         Prior antibiotic exposure (detailed names)  \n285         Prior antibiotic exposure (detailed names)  \n286         Prior antibiotic exposure (detailed names)  \n287         Prior antibiotic exposure (detailed names)  \n288         Prior antibiotic exposure (detailed names)  \n289         Prior antibiotic exposure (detailed names)  \n290         Prior antibiotic exposure (detailed names)  \n291               Prior antibiotic exposure (subclass)  \n292               Prior antibiotic exposure (subclass)  \n293               Prior antibiotic exposure (subclass)  \n294               Prior antibiotic exposure (subclass)  \n295               Prior antibiotic exposure (subclass)  \n296               Prior antibiotic exposure (subclass)  \n297               Prior antibiotic exposure (subclass)  \n298                  Prior antibiotic exposure (class)  \n299                  Prior antibiotic exposure (class)  \n300                  Prior antibiotic exposure (class)  \n301                  Prior antibiotic exposure (class)  \n302                  Prior antibiotic exposure (class)  \n303                  Prior antibiotic exposure (class)  \n304                  Prior antibiotic exposure (class)  \n305                  Prior antibiotic exposure (class)  \n306                  Prior antibiotic exposure (class)  \n307                  Prior antibiotic exposure (class)  \n308                  Prior antibiotic exposure (class)  \n309                  Prior antibiotic exposure (class)  \n310                  Prior antibiotic exposure (class)  \n311                  Prior antibiotic exposure (class)  \n312                  Prior antibiotic exposure (class)  \n313         Prior antibiotic exposure (detailed names)  \n314         Prior antibiotic exposure (detailed names)  \n315         Prior antibiotic exposure (detailed names)  \n316         Prior antibiotic exposure (detailed names)  \n317         Prior antibiotic exposure (detailed names)  \n318         Prior antibiotic exposure (detailed names)  \n319         Prior antibiotic exposure (detailed names)  \n320         Prior antibiotic exposure (detailed names)  \n321         Prior antibiotic exposure (detailed names)  \n322         Prior antibiotic exposure (detailed names)  \n323         Prior antibiotic exposure (detailed names)  \n324         Prior antibiotic exposure (detailed names)  \n325         Prior antibiotic exposure (detailed names)  \n326         Prior antibiotic exposure (detailed names)  \n327         Prior antibiotic exposure (detailed names)  \n328         Prior antibiotic exposure (detailed names)  \n329         Prior antibiotic exposure (detailed names)  \n330         Prior antibiotic exposure (detailed names)  \n331         Prior antibiotic exposure (detailed names)  \n332         Prior antibiotic exposure (detailed names)  \n333         Prior antibiotic exposure (detailed names)  \n334         Prior antibiotic exposure (detailed names)  \n335         Prior antibiotic exposure (detailed names)  \n336         Prior antibiotic exposure (detailed names)  \n337         Prior antibiotic exposure (detailed names)  \n338         Prior antibiotic exposure (detailed names)  \n339         Prior antibiotic exposure (detailed names)  \n340         Prior antibiotic exposure (detailed names)  \n341         Prior antibiotic exposure (detailed names)  \n342         Prior antibiotic exposure (detailed names)  \n343         Prior antibiotic exposure (detailed names)  \n344         Prior antibiotic exposure (detailed names)  \n345         Prior antibiotic exposure (detailed names)  \n346         Prior antibiotic exposure (detailed names)  \n347         Prior antibiotic exposure (detailed names)  \n348         Prior antibiotic exposure (detailed names)  \n349         Prior antibiotic exposure (detailed names)  \n350         Prior antibiotic exposure (detailed names)  \n351         Prior antibiotic exposure (detailed names)  \n352         Prior antibiotic exposure (detailed names)  \n353         Prior antibiotic exposure (detailed names)  \n354         Prior antibiotic exposure (detailed names)  \n355               Prior antibiotic exposure (subclass)  \n356               Prior antibiotic exposure (subclass)  \n357               Prior antibiotic exposure (subclass)  \n358               Prior antibiotic exposure (subclass)  \n359               Prior antibiotic exposure (subclass)  \n360               Prior antibiotic exposure (subclass)  \n361               Prior antibiotic exposure (subclass)  \n362               Prior antibiotic exposure (subclass)  \n363               Prior antibiotic exposure (subclass)  \n364                  Prior antibiotic exposure (class)  \n365                  Prior antibiotic exposure (class)  \n366                  Prior antibiotic exposure (class)  \n367                  Prior antibiotic exposure (class)  \n368                  Prior antibiotic exposure (class)  \n369                  Prior antibiotic exposure (class)  \n370                  Prior antibiotic exposure (class)  \n371                  Prior antibiotic exposure (class)  \n372                  Prior antibiotic exposure (class)  \n373                  Prior antibiotic exposure (class)  \n374                  Prior antibiotic exposure (class)  \n375                  Prior antibiotic exposure (class)  \n376                  Prior antibiotic exposure (class)  \n377                  Prior antibiotic exposure (class)  \n378                  Prior antibiotic exposure (class)  \n379                  Prior antibiotic exposure (class)  \n380         Prior antibiotic exposure (detailed names)  \n381         Prior antibiotic exposure (detailed names)  \n382         Prior antibiotic exposure (detailed names)  \n383         Prior antibiotic exposure (detailed names)  \n384         Prior antibiotic exposure (detailed names)  \n385         Prior antibiotic exposure (detailed names)  \n386         Prior antibiotic exposure (detailed names)  \n387         Prior antibiotic exposure (detailed names)  \n388         Prior antibiotic exposure (detailed names)  \n389         Prior antibiotic exposure (detailed names)  \n390         Prior antibiotic exposure (detailed names)  \n391         Prior antibiotic exposure (detailed names)  \n392         Prior antibiotic exposure (detailed names)  \n393         Prior antibiotic exposure (detailed names)  \n394         Prior antibiotic exposure (detailed names)  \n395         Prior antibiotic exposure (detailed names)  \n396         Prior antibiotic exposure (detailed names)  \n397         Prior antibiotic exposure (detailed names)  \n398         Prior antibiotic exposure (detailed names)  \n399         Prior antibiotic exposure (detailed names)  \n400         Prior antibiotic exposure (detailed names)  \n401         Prior antibiotic exposure (detailed names)  \n402         Prior antibiotic exposure (detailed names)  \n403         Prior antibiotic exposure (detailed names)  \n404         Prior antibiotic exposure (detailed names)  \n405         Prior antibiotic exposure (detailed names)  \n406         Prior antibiotic exposure (detailed names)  \n407         Prior antibiotic exposure (detailed names)  \n408         Prior antibiotic exposure (detailed names)  \n409         Prior antibiotic exposure (detailed names)  \n410         Prior antibiotic exposure (detailed names)  \n411         Prior antibiotic exposure (detailed names)  \n412         Prior antibiotic exposure (detailed names)  \n413         Prior antibiotic exposure (detailed names)  \n414         Prior antibiotic exposure (detailed names)  \n415         Prior antibiotic exposure (detailed names)  \n416         Prior antibiotic exposure (detailed names)  \n417         Prior antibiotic exposure (detailed names)  \n418         Prior antibiotic exposure (detailed names)  \n419         Prior antibiotic exposure (detailed names)  \n420         Prior antibiotic exposure (detailed names)  \n421         Prior antibiotic exposure (detailed names)  \n422         Prior antibiotic exposure (detailed names)  \n423         Prior antibiotic exposure (detailed names)  \n424         Prior antibiotic exposure (detailed names)  \n425         Prior antibiotic exposure (detailed names)  \n426         Prior antibiotic exposure (detailed names)  \n427         Prior antibiotic exposure (detailed names)  \n428               Prior antibiotic exposure (subclass)  \n429               Prior antibiotic exposure (subclass)  \n430               Prior antibiotic exposure (subclass)  \n431               Prior antibiotic exposure (subclass)  \n432               Prior antibiotic exposure (subclass)  \n433               Prior antibiotic exposure (subclass)  \n434               Prior antibiotic exposure (subclass)  \n435               Prior antibiotic exposure (subclass)  \n436               Prior antibiotic exposure (subclass)  \n437               Prior antibiotic exposure (subclass)  \n438               Prior antibiotic exposure (subclass)  \n439                  Prior antibiotic exposure (class)  \n440                  Prior antibiotic exposure (class)  \n441                  Prior antibiotic exposure (class)  \n442                  Prior antibiotic exposure (class)  \n443                  Prior antibiotic exposure (class)  \n444                  Prior antibiotic exposure (class)  \n445                  Prior antibiotic exposure (class)  \n446                  Prior antibiotic exposure (class)  \n447                  Prior antibiotic exposure (class)  \n448                  Prior antibiotic exposure (class)  \n449                  Prior antibiotic exposure (class)  \n450                  Prior antibiotic exposure (class)  \n451                  Prior antibiotic exposure (class)  \n452                  Prior antibiotic exposure (class)  \n453                  Prior antibiotic exposure (class)  \n454                  Prior antibiotic exposure (class)  \n455         Prior antibiotic exposure (detailed names)  \n456         Prior antibiotic exposure (detailed names)  \n457         Prior antibiotic exposure (detailed names)  \n458         Prior antibiotic exposure (detailed names)  \n459         Prior antibiotic exposure (detailed names)  \n460         Prior antibiotic exposure (detailed names)  \n461         Prior antibiotic exposure (detailed names)  \n462         Prior antibiotic exposure (detailed names)  \n463         Prior antibiotic exposure (detailed names)  \n464         Prior antibiotic exposure (detailed names)  \n465         Prior antibiotic exposure (detailed names)  \n466         Prior antibiotic exposure (detailed names)  \n467         Prior antibiotic exposure (detailed names)  \n468         Prior antibiotic exposure (detailed names)  \n469         Prior antibiotic exposure (detailed names)  \n470         Prior antibiotic exposure (detailed names)  \n471         Prior antibiotic exposure (detailed names)  \n472         Prior antibiotic exposure (detailed names)  \n473         Prior antibiotic exposure (detailed names)  \n474         Prior antibiotic exposure (detailed names)  \n475         Prior antibiotic exposure (detailed names)  \n476         Prior antibiotic exposure (detailed names)  \n477         Prior antibiotic exposure (detailed names)  \n478         Prior antibiotic exposure (detailed names)  \n479         Prior antibiotic exposure (detailed names)  \n480         Prior antibiotic exposure (detailed names)  \n481         Prior antibiotic exposure (detailed names)  \n482         Prior antibiotic exposure (detailed names)  \n483         Prior antibiotic exposure (detailed names)  \n484         Prior antibiotic exposure (detailed names)  \n485         Prior antibiotic exposure (detailed names)  \n486         Prior antibiotic exposure (detailed names)  \n487         Prior antibiotic exposure (detailed names)  \n488         Prior antibiotic exposure (detailed names)  \n489         Prior antibiotic exposure (detailed names)  \n490         Prior antibiotic exposure (detailed names)  \n491         Prior antibiotic exposure (detailed names)  \n492         Prior antibiotic exposure (detailed names)  \n493         Prior antibiotic exposure (detailed names)  \n494         Prior antibiotic exposure (detailed names)  \n495         Prior antibiotic exposure (detailed names)  \n496         Prior antibiotic exposure (detailed names)  \n497         Prior antibiotic exposure (detailed names)  \n498         Prior antibiotic exposure (detailed names)  \n499         Prior antibiotic exposure (detailed names)  \n500         Prior antibiotic exposure (detailed names)  \n501         Prior antibiotic exposure (detailed names)  \n502         Prior antibiotic exposure (detailed names)  \n503         Prior antibiotic exposure (detailed names)  \n504               Prior antibiotic exposure (subclass)  \n505               Prior antibiotic exposure (subclass)  \n506               Prior antibiotic exposure (subclass)  \n507               Prior antibiotic exposure (subclass)  \n508               Prior antibiotic exposure (subclass)  \n509               Prior antibiotic exposure (subclass)  \n510               Prior antibiotic exposure (subclass)  \n511               Prior antibiotic exposure (subclass)  \n512               Prior antibiotic exposure (subclass)  \n513               Prior antibiotic exposure (subclass)  \n514               Prior antibiotic exposure (subclass)  \n515                           Prior infecting organism  \n516                           Prior infecting organism  \n517                           Prior infecting organism  \n518                           Prior infecting organism  \n519                           Prior infecting organism  \n520                           Prior infecting organism  \n521                           Prior infecting organism  \n522                           Prior infecting organism  \n523                           Prior infecting organism  \n524                           Prior infecting organism  \n525                           Prior infecting organism  \n526                           Prior infecting organism  \n527                           Prior infecting organism  \n528                           Prior infecting organism  \n529                           Prior infecting organism  \n530                           Prior infecting organism  \n531                           Prior infecting organism  \n532                           Prior infecting organism  \n533                           Prior infecting organism  \n534                           Prior infecting organism  \n535                           Prior infecting organism  \n536                           Prior infecting organism  \n537                           Prior infecting organism  \n538                           Prior infecting organism  \n539                           Prior infecting organism  \n540                           Prior infecting organism  \n541                           Prior infecting organism  \n542                           Prior infecting organism  \n543                           Prior infecting organism  \n544                           Prior infecting organism  \n545                           Prior infecting organism  \n546                           Prior infecting organism  \n547                           Prior infecting organism  \n548                           Prior infecting organism  \n549                           Prior infecting organism  \n550                           Prior infecting organism  \n551                           Elixhauser Comorbidities  \n552                           Elixhauser Comorbidities  \n553                           Elixhauser Comorbidities  \n554                           Elixhauser Comorbidities  \n555                           Elixhauser Comorbidities  \n556                           Elixhauser Comorbidities  \n557                           Elixhauser Comorbidities  \n558                           Elixhauser Comorbidities  \n559                           Elixhauser Comorbidities  \n560                           Elixhauser Comorbidities  \n561                           Elixhauser Comorbidities  \n562                           Elixhauser Comorbidities  \n563                           Elixhauser Comorbidities  \n564                           Elixhauser Comorbidities  \n565                           Elixhauser Comorbidities  \n566                           Elixhauser Comorbidities  \n567                           Elixhauser Comorbidities  \n568                           Elixhauser Comorbidities  \n569                           Elixhauser Comorbidities  \n570                           Elixhauser Comorbidities  \n571                           Elixhauser Comorbidities  \n572                           Elixhauser Comorbidities  \n573                           Elixhauser Comorbidities  \n574                           Elixhauser Comorbidities  \n575                           Elixhauser Comorbidities  \n576                           Elixhauser Comorbidities  \n577                           Elixhauser Comorbidities  \n578                           Elixhauser Comorbidities  \n579                           Elixhauser Comorbidities  \n580                           Elixhauser Comorbidities  \n581                           Elixhauser Comorbidities  \n582                           Elixhauser Comorbidities  \n583                           Elixhauser Comorbidities  \n584                           Elixhauser Comorbidities  \n585                           Elixhauser Comorbidities  \n586                           Elixhauser Comorbidities  \n587                           Elixhauser Comorbidities  \n588                           Elixhauser Comorbidities  \n589                           Elixhauser Comorbidities  \n590                           Elixhauser Comorbidities  \n591                           Elixhauser Comorbidities  \n592                           Elixhauser Comorbidities  \n593                           Elixhauser Comorbidities  \n594                           Elixhauser Comorbidities  \n595                           Elixhauser Comorbidities  \n596                           Elixhauser Comorbidities  \n597                           Elixhauser Comorbidities  \n598                           Elixhauser Comorbidities  \n599                           Elixhauser Comorbidities  \n600                           Elixhauser Comorbidities  \n601                           Elixhauser Comorbidities  \n602                           Elixhauser Comorbidities  \n603                           Elixhauser Comorbidities  \n604                           Elixhauser Comorbidities  \n605                           Elixhauser Comorbidities  \n606                           Elixhauser Comorbidities  \n607                           Elixhauser Comorbidities  \n608                           Elixhauser Comorbidities  \n609                           Elixhauser Comorbidities  \n610                           Elixhauser Comorbidities  \n611                           Elixhauser Comorbidities  \n612                           Elixhauser Comorbidities  \n613                           Elixhauser Comorbidities  \n614                           Elixhauser Comorbidities  \n615                           Elixhauser Comorbidities  \n616                           Elixhauser Comorbidities  \n617                           Elixhauser Comorbidities  \n618                           Elixhauser Comorbidities  \n619                           Elixhauser Comorbidities  \n620                           Elixhauser Comorbidities  \n621                           Elixhauser Comorbidities  \n622                           Elixhauser Comorbidities  \n623                           Elixhauser Comorbidities  \n624                           Elixhauser Comorbidities  \n625                           Elixhauser Comorbidities  \n626                           Elixhauser Comorbidities  \n627                           Elixhauser Comorbidities  \n628                           Elixhauser Comorbidities  \n629                           Elixhauser Comorbidities  \n630                           Elixhauser Comorbidities  \n631                           Elixhauser Comorbidities  \n632                           Elixhauser Comorbidities  \n633                           Elixhauser Comorbidities  \n634                           Elixhauser Comorbidities  \n635                           Elixhauser Comorbidities  \n636                           Elixhauser Comorbidities  \n637                           Elixhauser Comorbidities  \n638                           Elixhauser Comorbidities  \n639                           Elixhauser Comorbidities  \n640                           Elixhauser Comorbidities  \n641                           Elixhauser Comorbidities  \n642                           Elixhauser Comorbidities  \n643                           Elixhauser Comorbidities  \n644                           Elixhauser Comorbidities  \n645                           Elixhauser Comorbidities  \n646                           Elixhauser Comorbidities  \n647                           Elixhauser Comorbidities  \n648                           Elixhauser Comorbidities  \n649                           Elixhauser Comorbidities  \n650                           Elixhauser Comorbidities  \n651                           Elixhauser Comorbidities  \n652                           Elixhauser Comorbidities  \n653                           Elixhauser Comorbidities  \n654                           Elixhauser Comorbidities  \n655                           Elixhauser Comorbidities  \n656                           Elixhauser Comorbidities  \n657                           Elixhauser Comorbidities  \n658                           Elixhauser Comorbidities  \n659                           Elixhauser Comorbidities  \n660                           Elixhauser Comorbidities  \n661                           Elixhauser Comorbidities  \n662                           Elixhauser Comorbidities  \n663                           Elixhauser Comorbidities  \n664                           Elixhauser Comorbidities  \n665                           Elixhauser Comorbidities  \n666                           Elixhauser Comorbidities  \n667                           Elixhauser Comorbidities  \n668                           Elixhauser Comorbidities  \n669                           Elixhauser Comorbidities  \n670                           Elixhauser Comorbidities  \n671                           Elixhauser Comorbidities  \n672                           Elixhauser Comorbidities  \n673                           Elixhauser Comorbidities  \n674                           Elixhauser Comorbidities  \n675                           Elixhauser Comorbidities  \n676                           Elixhauser Comorbidities  \n677                           Elixhauser Comorbidities  \n678                           Elixhauser Comorbidities  \n679                           Elixhauser Comorbidities  \n680                           Elixhauser Comorbidities  \n681                           Elixhauser Comorbidities  \n682                           Elixhauser Comorbidities  \n683                           Elixhauser Comorbidities  \n684                           Elixhauser Comorbidities  \n685                           Elixhauser Comorbidities  \n686                           Elixhauser Comorbidities  \n687                           Elixhauser Comorbidities  \n688                           Elixhauser Comorbidities  \n689                           Elixhauser Comorbidities  \n690                           Elixhauser Comorbidities  \n691                           Elixhauser Comorbidities  \n692                           Elixhauser Comorbidities  \n693                           Elixhauser Comorbidities  \n694                           Elixhauser Comorbidities  \n695                           Elixhauser Comorbidities  \n696                           Elixhauser Comorbidities  \n697                           Elixhauser Comorbidities  \n698                           Elixhauser Comorbidities  \n699                           Elixhauser Comorbidities  \n700                           Elixhauser Comorbidities  \n701                           Elixhauser Comorbidities  \n702                           Elixhauser Comorbidities  \n703                           Elixhauser Comorbidities  \n704                           Elixhauser Comorbidities  \n705                           Elixhauser Comorbidities  \n706                Prior central venous catheter (CVC)  \n707                           Prior surgical procedure  \n708                       Prior mechanical ventilation  \n709                                 Prior hemodialysis  \n710                         Prior parenteral nutrition  \n711            Prior visit to skilled nursing facility  \n712            Prior visit to skilled nursing facility  \n713            Prior visit to skilled nursing facility  \n714            Prior visit to skilled nursing facility  \n715                              Other infection sites  \n716                              Other infection sites  \n717                              Other infection sites  \n718                              Other infection sites  \n719                              Other infection sites  \n720                              Other infection sites  \n721               Specimen collected in Emergency Room  \n722          Specimen collected in Intensive Care Unit  \n723            Specimen collected in inpatient setting  \n724           Specimen collected in outpatient setting  \n725          Resistance rate at same floor/ward/clinic  \n726          Resistance rate at same floor/ward/clinic  \n727          Resistance rate at same floor/ward/clinic  \n728          Resistance rate at same floor/ward/clinic  \n729          Resistance rate at same floor/ward/clinic  \n730          Resistance rate at same floor/ward/clinic  \n731          Resistance rate at same floor/ward/clinic  \n732          Resistance rate at same floor/ward/clinic  \n733          Resistance rate at same floor/ward/clinic  \n734          Resistance rate at same floor/ward/clinic  \n735          Resistance rate at same floor/ward/clinic  \n736          Resistance rate at same floor/ward/clinic  \n737          Resistance rate at same floor/ward/clinic  \n738          Resistance rate at same floor/ward/clinic  \n739          Resistance rate at same floor/ward/clinic  \n740          Resistance rate at same floor/ward/clinic  \n741          Resistance rate at same floor/ward/clinic  \n742          Resistance rate at same floor/ward/clinic  \n743          Resistance rate at same floor/ward/clinic  \n744          Resistance rate at same floor/ward/clinic  \n745          Resistance rate at same floor/ward/clinic  \n746          Resistance rate at same floor/ward/clinic  \n747          Resistance rate at same floor/ward/clinic  \n748          Resistance rate at same floor/ward/clinic  \n749  Resistance rate at same hospital / department ...  \n750  Resistance rate at same hospital / department ...  \n751  Resistance rate at same hospital / department ...  \n752  Resistance rate at same hospital / department ...  \n753  Resistance rate at same hospital / department ...  \n754  Resistance rate at same hospital / department ...  \n755  Resistance rate at same hospital / department ...  \n756  Resistance rate at same hospital / department ...  \n757  Resistance rate at same hospital / department ...  \n758  Resistance rate at same hospital / department ...  \n759  Resistance rate at same hospital / department ...  \n760  Resistance rate at same hospital / department ...  \n761  Resistance rate at same hospital / department ...  \n762  Resistance rate at same hospital / department ...  \n763  Resistance rate at same hospital / department ...  \n764  Resistance rate at same hospital / department ...  \n765  Resistance rate at same hospital / department ...  \n766  Resistance rate at same hospital / department ...  \n767  Resistance rate at same hospital / department ...  \n768  Resistance rate at same hospital / department ...  \n769  Resistance rate at same hospital / department ...  \n770  Resistance rate at same hospital / department ...  \n771  Resistance rate at same hospital / department ...  \n772  Resistance rate at same hospital / department ...  \n773  Resistance rate at same hospital / department ...  \n774               Resistance rate across all specimens  \n775               Resistance rate across all specimens  \n776               Resistance rate across all specimens  \n777               Resistance rate across all specimens  \n778               Resistance rate across all specimens  \n779               Resistance rate across all specimens  \n780               Resistance rate across all specimens  \n781               Resistance rate across all specimens  \n782               Resistance rate across all specimens  \n783               Resistance rate across all specimens  \n784               Resistance rate across all specimens  \n785               Resistance rate across all specimens  \n786               Resistance rate across all specimens  \n787               Resistance rate across all specimens  \n788               Resistance rate across all specimens  \n789               Resistance rate across all specimens  \n790               Resistance rate across all specimens  \n791               Resistance rate across all specimens  \n792               Resistance rate across all specimens  \n793               Resistance rate across all specimens  \n794               Resistance rate across all specimens  \n795               Resistance rate across all specimens  \n796               Resistance rate across all specimens  \n797               Resistance rate across all specimens  \n798               Resistance rate across all specimens  \n799  Used to denote membership in training set (200...  \n800  Used to denote membership in uncomplicated UTI...  ","text/html":"<div>\n<style scoped>\n    .dataframe tbody tr th:only-of-type {\n        vertical-align: middle;\n    }\n\n    .dataframe tbody tr th {\n        vertical-align: top;\n    }\n\n    .dataframe thead th {\n        text-align: right;\n    }\n</style>\n<table border=\"1\" class=\"dataframe\">\n  <thead>\n    <tr style=\"text-align: right;\">\n      <th></th>\n      <th>file</th>\n      <th>column</th>\n      <th>until</th>\n      <th>from</th>\n      <th>description</th>\n    </tr>\n  </thead>\n  <tbody>\n    <tr>\n      <th>0</th>\n      <td>all_uti_resist_labels.csv</td>\n      <td>example_id</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>Unique specimen ID used to link between files</td>\n    </tr>\n    <tr>\n      <th>1</th>\n      <td>all_uti_resist_labels.csv</td>\n      <td>NIT</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>Indicator of resistance to nitrofurantoin</td>\n    </tr>\n    <tr>\n      <th>2</th>\n      <td>all_uti_resist_labels.csv</td>\n      <td>SXT</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>Indicator of resistance to trimethoprim-sulfam...</td>\n    </tr>\n    <tr>\n      <th>3</th>\n      <td>all_uti_resist_labels.csv</td>\n      <td>CIP</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>Indicator of resistance to ciprofloxacin</td>\n    </tr>\n    <tr>\n      <th>4</th>\n      <td>all_uti_resist_labels.csv</td>\n      <td>LVX</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>Indicator of resistance to levofloxacin</td>\n    </tr>\n    <tr>\n      <th>5</th>\n      <td>all_uti_resist_labels.csv</td>\n      <td>is_train</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>Used to denote membership in training set (200...</td>\n    </tr>\n    <tr>\n      <th>6</th>\n      <td>all_uti_resist_labels.csv</td>\n      <td>uncomplicated</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>Used to denote membership in uncomplicated UTI...</td>\n    </tr>\n    <tr>\n      <th>7</th>\n      <td>all_prescriptions.csv</td>\n      <td>example_id</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>Unique specimen ID used to link between files</td>\n    </tr>\n    <tr>\n      <th>8</th>\n      <td>all_prescriptions.csv</td>\n      <td>prescription</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>Observed empiric prescription (one of NIT, SXT...</td>\n    </tr>\n    <tr>\n      <th>9</th>\n      <td>all_prescriptions.csv</td>\n      <td>is_train</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>Used to denote membership in training set (200...</td>\n    </tr>\n    <tr>\n      <th>10</th>\n      <td>all_uti_features.csv</td>\n      <td>example_id</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>Unique specimen ID used to link between files</td>\n    </tr>\n    <tr>\n      <th>11</th>\n      <td>all_uti_features.csv</td>\n      <td>demographics - age</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>Age (years)</td>\n    </tr>\n    <tr>\n      <th>12</th>\n      <td>all_uti_features.csv</td>\n      <td>demographics - is_white</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>Race (white)</td>\n    </tr>\n    <tr>\n      <th>13</th>\n      <td>all_uti_features.csv</td>\n      <td>demographics - is_veteran</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>Veteran Status (true)</td>\n    </tr>\n    <tr>\n      <th>14</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance LVX 14</td>\n      <td>7.0</td>\n      <td>14.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>15</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance AMP 14</td>\n      <td>7.0</td>\n      <td>14.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>16</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance CFZ 14</td>\n      <td>7.0</td>\n      <td>14.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>17</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance NIT 14</td>\n      <td>7.0</td>\n      <td>14.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>18</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance GEN 14</td>\n      <td>7.0</td>\n      <td>14.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>19</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance SXT 14</td>\n      <td>7.0</td>\n      <td>14.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>20</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance TET 14</td>\n      <td>7.0</td>\n      <td>14.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>21</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance AMC 14</td>\n      <td>7.0</td>\n      <td>14.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>22</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance CIP 14</td>\n      <td>7.0</td>\n      <td>14.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>23</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance SAM 14</td>\n      <td>7.0</td>\n      <td>14.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>24</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance ERY 30</td>\n      <td>7.0</td>\n      <td>30.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>25</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance OXA 30</td>\n      <td>7.0</td>\n      <td>30.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>26</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance QUD 30</td>\n      <td>7.0</td>\n      <td>30.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>27</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance RIF 30</td>\n      <td>7.0</td>\n      <td>30.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>28</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance AMP 30</td>\n      <td>7.0</td>\n      <td>30.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>29</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance CFZ 30</td>\n      <td>7.0</td>\n      <td>30.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>30</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance PEN 30</td>\n      <td>7.0</td>\n      <td>30.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>31</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance LVX 30</td>\n      <td>7.0</td>\n      <td>30.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>32</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance CLI 30</td>\n      <td>7.0</td>\n      <td>30.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>33</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance DOX 30</td>\n      <td>7.0</td>\n      <td>30.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>34</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance NIT 30</td>\n      <td>7.0</td>\n      <td>30.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>35</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance TET 30</td>\n      <td>7.0</td>\n      <td>30.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>36</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance CIP 30</td>\n      <td>7.0</td>\n      <td>30.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>37</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance CRO 30</td>\n      <td>7.0</td>\n      <td>30.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>38</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance GEN 30</td>\n      <td>7.0</td>\n      <td>30.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>39</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance SXT 30</td>\n      <td>7.0</td>\n      <td>30.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>40</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance AMC 30</td>\n      <td>7.0</td>\n      <td>30.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>41</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance ATM 30</td>\n      <td>7.0</td>\n      <td>30.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>42</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance PIP 30</td>\n      <td>7.0</td>\n      <td>30.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>43</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance TOB 30</td>\n      <td>7.0</td>\n      <td>30.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>44</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance TZP 30</td>\n      <td>7.0</td>\n      <td>30.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>45</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance SAM 30</td>\n      <td>7.0</td>\n      <td>30.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>46</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance STRS 30</td>\n      <td>7.0</td>\n      <td>30.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>47</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance MXF 30</td>\n      <td>7.0</td>\n      <td>30.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>48</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance FOX 30</td>\n      <td>7.0</td>\n      <td>30.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>49</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance AMC 90</td>\n      <td>7.0</td>\n      <td>90.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>50</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance AMP 90</td>\n      <td>7.0</td>\n      <td>90.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>51</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance ATM 90</td>\n      <td>7.0</td>\n      <td>90.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>52</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance CAZ 90</td>\n      <td>7.0</td>\n      <td>90.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>53</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance CIP 90</td>\n      <td>7.0</td>\n      <td>90.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>54</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance CRO 90</td>\n      <td>7.0</td>\n      <td>90.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>55</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance NAL 90</td>\n      <td>7.0</td>\n      <td>90.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>56</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance PIP 90</td>\n      <td>7.0</td>\n      <td>90.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>57</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance SXT 90</td>\n      <td>7.0</td>\n      <td>90.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>58</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance TET 90</td>\n      <td>7.0</td>\n      <td>90.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>59</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance CFZ 90</td>\n      <td>7.0</td>\n      <td>90.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>60</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance LVX 90</td>\n      <td>7.0</td>\n      <td>90.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>61</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance NIT 90</td>\n      <td>7.0</td>\n      <td>90.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>62</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance OXA 90</td>\n      <td>7.0</td>\n      <td>90.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>63</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance PEN 90</td>\n      <td>7.0</td>\n      <td>90.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>64</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance ERY 90</td>\n      <td>7.0</td>\n      <td>90.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>65</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance CHL 90</td>\n      <td>7.0</td>\n      <td>90.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>66</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance QUD 90</td>\n      <td>7.0</td>\n      <td>90.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>67</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance DOX 90</td>\n      <td>7.0</td>\n      <td>90.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>68</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance RIF 90</td>\n      <td>7.0</td>\n      <td>90.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>69</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance CLI 90</td>\n      <td>7.0</td>\n      <td>90.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>70</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance GEN 90</td>\n      <td>7.0</td>\n      <td>90.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>71</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance IPM 90</td>\n      <td>7.0</td>\n      <td>90.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>72</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance TIC 90</td>\n      <td>7.0</td>\n      <td>90.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>73</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance TOB 90</td>\n      <td>7.0</td>\n      <td>90.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>74</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance CTT 90</td>\n      <td>7.0</td>\n      <td>90.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>75</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance FEP 90</td>\n      <td>7.0</td>\n      <td>90.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>76</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance TZP 90</td>\n      <td>7.0</td>\n      <td>90.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>77</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance AMK 90</td>\n      <td>7.0</td>\n      <td>90.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>78</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance LZD 90</td>\n      <td>7.0</td>\n      <td>90.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>79</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance SAM 90</td>\n      <td>7.0</td>\n      <td>90.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>80</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance STRS 90</td>\n      <td>7.0</td>\n      <td>90.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>81</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance GENS 90</td>\n      <td>7.0</td>\n      <td>90.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>82</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance MXF 90</td>\n      <td>7.0</td>\n      <td>90.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>83</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance FOX 90</td>\n      <td>7.0</td>\n      <td>90.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>84</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance LVX 180</td>\n      <td>7.0</td>\n      <td>180.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>85</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance AMP 180</td>\n      <td>7.0</td>\n      <td>180.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>86</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance CFZ 180</td>\n      <td>7.0</td>\n      <td>180.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>87</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance CIP 180</td>\n      <td>7.0</td>\n      <td>180.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>88</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance GEN 180</td>\n      <td>7.0</td>\n      <td>180.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>89</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance PIP 180</td>\n      <td>7.0</td>\n      <td>180.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>90</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance ATM 180</td>\n      <td>7.0</td>\n      <td>180.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>91</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance IPM 180</td>\n      <td>7.0</td>\n      <td>180.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>92</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance TIC 180</td>\n      <td>7.0</td>\n      <td>180.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>93</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance TOB 180</td>\n      <td>7.0</td>\n      <td>180.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>94</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance ERY 180</td>\n      <td>7.0</td>\n      <td>180.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>95</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance OXA 180</td>\n      <td>7.0</td>\n      <td>180.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>96</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance PEN 180</td>\n      <td>7.0</td>\n      <td>180.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>97</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance CLI 180</td>\n      <td>7.0</td>\n      <td>180.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>98</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance NAL 180</td>\n      <td>7.0</td>\n      <td>180.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>99</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance DOX 180</td>\n      <td>7.0</td>\n      <td>180.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>100</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance QUD 180</td>\n      <td>7.0</td>\n      <td>180.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>101</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance RIF 180</td>\n      <td>7.0</td>\n      <td>180.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>102</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance TET 180</td>\n      <td>7.0</td>\n      <td>180.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>103</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance AMC 180</td>\n      <td>7.0</td>\n      <td>180.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>104</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance AMK 180</td>\n      <td>7.0</td>\n      <td>180.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>105</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance CAZ 180</td>\n      <td>7.0</td>\n      <td>180.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>106</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance CHL 180</td>\n      <td>7.0</td>\n      <td>180.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>107</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance CRO 180</td>\n      <td>7.0</td>\n      <td>180.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>108</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance CTT 180</td>\n      <td>7.0</td>\n      <td>180.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>109</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance FEP 180</td>\n      <td>7.0</td>\n      <td>180.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>110</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance NIT 180</td>\n      <td>7.0</td>\n      <td>180.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>111</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance SXT 180</td>\n      <td>7.0</td>\n      <td>180.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>112</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance VAN 180</td>\n      <td>7.0</td>\n      <td>180.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>113</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance TZP 180</td>\n      <td>7.0</td>\n      <td>180.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>114</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance ERT 180</td>\n      <td>7.0</td>\n      <td>180.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>115</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance LZD 180</td>\n      <td>7.0</td>\n      <td>180.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>116</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance SAM 180</td>\n      <td>7.0</td>\n      <td>180.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>117</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance STRS 180</td>\n      <td>7.0</td>\n      <td>180.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>118</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance GENS 180</td>\n      <td>7.0</td>\n      <td>180.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>119</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance MXF 180</td>\n      <td>7.0</td>\n      <td>180.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>120</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance FOX 180</td>\n      <td>7.0</td>\n      <td>180.0</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>121</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance CFZ ALL</td>\n      <td>7.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>122</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance ERY ALL</td>\n      <td>7.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>123</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance LVX ALL</td>\n      <td>7.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>124</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance OXA ALL</td>\n      <td>7.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>125</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance PEN ALL</td>\n      <td>7.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>126</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance TET ALL</td>\n      <td>7.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>127</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance AMP ALL</td>\n      <td>7.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>128</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance CIP ALL</td>\n      <td>7.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>129</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance SXT ALL</td>\n      <td>7.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>130</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance DOX ALL</td>\n      <td>7.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>131</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance RIF ALL</td>\n      <td>7.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>132</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance NIT ALL</td>\n      <td>7.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>133</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance VAN ALL</td>\n      <td>7.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>134</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance QUD ALL</td>\n      <td>7.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>135</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance CLI ALL</td>\n      <td>7.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>136</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance AMC ALL</td>\n      <td>7.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>137</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance ATM ALL</td>\n      <td>7.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>138</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance CAZ ALL</td>\n      <td>7.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>139</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance CRO ALL</td>\n      <td>7.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>140</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance FEP ALL</td>\n      <td>7.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>141</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance NAL ALL</td>\n      <td>7.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>142</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance PIP ALL</td>\n      <td>7.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>143</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance GEN ALL</td>\n      <td>7.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>144</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance ERT ALL</td>\n      <td>7.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>145</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance CHL ALL</td>\n      <td>7.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>146</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance AMK ALL</td>\n      <td>7.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>147</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance CTT ALL</td>\n      <td>7.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>148</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance IPM ALL</td>\n      <td>7.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>149</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance TOB ALL</td>\n      <td>7.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>150</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance TIC ALL</td>\n      <td>7.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>151</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance TZP ALL</td>\n      <td>7.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>152</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance LZD ALL</td>\n      <td>7.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>153</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance SAM ALL</td>\n      <td>7.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>154</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance GENS ALL</td>\n      <td>7.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>155</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance STRS ALL</td>\n      <td>7.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>156</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance MXF ALL</td>\n      <td>7.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>157</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev resistance FOX ALL</td>\n      <td>7.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic resistance, see documentation...</td>\n    </tr>\n    <tr>\n      <th>158</th>\n      <td>all_uti_features.csv</td>\n      <td>ab class 7 - fluoroquinolone</td>\n      <td>2.0</td>\n      <td>7</td>\n      <td>Prior antibiotic exposure (class)</td>\n    </tr>\n    <tr>\n      <th>159</th>\n      <td>all_uti_features.csv</td>\n      <td>ab class 7 - glycopeptides</td>\n      <td>2.0</td>\n      <td>7</td>\n      <td>Prior antibiotic exposure (class)</td>\n    </tr>\n    <tr>\n      <th>160</th>\n      <td>all_uti_features.csv</td>\n      <td>ab class 7 - nitroimidazole</td>\n      <td>2.0</td>\n      <td>7</td>\n      <td>Prior antibiotic exposure (class)</td>\n    </tr>\n    <tr>\n      <th>161</th>\n      <td>all_uti_features.csv</td>\n      <td>ab class 7 - macrolide_lincosamide</td>\n      <td>2.0</td>\n      <td>7</td>\n      <td>Prior antibiotic exposure (class)</td>\n    </tr>\n    <tr>\n      <th>162</th>\n      <td>all_uti_features.csv</td>\n      <td>ab class 7 - nitrofuran</td>\n      <td>2.0</td>\n      <td>7</td>\n      <td>Prior antibiotic exposure (class)</td>\n    </tr>\n    <tr>\n      <th>163</th>\n      <td>all_uti_features.csv</td>\n      <td>ab class 7 - folate_inhibitor</td>\n      <td>2.0</td>\n      <td>7</td>\n      <td>Prior antibiotic exposure (class)</td>\n    </tr>\n    <tr>\n      <th>164</th>\n      <td>all_uti_features.csv</td>\n      <td>ab class 7 - beta_lactam</td>\n      <td>2.0</td>\n      <td>7</td>\n      <td>Prior antibiotic exposure (class)</td>\n    </tr>\n    <tr>\n      <th>165</th>\n      <td>all_uti_features.csv</td>\n      <td>ab class 7 - antifungal</td>\n      <td>2.0</td>\n      <td>7</td>\n      <td>Prior antibiotic exposure (class)</td>\n    </tr>\n    <tr>\n      <th>166</th>\n      <td>all_uti_features.csv</td>\n      <td>ab class 7 - tetracycline</td>\n      <td>2.0</td>\n      <td>7</td>\n      <td>Prior antibiotic exposure (class)</td>\n    </tr>\n    <tr>\n      <th>167</th>\n      <td>all_uti_features.csv</td>\n      <td>ab class 7 - ansamycin</td>\n      <td>2.0</td>\n      <td>7</td>\n      <td>Prior antibiotic exposure (class)</td>\n    </tr>\n    <tr>\n      <th>168</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 7 - ciprofloxacin</td>\n      <td>2.0</td>\n      <td>7</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>169</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 7 - levofloxacin</td>\n      <td>2.0</td>\n      <td>7</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>170</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 7 - vancomycin</td>\n      <td>2.0</td>\n      <td>7</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>171</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 7 - metronidazole</td>\n      <td>2.0</td>\n      <td>7</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>172</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 7 - clindamycin</td>\n      <td>2.0</td>\n      <td>7</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>173</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 7 - azithromycin</td>\n      <td>2.0</td>\n      <td>7</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>174</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 7 - nitrofurantoin</td>\n      <td>2.0</td>\n      <td>7</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>175</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 7 - trimethoprim/sulfamethoxazole</td>\n      <td>2.0</td>\n      <td>7</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>176</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 7 - amoxicillin</td>\n      <td>2.0</td>\n      <td>7</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>177</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 7 - cephalexin</td>\n      <td>2.0</td>\n      <td>7</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>178</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 7 - fluconazole</td>\n      <td>2.0</td>\n      <td>7</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>179</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 7 - penicillin</td>\n      <td>2.0</td>\n      <td>7</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>180</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 7 - amoxicillin/clavulanate</td>\n      <td>2.0</td>\n      <td>7</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>181</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 7 - ceftazidime</td>\n      <td>2.0</td>\n      <td>7</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>182</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 7 - doxycycline</td>\n      <td>2.0</td>\n      <td>7</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>183</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 7 - cefpodoxime</td>\n      <td>2.0</td>\n      <td>7</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>184</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 7 - tetracycline</td>\n      <td>2.0</td>\n      <td>7</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>185</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 7 - dicloxacillin</td>\n      <td>2.0</td>\n      <td>7</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>186</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 7 - cefuroxime</td>\n      <td>2.0</td>\n      <td>7</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>187</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 7 - minocycline</td>\n      <td>2.0</td>\n      <td>7</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>188</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 7 - rifampin</td>\n      <td>2.0</td>\n      <td>7</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>189</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 7 - clarithromycin</td>\n      <td>2.0</td>\n      <td>7</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>190</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 7 - nafcillin</td>\n      <td>2.0</td>\n      <td>7</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>191</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 7 - erythromycin</td>\n      <td>2.0</td>\n      <td>7</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>192</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 7 - cefadroxil</td>\n      <td>2.0</td>\n      <td>7</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>193</th>\n      <td>all_uti_features.csv</td>\n      <td>ab subtype 7 - penicillins</td>\n      <td>2.0</td>\n      <td>7</td>\n      <td>Prior antibiotic exposure (subclass)</td>\n    </tr>\n    <tr>\n      <th>194</th>\n      <td>all_uti_features.csv</td>\n      <td>ab subtype 7 - cephalosporin_gen1</td>\n      <td>2.0</td>\n      <td>7</td>\n      <td>Prior antibiotic exposure (subclass)</td>\n    </tr>\n    <tr>\n      <th>195</th>\n      <td>all_uti_features.csv</td>\n      <td>ab subtype 7 - azole</td>\n      <td>2.0</td>\n      <td>7</td>\n      <td>Prior antibiotic exposure (subclass)</td>\n    </tr>\n    <tr>\n      <th>196</th>\n      <td>all_uti_features.csv</td>\n      <td>ab subtype 7 - beta_lactam_combo</td>\n      <td>2.0</td>\n      <td>7</td>\n      <td>Prior antibiotic exposure (subclass)</td>\n    </tr>\n    <tr>\n      <th>197</th>\n      <td>all_uti_features.csv</td>\n      <td>ab subtype 7 - cephalosporin_gen3</td>\n      <td>2.0</td>\n      <td>7</td>\n      <td>Prior antibiotic exposure (subclass)</td>\n    </tr>\n    <tr>\n      <th>198</th>\n      <td>all_uti_features.csv</td>\n      <td>ab subtype 7 - antistaphylococcal</td>\n      <td>2.0</td>\n      <td>7</td>\n      <td>Prior antibiotic exposure (subclass)</td>\n    </tr>\n    <tr>\n      <th>199</th>\n      <td>all_uti_features.csv</td>\n      <td>ab subtype 7 - cephalosporin_gen2</td>\n      <td>2.0</td>\n      <td>7</td>\n      <td>Prior antibiotic exposure (subclass)</td>\n    </tr>\n    <tr>\n      <th>200</th>\n      <td>all_uti_features.csv</td>\n      <td>ab class 14 - tetracycline</td>\n      <td>2.0</td>\n      <td>14</td>\n      <td>Prior antibiotic exposure (class)</td>\n    </tr>\n    <tr>\n      <th>201</th>\n      <td>all_uti_features.csv</td>\n      <td>ab class 14 - fluoroquinolone</td>\n      <td>2.0</td>\n      <td>14</td>\n      <td>Prior antibiotic exposure (class)</td>\n    </tr>\n    <tr>\n      <th>202</th>\n      <td>all_uti_features.csv</td>\n      <td>ab class 14 - nitrofuran</td>\n      <td>2.0</td>\n      <td>14</td>\n      <td>Prior antibiotic exposure (class)</td>\n    </tr>\n    <tr>\n      <th>203</th>\n      <td>all_uti_features.csv</td>\n      <td>ab class 14 - glycopeptides</td>\n      <td>2.0</td>\n      <td>14</td>\n      <td>Prior antibiotic exposure (class)</td>\n    </tr>\n    <tr>\n      <th>204</th>\n      <td>all_uti_features.csv</td>\n      <td>ab class 14 - nitroimidazole</td>\n      <td>2.0</td>\n      <td>14</td>\n      <td>Prior antibiotic exposure (class)</td>\n    </tr>\n    <tr>\n      <th>205</th>\n      <td>all_uti_features.csv</td>\n      <td>ab class 14 - macrolide_lincosamide</td>\n      <td>2.0</td>\n      <td>14</td>\n      <td>Prior antibiotic exposure (class)</td>\n    </tr>\n    <tr>\n      <th>206</th>\n      <td>all_uti_features.csv</td>\n      <td>ab class 14 - folate_inhibitor</td>\n      <td>2.0</td>\n      <td>14</td>\n      <td>Prior antibiotic exposure (class)</td>\n    </tr>\n    <tr>\n      <th>207</th>\n      <td>all_uti_features.csv</td>\n      <td>ab class 14 - beta_lactam</td>\n      <td>2.0</td>\n      <td>14</td>\n      <td>Prior antibiotic exposure (class)</td>\n    </tr>\n    <tr>\n      <th>208</th>\n      <td>all_uti_features.csv</td>\n      <td>ab class 14 - antifungal</td>\n      <td>2.0</td>\n      <td>14</td>\n      <td>Prior antibiotic exposure (class)</td>\n    </tr>\n    <tr>\n      <th>209</th>\n      <td>all_uti_features.csv</td>\n      <td>ab class 14 - fosfomycin</td>\n      <td>2.0</td>\n      <td>14</td>\n      <td>Prior antibiotic exposure (class)</td>\n    </tr>\n    <tr>\n      <th>210</th>\n      <td>all_uti_features.csv</td>\n      <td>ab class 14 - ansamycin</td>\n      <td>2.0</td>\n      <td>14</td>\n      <td>Prior antibiotic exposure (class)</td>\n    </tr>\n    <tr>\n      <th>211</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 14 - tetracycline</td>\n      <td>2.0</td>\n      <td>14</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>212</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 14 - ciprofloxacin</td>\n      <td>2.0</td>\n      <td>14</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>213</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 14 - nitrofurantoin</td>\n      <td>2.0</td>\n      <td>14</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>214</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 14 - levofloxacin</td>\n      <td>2.0</td>\n      <td>14</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>215</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 14 - vancomycin</td>\n      <td>2.0</td>\n      <td>14</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>216</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 14 - metronidazole</td>\n      <td>2.0</td>\n      <td>14</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>217</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 14 - clindamycin</td>\n      <td>2.0</td>\n      <td>14</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>218</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 14 - azithromycin</td>\n      <td>2.0</td>\n      <td>14</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>219</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 14 - doxycycline</td>\n      <td>2.0</td>\n      <td>14</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>220</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 14 - trimethoprim/sulfamethoxazole</td>\n      <td>2.0</td>\n      <td>14</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>221</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 14 - amoxicillin/clavulanate</td>\n      <td>2.0</td>\n      <td>14</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>222</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 14 - fluconazole</td>\n      <td>2.0</td>\n      <td>14</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>223</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 14 - amoxicillin</td>\n      <td>2.0</td>\n      <td>14</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>224</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 14 - cephalexin</td>\n      <td>2.0</td>\n      <td>14</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>225</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 14 - dicloxacillin</td>\n      <td>2.0</td>\n      <td>14</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>226</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 14 - penicillin</td>\n      <td>2.0</td>\n      <td>14</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>227</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 14 - ceftazidime</td>\n      <td>2.0</td>\n      <td>14</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>228</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 14 - cefpodoxime</td>\n      <td>2.0</td>\n      <td>14</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>229</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 14 - erythromycin</td>\n      <td>2.0</td>\n      <td>14</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>230</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 14 - clarithromycin</td>\n      <td>2.0</td>\n      <td>14</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>231</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 14 - moxifloxacin</td>\n      <td>2.0</td>\n      <td>14</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>232</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 14 - nafcillin</td>\n      <td>2.0</td>\n      <td>14</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>233</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 14 - fosfomycin</td>\n      <td>2.0</td>\n      <td>14</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>234</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 14 - cefuroxime</td>\n      <td>2.0</td>\n      <td>14</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>235</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 14 - minocycline</td>\n      <td>2.0</td>\n      <td>14</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>236</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 14 - rifampin</td>\n      <td>2.0</td>\n      <td>14</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>237</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 14 - cefadroxil</td>\n      <td>2.0</td>\n      <td>14</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>238</th>\n      <td>all_uti_features.csv</td>\n      <td>ab subtype 14 - beta_lactam_combo</td>\n      <td>2.0</td>\n      <td>14</td>\n      <td>Prior antibiotic exposure (subclass)</td>\n    </tr>\n    <tr>\n      <th>239</th>\n      <td>all_uti_features.csv</td>\n      <td>ab subtype 14 - azole</td>\n      <td>2.0</td>\n      <td>14</td>\n      <td>Prior antibiotic exposure (subclass)</td>\n    </tr>\n    <tr>\n      <th>240</th>\n      <td>all_uti_features.csv</td>\n      <td>ab subtype 14 - penicillins</td>\n      <td>2.0</td>\n      <td>14</td>\n      <td>Prior antibiotic exposure (subclass)</td>\n    </tr>\n    <tr>\n      <th>241</th>\n      <td>all_uti_features.csv</td>\n      <td>ab subtype 14 - cephalosporin_gen1</td>\n      <td>2.0</td>\n      <td>14</td>\n      <td>Prior antibiotic exposure (subclass)</td>\n    </tr>\n    <tr>\n      <th>242</th>\n      <td>all_uti_features.csv</td>\n      <td>ab subtype 14 - antistaphylococcal</td>\n      <td>2.0</td>\n      <td>14</td>\n      <td>Prior antibiotic exposure (subclass)</td>\n    </tr>\n    <tr>\n      <th>243</th>\n      <td>all_uti_features.csv</td>\n      <td>ab subtype 14 - cephalosporin_gen3</td>\n      <td>2.0</td>\n      <td>14</td>\n      <td>Prior antibiotic exposure (subclass)</td>\n    </tr>\n    <tr>\n      <th>244</th>\n      <td>all_uti_features.csv</td>\n      <td>ab subtype 14 - cephalosporin_gen2</td>\n      <td>2.0</td>\n      <td>14</td>\n      <td>Prior antibiotic exposure (subclass)</td>\n    </tr>\n    <tr>\n      <th>245</th>\n      <td>all_uti_features.csv</td>\n      <td>ab class 30 - macrolide_lincosamide</td>\n      <td>2.0</td>\n      <td>30</td>\n      <td>Prior antibiotic exposure (class)</td>\n    </tr>\n    <tr>\n      <th>246</th>\n      <td>all_uti_features.csv</td>\n      <td>ab class 30 - tetracycline</td>\n      <td>2.0</td>\n      <td>30</td>\n      <td>Prior antibiotic exposure (class)</td>\n    </tr>\n    <tr>\n      <th>247</th>\n      <td>all_uti_features.csv</td>\n      <td>ab class 30 - fluoroquinolone</td>\n      <td>2.0</td>\n      <td>30</td>\n      <td>Prior antibiotic exposure (class)</td>\n    </tr>\n    <tr>\n      <th>248</th>\n      <td>all_uti_features.csv</td>\n      <td>ab class 30 - nitrofuran</td>\n      <td>2.0</td>\n      <td>30</td>\n      <td>Prior antibiotic exposure (class)</td>\n    </tr>\n    <tr>\n      <th>249</th>\n      <td>all_uti_features.csv</td>\n      <td>ab class 30 - glycopeptides</td>\n      <td>2.0</td>\n      <td>30</td>\n      <td>Prior antibiotic exposure (class)</td>\n    </tr>\n    <tr>\n      <th>250</th>\n      <td>all_uti_features.csv</td>\n      <td>ab class 30 - nitroimidazole</td>\n      <td>2.0</td>\n      <td>30</td>\n      <td>Prior antibiotic exposure (class)</td>\n    </tr>\n    <tr>\n      <th>251</th>\n      <td>all_uti_features.csv</td>\n      <td>ab class 30 - beta_lactam</td>\n      <td>2.0</td>\n      <td>30</td>\n      <td>Prior antibiotic exposure (class)</td>\n    </tr>\n    <tr>\n      <th>252</th>\n      <td>all_uti_features.csv</td>\n      <td>ab class 30 - folate_inhibitor</td>\n      <td>2.0</td>\n      <td>30</td>\n      <td>Prior antibiotic exposure (class)</td>\n    </tr>\n    <tr>\n      <th>253</th>\n      <td>all_uti_features.csv</td>\n      <td>ab class 30 - antifungal</td>\n      <td>2.0</td>\n      <td>30</td>\n      <td>Prior antibiotic exposure (class)</td>\n    </tr>\n    <tr>\n      <th>254</th>\n      <td>all_uti_features.csv</td>\n      <td>ab class 30 - monobactam</td>\n      <td>2.0</td>\n      <td>30</td>\n      <td>Prior antibiotic exposure (class)</td>\n    </tr>\n    <tr>\n      <th>255</th>\n      <td>all_uti_features.csv</td>\n      <td>ab class 30 - aminoglycoside</td>\n      <td>2.0</td>\n      <td>30</td>\n      <td>Prior antibiotic exposure (class)</td>\n    </tr>\n    <tr>\n      <th>256</th>\n      <td>all_uti_features.csv</td>\n      <td>ab class 30 - fosfomycin</td>\n      <td>2.0</td>\n      <td>30</td>\n      <td>Prior antibiotic exposure (class)</td>\n    </tr>\n    <tr>\n      <th>257</th>\n      <td>all_uti_features.csv</td>\n      <td>ab class 30 - ansamycin</td>\n      <td>2.0</td>\n      <td>30</td>\n      <td>Prior antibiotic exposure (class)</td>\n    </tr>\n    <tr>\n      <th>258</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 30 - azithromycin</td>\n      <td>2.0</td>\n      <td>30</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>259</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 30 - tetracycline</td>\n      <td>2.0</td>\n      <td>30</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>260</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 30 - moxifloxacin</td>\n      <td>2.0</td>\n      <td>30</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>261</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 30 - ciprofloxacin</td>\n      <td>2.0</td>\n      <td>30</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>262</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 30 - nitrofurantoin</td>\n      <td>2.0</td>\n      <td>30</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>263</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 30 - levofloxacin</td>\n      <td>2.0</td>\n      <td>30</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>264</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 30 - vancomycin</td>\n      <td>2.0</td>\n      <td>30</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>265</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 30 - metronidazole</td>\n      <td>2.0</td>\n      <td>30</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>266</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 30 - clarithromycin</td>\n      <td>2.0</td>\n      <td>30</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>267</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 30 - clindamycin</td>\n      <td>2.0</td>\n      <td>30</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>268</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 30 - doxycycline</td>\n      <td>2.0</td>\n      <td>30</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>269</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 30 - cefazolin</td>\n      <td>2.0</td>\n      <td>30</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>270</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 30 - trimethoprim/sulfamethoxazole</td>\n      <td>2.0</td>\n      <td>30</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>271</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 30 - amoxicillin/clavulanate</td>\n      <td>2.0</td>\n      <td>30</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>272</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 30 - amoxicillin</td>\n      <td>2.0</td>\n      <td>30</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>273</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 30 - fluconazole</td>\n      <td>2.0</td>\n      <td>30</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>274</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 30 - aztreonam</td>\n      <td>2.0</td>\n      <td>30</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>275</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 30 - cephalexin</td>\n      <td>2.0</td>\n      <td>30</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>276</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 30 - dicloxacillin</td>\n      <td>2.0</td>\n      <td>30</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>277</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 30 - ceftriaxone</td>\n      <td>2.0</td>\n      <td>30</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>278</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 30 - cefoxitin</td>\n      <td>2.0</td>\n      <td>30</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>279</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 30 - cefpodoxime</td>\n      <td>2.0</td>\n      <td>30</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>280</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 30 - penicillin</td>\n      <td>2.0</td>\n      <td>30</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>281</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 30 - ceftazidime</td>\n      <td>2.0</td>\n      <td>30</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>282</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 30 - ampicillin/sulbactam</td>\n      <td>2.0</td>\n      <td>30</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>283</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 30 - fosfomycin</td>\n      <td>2.0</td>\n      <td>30</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>284</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 30 - erythromycin</td>\n      <td>2.0</td>\n      <td>30</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>285</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 30 - gentamicin</td>\n      <td>2.0</td>\n      <td>30</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>286</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 30 - nafcillin</td>\n      <td>2.0</td>\n      <td>30</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>287</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 30 - cefuroxime</td>\n      <td>2.0</td>\n      <td>30</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>288</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 30 - minocycline</td>\n      <td>2.0</td>\n      <td>30</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>289</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 30 - rifampin</td>\n      <td>2.0</td>\n      <td>30</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>290</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 30 - cefadroxil</td>\n      <td>2.0</td>\n      <td>30</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>291</th>\n      <td>all_uti_features.csv</td>\n      <td>ab subtype 30 - cephalosporin_gen1</td>\n      <td>2.0</td>\n      <td>30</td>\n      <td>Prior antibiotic exposure (subclass)</td>\n    </tr>\n    <tr>\n      <th>292</th>\n      <td>all_uti_features.csv</td>\n      <td>ab subtype 30 - beta_lactam_combo</td>\n      <td>2.0</td>\n      <td>30</td>\n      <td>Prior antibiotic exposure (subclass)</td>\n    </tr>\n    <tr>\n      <th>293</th>\n      <td>all_uti_features.csv</td>\n      <td>ab subtype 30 - penicillins</td>\n      <td>2.0</td>\n      <td>30</td>\n      <td>Prior antibiotic exposure (subclass)</td>\n    </tr>\n    <tr>\n      <th>294</th>\n      <td>all_uti_features.csv</td>\n      <td>ab subtype 30 - azole</td>\n      <td>2.0</td>\n      <td>30</td>\n      <td>Prior antibiotic exposure (subclass)</td>\n    </tr>\n    <tr>\n      <th>295</th>\n      <td>all_uti_features.csv</td>\n      <td>ab subtype 30 - antistaphylococcal</td>\n      <td>2.0</td>\n      <td>30</td>\n      <td>Prior antibiotic exposure (subclass)</td>\n    </tr>\n    <tr>\n      <th>296</th>\n      <td>all_uti_features.csv</td>\n      <td>ab subtype 30 - cephalosporin_gen3</td>\n      <td>2.0</td>\n      <td>30</td>\n      <td>Prior antibiotic exposure (subclass)</td>\n    </tr>\n    <tr>\n      <th>297</th>\n      <td>all_uti_features.csv</td>\n      <td>ab subtype 30 - cephalosporin_gen2</td>\n      <td>2.0</td>\n      <td>30</td>\n      <td>Prior antibiotic exposure (subclass)</td>\n    </tr>\n    <tr>\n      <th>298</th>\n      <td>all_uti_features.csv</td>\n      <td>ab class 90 - macrolide_lincosamide</td>\n      <td>2.0</td>\n      <td>90</td>\n      <td>Prior antibiotic exposure (class)</td>\n    </tr>\n    <tr>\n      <th>299</th>\n      <td>all_uti_features.csv</td>\n      <td>ab class 90 - fluoroquinolone</td>\n      <td>2.0</td>\n      <td>90</td>\n      <td>Prior antibiotic exposure (class)</td>\n    </tr>\n    <tr>\n      <th>300</th>\n      <td>all_uti_features.csv</td>\n      <td>ab class 90 - tetracycline</td>\n      <td>2.0</td>\n      <td>90</td>\n      <td>Prior antibiotic exposure (class)</td>\n    </tr>\n    <tr>\n      <th>301</th>\n      <td>all_uti_features.csv</td>\n      <td>ab class 90 - nitrofuran</td>\n      <td>2.0</td>\n      <td>90</td>\n      <td>Prior antibiotic exposure (class)</td>\n    </tr>\n    <tr>\n      <th>302</th>\n      <td>all_uti_features.csv</td>\n      <td>ab class 90 - beta_lactam</td>\n      <td>2.0</td>\n      <td>90</td>\n      <td>Prior antibiotic exposure (class)</td>\n    </tr>\n    <tr>\n      <th>303</th>\n      <td>all_uti_features.csv</td>\n      <td>ab class 90 - glycopeptides</td>\n      <td>2.0</td>\n      <td>90</td>\n      <td>Prior antibiotic exposure (class)</td>\n    </tr>\n    <tr>\n      <th>304</th>\n      <td>all_uti_features.csv</td>\n      <td>ab class 90 - nitroimidazole</td>\n      <td>2.0</td>\n      <td>90</td>\n      <td>Prior antibiotic exposure (class)</td>\n    </tr>\n    <tr>\n      <th>305</th>\n      <td>all_uti_features.csv</td>\n      <td>ab class 90 - folate_inhibitor</td>\n      <td>2.0</td>\n      <td>90</td>\n      <td>Prior antibiotic exposure (class)</td>\n    </tr>\n    <tr>\n      <th>306</th>\n      <td>all_uti_features.csv</td>\n      <td>ab class 90 - antifungal</td>\n      <td>2.0</td>\n      <td>90</td>\n      <td>Prior antibiotic exposure (class)</td>\n    </tr>\n    <tr>\n      <th>307</th>\n      <td>all_uti_features.csv</td>\n      <td>ab class 90 - fosfomycin</td>\n      <td>2.0</td>\n      <td>90</td>\n      <td>Prior antibiotic exposure (class)</td>\n    </tr>\n    <tr>\n      <th>308</th>\n      <td>all_uti_features.csv</td>\n      <td>ab class 90 - monobactam</td>\n      <td>2.0</td>\n      <td>90</td>\n      <td>Prior antibiotic exposure (class)</td>\n    </tr>\n    <tr>\n      <th>309</th>\n      <td>all_uti_features.csv</td>\n      <td>ab class 90 - aminoglycoside</td>\n      <td>2.0</td>\n      <td>90</td>\n      <td>Prior antibiotic exposure (class)</td>\n    </tr>\n    <tr>\n      <th>310</th>\n      <td>all_uti_features.csv</td>\n      <td>ab class 90 - oxazolidinones</td>\n      <td>2.0</td>\n      <td>90</td>\n      <td>Prior antibiotic exposure (class)</td>\n    </tr>\n    <tr>\n      <th>311</th>\n      <td>all_uti_features.csv</td>\n      <td>ab class 90 - mixed</td>\n      <td>2.0</td>\n      <td>90</td>\n      <td>Prior antibiotic exposure (class)</td>\n    </tr>\n    <tr>\n      <th>312</th>\n      <td>all_uti_features.csv</td>\n      <td>ab class 90 - ansamycin</td>\n      <td>2.0</td>\n      <td>90</td>\n      <td>Prior antibiotic exposure (class)</td>\n    </tr>\n    <tr>\n      <th>313</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 90 - azithromycin</td>\n      <td>2.0</td>\n      <td>90</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>314</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 90 - ciprofloxacin</td>\n      <td>2.0</td>\n      <td>90</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>315</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 90 - tetracycline</td>\n      <td>2.0</td>\n      <td>90</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>316</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 90 - moxifloxacin</td>\n      <td>2.0</td>\n      <td>90</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>317</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 90 - levofloxacin</td>\n      <td>2.0</td>\n      <td>90</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>318</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 90 - nitrofurantoin</td>\n      <td>2.0</td>\n      <td>90</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>319</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 90 - amoxicillin/clavulanate</td>\n      <td>2.0</td>\n      <td>90</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>320</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 90 - vancomycin</td>\n      <td>2.0</td>\n      <td>90</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>321</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 90 - cefepime</td>\n      <td>2.0</td>\n      <td>90</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>322</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 90 - metronidazole</td>\n      <td>2.0</td>\n      <td>90</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>323</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 90 - trimethoprim/sulfamethoxazole</td>\n      <td>2.0</td>\n      <td>90</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>324</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 90 - clindamycin</td>\n      <td>2.0</td>\n      <td>90</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>325</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 90 - cefpodoxime</td>\n      <td>2.0</td>\n      <td>90</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>326</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 90 - fluconazole</td>\n      <td>2.0</td>\n      <td>90</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>327</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 90 - clarithromycin</td>\n      <td>2.0</td>\n      <td>90</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>328</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 90 - ceftriaxone</td>\n      <td>2.0</td>\n      <td>90</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>329</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 90 - doxycycline</td>\n      <td>2.0</td>\n      <td>90</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>330</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 90 - cephalexin</td>\n      <td>2.0</td>\n      <td>90</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>331</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 90 - cefazolin</td>\n      <td>2.0</td>\n      <td>90</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>332</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 90 - trimethoprim</td>\n      <td>2.0</td>\n      <td>90</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>333</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 90 - amoxicillin</td>\n      <td>2.0</td>\n      <td>90</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>334</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 90 - fosfomycin</td>\n      <td>2.0</td>\n      <td>90</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>335</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 90 - aztreonam</td>\n      <td>2.0</td>\n      <td>90</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>336</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 90 - cefotetan</td>\n      <td>2.0</td>\n      <td>90</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>337</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 90 - penicillin</td>\n      <td>2.0</td>\n      <td>90</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>338</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 90 - dicloxacillin</td>\n      <td>2.0</td>\n      <td>90</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>339</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 90 - ceftazidime</td>\n      <td>2.0</td>\n      <td>90</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>340</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 90 - linezolid</td>\n      <td>2.0</td>\n      <td>90</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>341</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 90 - gentamicin</td>\n      <td>2.0</td>\n      <td>90</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>342</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 90 - cefixime</td>\n      <td>2.0</td>\n      <td>90</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>343</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 90 - cefuroxime</td>\n      <td>2.0</td>\n      <td>90</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>344</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 90 - ampicillin/sulbactam</td>\n      <td>2.0</td>\n      <td>90</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>345</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 90 - cefoxitin</td>\n      <td>2.0</td>\n      <td>90</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>346</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 90 - ertapenem</td>\n      <td>2.0</td>\n      <td>90</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>347</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 90 - erythromycin</td>\n      <td>2.0</td>\n      <td>90</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>348</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 90 - cefprozil</td>\n      <td>2.0</td>\n      <td>90</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>349</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 90 - cefaclor</td>\n      <td>2.0</td>\n      <td>90</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>350</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 90 - cefadroxil</td>\n      <td>2.0</td>\n      <td>90</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>351</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 90 - nafcillin</td>\n      <td>2.0</td>\n      <td>90</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>352</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 90 - amoxicillin_clarithromycin</td>\n      <td>2.0</td>\n      <td>90</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>353</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 90 - minocycline</td>\n      <td>2.0</td>\n      <td>90</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>354</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 90 - rifampin</td>\n      <td>2.0</td>\n      <td>90</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>355</th>\n      <td>all_uti_features.csv</td>\n      <td>ab subtype 90 - beta_lactam_combo</td>\n      <td>2.0</td>\n      <td>90</td>\n      <td>Prior antibiotic exposure (subclass)</td>\n    </tr>\n    <tr>\n      <th>356</th>\n      <td>all_uti_features.csv</td>\n      <td>ab subtype 90 - cephalosporin_gen4</td>\n      <td>2.0</td>\n      <td>90</td>\n      <td>Prior antibiotic exposure (subclass)</td>\n    </tr>\n    <tr>\n      <th>357</th>\n      <td>all_uti_features.csv</td>\n      <td>ab subtype 90 - carbapenem</td>\n      <td>2.0</td>\n      <td>90</td>\n      <td>Prior antibiotic exposure (subclass)</td>\n    </tr>\n    <tr>\n      <th>358</th>\n      <td>all_uti_features.csv</td>\n      <td>ab subtype 90 - cephalosporin_gen3</td>\n      <td>2.0</td>\n      <td>90</td>\n      <td>Prior antibiotic exposure (subclass)</td>\n    </tr>\n    <tr>\n      <th>359</th>\n      <td>all_uti_features.csv</td>\n      <td>ab subtype 90 - azole</td>\n      <td>2.0</td>\n      <td>90</td>\n      <td>Prior antibiotic exposure (subclass)</td>\n    </tr>\n    <tr>\n      <th>360</th>\n      <td>all_uti_features.csv</td>\n      <td>ab subtype 90 - cephalosporin_gen1</td>\n      <td>2.0</td>\n      <td>90</td>\n      <td>Prior antibiotic exposure (subclass)</td>\n    </tr>\n    <tr>\n      <th>361</th>\n      <td>all_uti_features.csv</td>\n      <td>ab subtype 90 - penicillins</td>\n      <td>2.0</td>\n      <td>90</td>\n      <td>Prior antibiotic exposure (subclass)</td>\n    </tr>\n    <tr>\n      <th>362</th>\n      <td>all_uti_features.csv</td>\n      <td>ab subtype 90 - cephalosporin_gen2</td>\n      <td>2.0</td>\n      <td>90</td>\n      <td>Prior antibiotic exposure (subclass)</td>\n    </tr>\n    <tr>\n      <th>363</th>\n      <td>all_uti_features.csv</td>\n      <td>ab subtype 90 - antistaphylococcal</td>\n      <td>2.0</td>\n      <td>90</td>\n      <td>Prior antibiotic exposure (subclass)</td>\n    </tr>\n    <tr>\n      <th>364</th>\n      <td>all_uti_features.csv</td>\n      <td>ab class 180 - folate_inhibitor</td>\n      <td>2.0</td>\n      <td>180</td>\n      <td>Prior antibiotic exposure (class)</td>\n    </tr>\n    <tr>\n      <th>365</th>\n      <td>all_uti_features.csv</td>\n      <td>ab class 180 - macrolide_lincosamide</td>\n      <td>2.0</td>\n      <td>180</td>\n      <td>Prior antibiotic exposure (class)</td>\n    </tr>\n    <tr>\n      <th>366</th>\n      <td>all_uti_features.csv</td>\n      <td>ab class 180 - fluoroquinolone</td>\n      <td>2.0</td>\n      <td>180</td>\n      <td>Prior antibiotic exposure (class)</td>\n    </tr>\n    <tr>\n      <th>367</th>\n      <td>all_uti_features.csv</td>\n      <td>ab class 180 - tetracycline</td>\n      <td>2.0</td>\n      <td>180</td>\n      <td>Prior antibiotic exposure (class)</td>\n    </tr>\n    <tr>\n      <th>368</th>\n      <td>all_uti_features.csv</td>\n      <td>ab class 180 - nitrofuran</td>\n      <td>2.0</td>\n      <td>180</td>\n      <td>Prior antibiotic exposure (class)</td>\n    </tr>\n    <tr>\n      <th>369</th>\n      <td>all_uti_features.csv</td>\n      <td>ab class 180 - beta_lactam</td>\n      <td>2.0</td>\n      <td>180</td>\n      <td>Prior antibiotic exposure (class)</td>\n    </tr>\n    <tr>\n      <th>370</th>\n      <td>all_uti_features.csv</td>\n      <td>ab class 180 - antifungal</td>\n      <td>2.0</td>\n      <td>180</td>\n      <td>Prior antibiotic exposure (class)</td>\n    </tr>\n    <tr>\n      <th>371</th>\n      <td>all_uti_features.csv</td>\n      <td>ab class 180 - glycopeptides</td>\n      <td>2.0</td>\n      <td>180</td>\n      <td>Prior antibiotic exposure (class)</td>\n    </tr>\n    <tr>\n      <th>372</th>\n      <td>all_uti_features.csv</td>\n      <td>ab class 180 - nitroimidazole</td>\n      <td>2.0</td>\n      <td>180</td>\n      <td>Prior antibiotic exposure (class)</td>\n    </tr>\n    <tr>\n      <th>373</th>\n      <td>all_uti_features.csv</td>\n      <td>ab class 180 - aminoglycoside</td>\n      <td>2.0</td>\n      <td>180</td>\n      <td>Prior antibiotic exposure (class)</td>\n    </tr>\n    <tr>\n      <th>374</th>\n      <td>all_uti_features.csv</td>\n      <td>ab class 180 - fosfomycin</td>\n      <td>2.0</td>\n      <td>180</td>\n      <td>Prior antibiotic exposure (class)</td>\n    </tr>\n    <tr>\n      <th>375</th>\n      <td>all_uti_features.csv</td>\n      <td>ab class 180 - monobactam</td>\n      <td>2.0</td>\n      <td>180</td>\n      <td>Prior antibiotic exposure (class)</td>\n    </tr>\n    <tr>\n      <th>376</th>\n      <td>all_uti_features.csv</td>\n      <td>ab class 180 - oxazolidinones</td>\n      <td>2.0</td>\n      <td>180</td>\n      <td>Prior antibiotic exposure (class)</td>\n    </tr>\n    <tr>\n      <th>377</th>\n      <td>all_uti_features.csv</td>\n      <td>ab class 180 - polymyxin</td>\n      <td>2.0</td>\n      <td>180</td>\n      <td>Prior antibiotic exposure (class)</td>\n    </tr>\n    <tr>\n      <th>378</th>\n      <td>all_uti_features.csv</td>\n      <td>ab class 180 - ansamycin</td>\n      <td>2.0</td>\n      <td>180</td>\n      <td>Prior antibiotic exposure (class)</td>\n    </tr>\n    <tr>\n      <th>379</th>\n      <td>all_uti_features.csv</td>\n      <td>ab class 180 - mixed</td>\n      <td>2.0</td>\n      <td>180</td>\n      <td>Prior antibiotic exposure (class)</td>\n    </tr>\n    <tr>\n      <th>380</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 180 - trimethoprim/sulfamethoxazole</td>\n      <td>2.0</td>\n      <td>180</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>381</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 180 - azithromycin</td>\n      <td>2.0</td>\n      <td>180</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>382</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 180 - ciprofloxacin</td>\n      <td>2.0</td>\n      <td>180</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>383</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 180 - tetracycline</td>\n      <td>2.0</td>\n      <td>180</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>384</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 180 - nitrofurantoin</td>\n      <td>2.0</td>\n      <td>180</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>385</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 180 - moxifloxacin</td>\n      <td>2.0</td>\n      <td>180</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>386</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 180 - levofloxacin</td>\n      <td>2.0</td>\n      <td>180</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>387</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 180 - amoxicillin/clavulanate</td>\n      <td>2.0</td>\n      <td>180</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>388</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 180 - fluconazole</td>\n      <td>2.0</td>\n      <td>180</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>389</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 180 - meropenem</td>\n      <td>2.0</td>\n      <td>180</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>390</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 180 - vancomycin</td>\n      <td>2.0</td>\n      <td>180</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>391</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 180 - cefepime</td>\n      <td>2.0</td>\n      <td>180</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>392</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 180 - micafungin</td>\n      <td>2.0</td>\n      <td>180</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>393</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 180 - metronidazole</td>\n      <td>2.0</td>\n      <td>180</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>394</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 180 - clindamycin</td>\n      <td>2.0</td>\n      <td>180</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>395</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 180 - doxycycline</td>\n      <td>2.0</td>\n      <td>180</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>396</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 180 - ofloxacin</td>\n      <td>2.0</td>\n      <td>180</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>397</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 180 - cefpodoxime</td>\n      <td>2.0</td>\n      <td>180</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>398</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 180 - clarithromycin</td>\n      <td>2.0</td>\n      <td>180</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>399</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 180 - ceftriaxone</td>\n      <td>2.0</td>\n      <td>180</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>400</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 180 - amikacin</td>\n      <td>2.0</td>\n      <td>180</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>401</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 180 - cephalexin</td>\n      <td>2.0</td>\n      <td>180</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>402</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 180 - cefazolin</td>\n      <td>2.0</td>\n      <td>180</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>403</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 180 - cefixime</td>\n      <td>2.0</td>\n      <td>180</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>404</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 180 - trimethoprim</td>\n      <td>2.0</td>\n      <td>180</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>405</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 180 - amoxicillin</td>\n      <td>2.0</td>\n      <td>180</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>406</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 180 - fosfomycin</td>\n      <td>2.0</td>\n      <td>180</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>407</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 180 - aztreonam</td>\n      <td>2.0</td>\n      <td>180</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>408</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 180 - cefotetan</td>\n      <td>2.0</td>\n      <td>180</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>409</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 180 - penicillin</td>\n      <td>2.0</td>\n      <td>180</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>410</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 180 - dicloxacillin</td>\n      <td>2.0</td>\n      <td>180</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>411</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 180 - ceftazidime</td>\n      <td>2.0</td>\n      <td>180</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>412</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 180 - linezolid</td>\n      <td>2.0</td>\n      <td>180</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>413</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 180 - gentamicin</td>\n      <td>2.0</td>\n      <td>180</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>414</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 180 - cefuroxime</td>\n      <td>2.0</td>\n      <td>180</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>415</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 180 - cefaclor</td>\n      <td>2.0</td>\n      <td>180</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>416</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 180 - ampicillin/sulbactam</td>\n      <td>2.0</td>\n      <td>180</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>417</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 180 - cefoxitin</td>\n      <td>2.0</td>\n      <td>180</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>418</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 180 - ertapenem</td>\n      <td>2.0</td>\n      <td>180</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>419</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 180 - amphotericin_b</td>\n      <td>2.0</td>\n      <td>180</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>420</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 180 - erythromycin</td>\n      <td>2.0</td>\n      <td>180</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>421</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 180 - cefadroxil</td>\n      <td>2.0</td>\n      <td>180</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>422</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 180 - cefprozil</td>\n      <td>2.0</td>\n      <td>180</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>423</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 180 - rifampin</td>\n      <td>2.0</td>\n      <td>180</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>424</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 180 - amoxicillin_clarithromycin</td>\n      <td>2.0</td>\n      <td>180</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>425</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 180 - nafcillin</td>\n      <td>2.0</td>\n      <td>180</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>426</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 180 - minocycline</td>\n      <td>2.0</td>\n      <td>180</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>427</th>\n      <td>all_uti_features.csv</td>\n      <td>medication 180 - polymyxin_b</td>\n      <td>2.0</td>\n      <td>180</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>428</th>\n      <td>all_uti_features.csv</td>\n      <td>ab subtype 180 - beta_lactam_combo</td>\n      <td>2.0</td>\n      <td>180</td>\n      <td>Prior antibiotic exposure (subclass)</td>\n    </tr>\n    <tr>\n      <th>429</th>\n      <td>all_uti_features.csv</td>\n      <td>ab subtype 180 - azole</td>\n      <td>2.0</td>\n      <td>180</td>\n      <td>Prior antibiotic exposure (subclass)</td>\n    </tr>\n    <tr>\n      <th>430</th>\n      <td>all_uti_features.csv</td>\n      <td>ab subtype 180 - carbapenem</td>\n      <td>2.0</td>\n      <td>180</td>\n      <td>Prior antibiotic exposure (subclass)</td>\n    </tr>\n    <tr>\n      <th>431</th>\n      <td>all_uti_features.csv</td>\n      <td>ab subtype 180 - cephalosporin_gen4</td>\n      <td>2.0</td>\n      <td>180</td>\n      <td>Prior antibiotic exposure (subclass)</td>\n    </tr>\n    <tr>\n      <th>432</th>\n      <td>all_uti_features.csv</td>\n      <td>ab subtype 180 - echinocandin</td>\n      <td>2.0</td>\n      <td>180</td>\n      <td>Prior antibiotic exposure (subclass)</td>\n    </tr>\n    <tr>\n      <th>433</th>\n      <td>all_uti_features.csv</td>\n      <td>ab subtype 180 - cephalosporin_gen3</td>\n      <td>2.0</td>\n      <td>180</td>\n      <td>Prior antibiotic exposure (subclass)</td>\n    </tr>\n    <tr>\n      <th>434</th>\n      <td>all_uti_features.csv</td>\n      <td>ab subtype 180 - cephalosporin_gen1</td>\n      <td>2.0</td>\n      <td>180</td>\n      <td>Prior antibiotic exposure (subclass)</td>\n    </tr>\n    <tr>\n      <th>435</th>\n      <td>all_uti_features.csv</td>\n      <td>ab subtype 180 - penicillins</td>\n      <td>2.0</td>\n      <td>180</td>\n      <td>Prior antibiotic exposure (subclass)</td>\n    </tr>\n    <tr>\n      <th>436</th>\n      <td>all_uti_features.csv</td>\n      <td>ab subtype 180 - cephalosporin_gen2</td>\n      <td>2.0</td>\n      <td>180</td>\n      <td>Prior antibiotic exposure (subclass)</td>\n    </tr>\n    <tr>\n      <th>437</th>\n      <td>all_uti_features.csv</td>\n      <td>ab subtype 180 - antistaphylococcal</td>\n      <td>2.0</td>\n      <td>180</td>\n      <td>Prior antibiotic exposure (subclass)</td>\n    </tr>\n    <tr>\n      <th>438</th>\n      <td>all_uti_features.csv</td>\n      <td>ab subtype 180 - polyene</td>\n      <td>2.0</td>\n      <td>180</td>\n      <td>Prior antibiotic exposure (subclass)</td>\n    </tr>\n    <tr>\n      <th>439</th>\n      <td>all_uti_features.csv</td>\n      <td>ab class ALL - fluoroquinolone</td>\n      <td>2.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic exposure (class)</td>\n    </tr>\n    <tr>\n      <th>440</th>\n      <td>all_uti_features.csv</td>\n      <td>ab class ALL - glycopeptides</td>\n      <td>2.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic exposure (class)</td>\n    </tr>\n    <tr>\n      <th>441</th>\n      <td>all_uti_features.csv</td>\n      <td>ab class ALL - macrolide_lincosamide</td>\n      <td>2.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic exposure (class)</td>\n    </tr>\n    <tr>\n      <th>442</th>\n      <td>all_uti_features.csv</td>\n      <td>ab class ALL - folate_inhibitor</td>\n      <td>2.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic exposure (class)</td>\n    </tr>\n    <tr>\n      <th>443</th>\n      <td>all_uti_features.csv</td>\n      <td>ab class ALL - nitrofuran</td>\n      <td>2.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic exposure (class)</td>\n    </tr>\n    <tr>\n      <th>444</th>\n      <td>all_uti_features.csv</td>\n      <td>ab class ALL - tetracycline</td>\n      <td>2.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic exposure (class)</td>\n    </tr>\n    <tr>\n      <th>445</th>\n      <td>all_uti_features.csv</td>\n      <td>ab class ALL - antifungal</td>\n      <td>2.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic exposure (class)</td>\n    </tr>\n    <tr>\n      <th>446</th>\n      <td>all_uti_features.csv</td>\n      <td>ab class ALL - beta_lactam</td>\n      <td>2.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic exposure (class)</td>\n    </tr>\n    <tr>\n      <th>447</th>\n      <td>all_uti_features.csv</td>\n      <td>ab class ALL - nitroimidazole</td>\n      <td>2.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic exposure (class)</td>\n    </tr>\n    <tr>\n      <th>448</th>\n      <td>all_uti_features.csv</td>\n      <td>ab class ALL - aminoglycoside</td>\n      <td>2.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic exposure (class)</td>\n    </tr>\n    <tr>\n      <th>449</th>\n      <td>all_uti_features.csv</td>\n      <td>ab class ALL - fosfomycin</td>\n      <td>2.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic exposure (class)</td>\n    </tr>\n    <tr>\n      <th>450</th>\n      <td>all_uti_features.csv</td>\n      <td>ab class ALL - monobactam</td>\n      <td>2.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic exposure (class)</td>\n    </tr>\n    <tr>\n      <th>451</th>\n      <td>all_uti_features.csv</td>\n      <td>ab class ALL - ansamycin</td>\n      <td>2.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic exposure (class)</td>\n    </tr>\n    <tr>\n      <th>452</th>\n      <td>all_uti_features.csv</td>\n      <td>ab class ALL - oxazolidinones</td>\n      <td>2.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic exposure (class)</td>\n    </tr>\n    <tr>\n      <th>453</th>\n      <td>all_uti_features.csv</td>\n      <td>ab class ALL - polymyxin</td>\n      <td>2.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic exposure (class)</td>\n    </tr>\n    <tr>\n      <th>454</th>\n      <td>all_uti_features.csv</td>\n      <td>ab class ALL - mixed</td>\n      <td>2.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic exposure (class)</td>\n    </tr>\n    <tr>\n      <th>455</th>\n      <td>all_uti_features.csv</td>\n      <td>medication ALL - levofloxacin</td>\n      <td>2.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>456</th>\n      <td>all_uti_features.csv</td>\n      <td>medication ALL - vancomycin</td>\n      <td>2.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>457</th>\n      <td>all_uti_features.csv</td>\n      <td>medication ALL - ciprofloxacin</td>\n      <td>2.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>458</th>\n      <td>all_uti_features.csv</td>\n      <td>medication ALL - azithromycin</td>\n      <td>2.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>459</th>\n      <td>all_uti_features.csv</td>\n      <td>medication ALL - trimethoprim/sulfamethoxazole</td>\n      <td>2.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>460</th>\n      <td>all_uti_features.csv</td>\n      <td>medication ALL - nitrofurantoin</td>\n      <td>2.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>461</th>\n      <td>all_uti_features.csv</td>\n      <td>medication ALL - tetracycline</td>\n      <td>2.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>462</th>\n      <td>all_uti_features.csv</td>\n      <td>medication ALL - moxifloxacin</td>\n      <td>2.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>463</th>\n      <td>all_uti_features.csv</td>\n      <td>medication ALL - fluconazole</td>\n      <td>2.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>464</th>\n      <td>all_uti_features.csv</td>\n      <td>medication ALL - amoxicillin</td>\n      <td>2.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>465</th>\n      <td>all_uti_features.csv</td>\n      <td>medication ALL - cephalexin</td>\n      <td>2.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>466</th>\n      <td>all_uti_features.csv</td>\n      <td>medication ALL - cefpodoxime</td>\n      <td>2.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>467</th>\n      <td>all_uti_features.csv</td>\n      <td>medication ALL - doxycycline</td>\n      <td>2.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>468</th>\n      <td>all_uti_features.csv</td>\n      <td>medication ALL - cefixime</td>\n      <td>2.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>469</th>\n      <td>all_uti_features.csv</td>\n      <td>medication ALL - ceftriaxone</td>\n      <td>2.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>470</th>\n      <td>all_uti_features.csv</td>\n      <td>medication ALL - amoxicillin/clavulanate</td>\n      <td>2.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>471</th>\n      <td>all_uti_features.csv</td>\n      <td>medication ALL - dicloxacillin</td>\n      <td>2.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>472</th>\n      <td>all_uti_features.csv</td>\n      <td>medication ALL - meropenem</td>\n      <td>2.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>473</th>\n      <td>all_uti_features.csv</td>\n      <td>medication ALL - cefepime</td>\n      <td>2.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>474</th>\n      <td>all_uti_features.csv</td>\n      <td>medication ALL - micafungin</td>\n      <td>2.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>475</th>\n      <td>all_uti_features.csv</td>\n      <td>medication ALL - metronidazole</td>\n      <td>2.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>476</th>\n      <td>all_uti_features.csv</td>\n      <td>medication ALL - clindamycin</td>\n      <td>2.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>477</th>\n      <td>all_uti_features.csv</td>\n      <td>medication ALL - ofloxacin</td>\n      <td>2.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>478</th>\n      <td>all_uti_features.csv</td>\n      <td>medication ALL - gentamicin</td>\n      <td>2.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>479</th>\n      <td>all_uti_features.csv</td>\n      <td>medication ALL - minocycline</td>\n      <td>2.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>480</th>\n      <td>all_uti_features.csv</td>\n      <td>medication ALL - clarithromycin</td>\n      <td>2.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>481</th>\n      <td>all_uti_features.csv</td>\n      <td>medication ALL - amikacin</td>\n      <td>2.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>482</th>\n      <td>all_uti_features.csv</td>\n      <td>medication ALL - ertapenem</td>\n      <td>2.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>483</th>\n      <td>all_uti_features.csv</td>\n      <td>medication ALL - cefuroxime</td>\n      <td>2.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>484</th>\n      <td>all_uti_features.csv</td>\n      <td>medication ALL - cefazolin</td>\n      <td>2.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>485</th>\n      <td>all_uti_features.csv</td>\n      <td>medication ALL - trimethoprim</td>\n      <td>2.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>486</th>\n      <td>all_uti_features.csv</td>\n      <td>medication ALL - fosfomycin</td>\n      <td>2.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>487</th>\n      <td>all_uti_features.csv</td>\n      <td>medication ALL - ampicillin/sulbactam</td>\n      <td>2.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>488</th>\n      <td>all_uti_features.csv</td>\n      <td>medication ALL - penicillin</td>\n      <td>2.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>489</th>\n      <td>all_uti_features.csv</td>\n      <td>medication ALL - aztreonam</td>\n      <td>2.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>490</th>\n      <td>all_uti_features.csv</td>\n      <td>medication ALL - cefotetan</td>\n      <td>2.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>491</th>\n      <td>all_uti_features.csv</td>\n      <td>medication ALL - rifampin</td>\n      <td>2.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>492</th>\n      <td>all_uti_features.csv</td>\n      <td>medication ALL - nafcillin</td>\n      <td>2.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>493</th>\n      <td>all_uti_features.csv</td>\n      <td>medication ALL - ceftazidime</td>\n      <td>2.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>494</th>\n      <td>all_uti_features.csv</td>\n      <td>medication ALL - linezolid</td>\n      <td>2.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>495</th>\n      <td>all_uti_features.csv</td>\n      <td>medication ALL - erythromycin</td>\n      <td>2.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>496</th>\n      <td>all_uti_features.csv</td>\n      <td>medication ALL - cefaclor</td>\n      <td>2.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>497</th>\n      <td>all_uti_features.csv</td>\n      <td>medication ALL - caspofungin</td>\n      <td>2.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>498</th>\n      <td>all_uti_features.csv</td>\n      <td>medication ALL - cefoxitin</td>\n      <td>2.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>499</th>\n      <td>all_uti_features.csv</td>\n      <td>medication ALL - polymyxin_b</td>\n      <td>2.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>500</th>\n      <td>all_uti_features.csv</td>\n      <td>medication ALL - amphotericin_b</td>\n      <td>2.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>501</th>\n      <td>all_uti_features.csv</td>\n      <td>medication ALL - cefadroxil</td>\n      <td>2.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>502</th>\n      <td>all_uti_features.csv</td>\n      <td>medication ALL - cefprozil</td>\n      <td>2.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>503</th>\n      <td>all_uti_features.csv</td>\n      <td>medication ALL - amoxicillin_clarithromycin</td>\n      <td>2.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic exposure (detailed names)</td>\n    </tr>\n    <tr>\n      <th>504</th>\n      <td>all_uti_features.csv</td>\n      <td>ab subtype ALL - azole</td>\n      <td>2.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic exposure (subclass)</td>\n    </tr>\n    <tr>\n      <th>505</th>\n      <td>all_uti_features.csv</td>\n      <td>ab subtype ALL - penicillins</td>\n      <td>2.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic exposure (subclass)</td>\n    </tr>\n    <tr>\n      <th>506</th>\n      <td>all_uti_features.csv</td>\n      <td>ab subtype ALL - cephalosporin_gen1</td>\n      <td>2.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic exposure (subclass)</td>\n    </tr>\n    <tr>\n      <th>507</th>\n      <td>all_uti_features.csv</td>\n      <td>ab subtype ALL - cephalosporin_gen3</td>\n      <td>2.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic exposure (subclass)</td>\n    </tr>\n    <tr>\n      <th>508</th>\n      <td>all_uti_features.csv</td>\n      <td>ab subtype ALL - beta_lactam_combo</td>\n      <td>2.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic exposure (subclass)</td>\n    </tr>\n    <tr>\n      <th>509</th>\n      <td>all_uti_features.csv</td>\n      <td>ab subtype ALL - antistaphylococcal</td>\n      <td>2.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic exposure (subclass)</td>\n    </tr>\n    <tr>\n      <th>510</th>\n      <td>all_uti_features.csv</td>\n      <td>ab subtype ALL - carbapenem</td>\n      <td>2.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic exposure (subclass)</td>\n    </tr>\n    <tr>\n      <th>511</th>\n      <td>all_uti_features.csv</td>\n      <td>ab subtype ALL - cephalosporin_gen4</td>\n      <td>2.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic exposure (subclass)</td>\n    </tr>\n    <tr>\n      <th>512</th>\n      <td>all_uti_features.csv</td>\n      <td>ab subtype ALL - echinocandin</td>\n      <td>2.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic exposure (subclass)</td>\n    </tr>\n    <tr>\n      <th>513</th>\n      <td>all_uti_features.csv</td>\n      <td>ab subtype ALL - cephalosporin_gen2</td>\n      <td>2.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic exposure (subclass)</td>\n    </tr>\n    <tr>\n      <th>514</th>\n      <td>all_uti_features.csv</td>\n      <td>ab subtype ALL - polyene</td>\n      <td>2.0</td>\n      <td>ALL</td>\n      <td>Prior antibiotic exposure (subclass)</td>\n    </tr>\n    <tr>\n      <th>515</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev organism Escherichia 14</td>\n      <td>7.0</td>\n      <td>14</td>\n      <td>Prior infecting organism</td>\n    </tr>\n    <tr>\n      <th>516</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev organism Klebsiella 14</td>\n      <td>7.0</td>\n      <td>14</td>\n      <td>Prior infecting organism</td>\n    </tr>\n    <tr>\n      <th>517</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev organism Enterococcus 30</td>\n      <td>7.0</td>\n      <td>30</td>\n      <td>Prior infecting organism</td>\n    </tr>\n    <tr>\n      <th>518</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev organism Escherichia 30</td>\n      <td>7.0</td>\n      <td>30</td>\n      <td>Prior infecting organism</td>\n    </tr>\n    <tr>\n      <th>519</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev organism Staphylococcus 30</td>\n      <td>7.0</td>\n      <td>30</td>\n      <td>Prior infecting organism</td>\n    </tr>\n    <tr>\n      <th>520</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev organism Klebsiella 30</td>\n      <td>7.0</td>\n      <td>30</td>\n      <td>Prior infecting organism</td>\n    </tr>\n    <tr>\n      <th>521</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev organism Proteus 30</td>\n      <td>7.0</td>\n      <td>30</td>\n      <td>Prior infecting organism</td>\n    </tr>\n    <tr>\n      <th>522</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev organism Staph_coag_neg 30</td>\n      <td>7.0</td>\n      <td>30</td>\n      <td>Prior infecting organism</td>\n    </tr>\n    <tr>\n      <th>523</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev organism Enterobacter 30</td>\n      <td>7.0</td>\n      <td>30</td>\n      <td>Prior infecting organism</td>\n    </tr>\n    <tr>\n      <th>524</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev organism Citrobacter 30</td>\n      <td>7.0</td>\n      <td>30</td>\n      <td>Prior infecting organism</td>\n    </tr>\n    <tr>\n      <th>525</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev organism Streptococcus 30</td>\n      <td>7.0</td>\n      <td>30</td>\n      <td>Prior infecting organism</td>\n    </tr>\n    <tr>\n      <th>526</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev organism Klebsiella 90</td>\n      <td>7.0</td>\n      <td>90</td>\n      <td>Prior infecting organism</td>\n    </tr>\n    <tr>\n      <th>527</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev organism Streptococcus 90</td>\n      <td>7.0</td>\n      <td>90</td>\n      <td>Prior infecting organism</td>\n    </tr>\n    <tr>\n      <th>528</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev organism Escherichia 90</td>\n      <td>7.0</td>\n      <td>90</td>\n      <td>Prior infecting organism</td>\n    </tr>\n    <tr>\n      <th>529</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev organism Staph_coag_neg 90</td>\n      <td>7.0</td>\n      <td>90</td>\n      <td>Prior infecting organism</td>\n    </tr>\n    <tr>\n      <th>530</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev organism Enterobacter 90</td>\n      <td>7.0</td>\n      <td>90</td>\n      <td>Prior infecting organism</td>\n    </tr>\n    <tr>\n      <th>531</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev organism Staphylococcus 90</td>\n      <td>7.0</td>\n      <td>90</td>\n      <td>Prior infecting organism</td>\n    </tr>\n    <tr>\n      <th>532</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev organism Proteus 90</td>\n      <td>7.0</td>\n      <td>90</td>\n      <td>Prior infecting organism</td>\n    </tr>\n    <tr>\n      <th>533</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev organism Enterococcus 90</td>\n      <td>7.0</td>\n      <td>90</td>\n      <td>Prior infecting organism</td>\n    </tr>\n    <tr>\n      <th>534</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev organism Pseudomonas 90</td>\n      <td>7.0</td>\n      <td>90</td>\n      <td>Prior infecting organism</td>\n    </tr>\n    <tr>\n      <th>535</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev organism Citrobacter 90</td>\n      <td>7.0</td>\n      <td>90</td>\n      <td>Prior infecting organism</td>\n    </tr>\n    <tr>\n      <th>536</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev organism Acinetobacter 90</td>\n      <td>7.0</td>\n      <td>90</td>\n      <td>Prior infecting organism</td>\n    </tr>\n    <tr>\n      <th>537</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev organism Pseudomonas 180</td>\n      <td>7.0</td>\n      <td>180</td>\n      <td>Prior infecting organism</td>\n    </tr>\n    <tr>\n      <th>538</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev organism Escherichia 180</td>\n      <td>7.0</td>\n      <td>180</td>\n      <td>Prior infecting organism</td>\n    </tr>\n    <tr>\n      <th>539</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev organism Staphylococcus 180</td>\n      <td>7.0</td>\n      <td>180</td>\n      <td>Prior infecting organism</td>\n    </tr>\n    <tr>\n      <th>540</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev organism Enterococcus 180</td>\n      <td>7.0</td>\n      <td>180</td>\n      <td>Prior infecting organism</td>\n    </tr>\n    <tr>\n      <th>541</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev organism Enterobacter 180</td>\n      <td>7.0</td>\n      <td>180</td>\n      <td>Prior infecting organism</td>\n    </tr>\n    <tr>\n      <th>542</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev organism Providencia 180</td>\n      <td>7.0</td>\n      <td>180</td>\n      <td>Prior infecting organism</td>\n    </tr>\n    <tr>\n      <th>543</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev organism Staph_coag_neg 180</td>\n      <td>7.0</td>\n      <td>180</td>\n      <td>Prior infecting organism</td>\n    </tr>\n    <tr>\n      <th>544</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev organism Streptococcus 180</td>\n      <td>7.0</td>\n      <td>180</td>\n      <td>Prior infecting organism</td>\n    </tr>\n    <tr>\n      <th>545</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev organism Acinetobacter 180</td>\n      <td>7.0</td>\n      <td>180</td>\n      <td>Prior infecting organism</td>\n    </tr>\n    <tr>\n      <th>546</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev organism Citrobacter 180</td>\n      <td>7.0</td>\n      <td>180</td>\n      <td>Prior infecting organism</td>\n    </tr>\n    <tr>\n      <th>547</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev organism Klebsiella 180</td>\n      <td>7.0</td>\n      <td>180</td>\n      <td>Prior infecting organism</td>\n    </tr>\n    <tr>\n      <th>548</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev organism Proteus 180</td>\n      <td>7.0</td>\n      <td>180</td>\n      <td>Prior infecting organism</td>\n    </tr>\n    <tr>\n      <th>549</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev organism Serratia 180</td>\n      <td>7.0</td>\n      <td>180</td>\n      <td>Prior infecting organism</td>\n    </tr>\n    <tr>\n      <th>550</th>\n      <td>all_uti_features.csv</td>\n      <td>micro - prev organism Morganella 180</td>\n      <td>7.0</td>\n      <td>180</td>\n      <td>Prior infecting organism</td>\n    </tr>\n    <tr>\n      <th>551</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 7 - Arrhythmia</td>\n      <td>0.0</td>\n      <td>7</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>552</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 7 - HTN</td>\n      <td>0.0</td>\n      <td>7</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>553</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 7 - Hypothyroid</td>\n      <td>0.0</td>\n      <td>7</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>554</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 7 - Pulmonary</td>\n      <td>0.0</td>\n      <td>7</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>555</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 7 - FluidsLytes</td>\n      <td>0.0</td>\n      <td>7</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>556</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 7 - Lymphoma</td>\n      <td>0.0</td>\n      <td>7</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>557</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 7 - CHF</td>\n      <td>0.0</td>\n      <td>7</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>558</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 7 - Obesity</td>\n      <td>0.0</td>\n      <td>7</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>559</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 7 - PVD</td>\n      <td>0.0</td>\n      <td>7</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>560</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 7 - Rheumatic</td>\n      <td>0.0</td>\n      <td>7</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>561</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 7 - BloodLoss</td>\n      <td>0.0</td>\n      <td>7</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>562</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 7 - DM</td>\n      <td>0.0</td>\n      <td>7</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>563</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 7 - Renal</td>\n      <td>0.0</td>\n      <td>7</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>564</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 7 - Depression</td>\n      <td>0.0</td>\n      <td>7</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>565</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 7 - NeuroOther</td>\n      <td>0.0</td>\n      <td>7</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>566</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 7 - Paralysis</td>\n      <td>0.0</td>\n      <td>7</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>567</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 7 - Valvular</td>\n      <td>0.0</td>\n      <td>7</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>568</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 7 - Coagulopathy</td>\n      <td>0.0</td>\n      <td>7</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>569</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 7 - Anemia</td>\n      <td>0.0</td>\n      <td>7</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>570</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 7 - Alcohol</td>\n      <td>0.0</td>\n      <td>7</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>571</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 7 - HTNcx</td>\n      <td>0.0</td>\n      <td>7</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>572</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 7 - Tumor</td>\n      <td>0.0</td>\n      <td>7</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>573</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 7 - WeightLoss</td>\n      <td>0.0</td>\n      <td>7</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>574</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 7 - Liver</td>\n      <td>0.0</td>\n      <td>7</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>575</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 7 - Psychoses</td>\n      <td>0.0</td>\n      <td>7</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>576</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 7 - DMcx</td>\n      <td>0.0</td>\n      <td>7</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>577</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 7 - Drugs</td>\n      <td>0.0</td>\n      <td>7</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>578</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 7 - Mets</td>\n      <td>0.0</td>\n      <td>7</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>579</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 7 - PUD</td>\n      <td>0.0</td>\n      <td>7</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>580</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 7 - PHTN</td>\n      <td>0.0</td>\n      <td>7</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>581</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 7 - HIV</td>\n      <td>0.0</td>\n      <td>7</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>582</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 14 - Arrhythmia</td>\n      <td>0.0</td>\n      <td>14</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>583</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 14 - HTN</td>\n      <td>0.0</td>\n      <td>14</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>584</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 14 - Hypothyroid</td>\n      <td>0.0</td>\n      <td>14</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>585</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 14 - Pulmonary</td>\n      <td>0.0</td>\n      <td>14</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>586</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 14 - CHF</td>\n      <td>0.0</td>\n      <td>14</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>587</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 14 - FluidsLytes</td>\n      <td>0.0</td>\n      <td>14</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>588</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 14 - Lymphoma</td>\n      <td>0.0</td>\n      <td>14</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>589</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 14 - Obesity</td>\n      <td>0.0</td>\n      <td>14</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>590</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 14 - PVD</td>\n      <td>0.0</td>\n      <td>14</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>591</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 14 - Rheumatic</td>\n      <td>0.0</td>\n      <td>14</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>592</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 14 - BloodLoss</td>\n      <td>0.0</td>\n      <td>14</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>593</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 14 - DM</td>\n      <td>0.0</td>\n      <td>14</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>594</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 14 - Renal</td>\n      <td>0.0</td>\n      <td>14</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>595</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 14 - Depression</td>\n      <td>0.0</td>\n      <td>14</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>596</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 14 - NeuroOther</td>\n      <td>0.0</td>\n      <td>14</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>597</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 14 - Paralysis</td>\n      <td>0.0</td>\n      <td>14</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>598</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 14 - Valvular</td>\n      <td>0.0</td>\n      <td>14</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>599</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 14 - Coagulopathy</td>\n      <td>0.0</td>\n      <td>14</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>600</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 14 - DMcx</td>\n      <td>0.0</td>\n      <td>14</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>601</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 14 - Anemia</td>\n      <td>0.0</td>\n      <td>14</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>602</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 14 - Alcohol</td>\n      <td>0.0</td>\n      <td>14</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>603</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 14 - HTNcx</td>\n      <td>0.0</td>\n      <td>14</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>604</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 14 - Tumor</td>\n      <td>0.0</td>\n      <td>14</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>605</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 14 - Psychoses</td>\n      <td>0.0</td>\n      <td>14</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>606</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 14 - WeightLoss</td>\n      <td>0.0</td>\n      <td>14</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>607</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 14 - Liver</td>\n      <td>0.0</td>\n      <td>14</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>608</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 14 - PHTN</td>\n      <td>0.0</td>\n      <td>14</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>609</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 14 - Drugs</td>\n      <td>0.0</td>\n      <td>14</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>610</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 14 - Mets</td>\n      <td>0.0</td>\n      <td>14</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>611</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 14 - PUD</td>\n      <td>0.0</td>\n      <td>14</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>612</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 14 - HIV</td>\n      <td>0.0</td>\n      <td>14</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>613</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 30 - Arrhythmia</td>\n      <td>0.0</td>\n      <td>30</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>614</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 30 - HTN</td>\n      <td>0.0</td>\n      <td>30</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>615</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 30 - Hypothyroid</td>\n      <td>0.0</td>\n      <td>30</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>616</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 30 - Pulmonary</td>\n      <td>0.0</td>\n      <td>30</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>617</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 30 - CHF</td>\n      <td>0.0</td>\n      <td>30</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>618</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 30 - FluidsLytes</td>\n      <td>0.0</td>\n      <td>30</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>619</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 30 - Lymphoma</td>\n      <td>0.0</td>\n      <td>30</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>620</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 30 - Obesity</td>\n      <td>0.0</td>\n      <td>30</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>621</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 30 - PVD</td>\n      <td>0.0</td>\n      <td>30</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>622</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 30 - Rheumatic</td>\n      <td>0.0</td>\n      <td>30</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>623</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 30 - BloodLoss</td>\n      <td>0.0</td>\n      <td>30</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>624</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 30 - DM</td>\n      <td>0.0</td>\n      <td>30</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>625</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 30 - Renal</td>\n      <td>0.0</td>\n      <td>30</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>626</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 30 - Depression</td>\n      <td>0.0</td>\n      <td>30</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>627</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 30 - NeuroOther</td>\n      <td>0.0</td>\n      <td>30</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>628</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 30 - Paralysis</td>\n      <td>0.0</td>\n      <td>30</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>629</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 30 - Valvular</td>\n      <td>0.0</td>\n      <td>30</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>630</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 30 - Coagulopathy</td>\n      <td>0.0</td>\n      <td>30</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>631</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 30 - DMcx</td>\n      <td>0.0</td>\n      <td>30</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>632</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 30 - Anemia</td>\n      <td>0.0</td>\n      <td>30</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>633</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 30 - Alcohol</td>\n      <td>0.0</td>\n      <td>30</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>634</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 30 - HTNcx</td>\n      <td>0.0</td>\n      <td>30</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>635</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 30 - Tumor</td>\n      <td>0.0</td>\n      <td>30</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>636</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 30 - Psychoses</td>\n      <td>0.0</td>\n      <td>30</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>637</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 30 - WeightLoss</td>\n      <td>0.0</td>\n      <td>30</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>638</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 30 - Liver</td>\n      <td>0.0</td>\n      <td>30</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>639</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 30 - PHTN</td>\n      <td>0.0</td>\n      <td>30</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>640</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 30 - Drugs</td>\n      <td>0.0</td>\n      <td>30</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>641</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 30 - Mets</td>\n      <td>0.0</td>\n      <td>30</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>642</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 30 - PUD</td>\n      <td>0.0</td>\n      <td>30</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>643</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 30 - HIV</td>\n      <td>0.0</td>\n      <td>30</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>644</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 90 - Arrhythmia</td>\n      <td>0.0</td>\n      <td>90</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>645</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 90 - HTN</td>\n      <td>0.0</td>\n      <td>90</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>646</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 90 - Hypothyroid</td>\n      <td>0.0</td>\n      <td>90</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>647</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 90 - Pulmonary</td>\n      <td>0.0</td>\n      <td>90</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>648</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 90 - CHF</td>\n      <td>0.0</td>\n      <td>90</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>649</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 90 - FluidsLytes</td>\n      <td>0.0</td>\n      <td>90</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>650</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 90 - Lymphoma</td>\n      <td>0.0</td>\n      <td>90</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>651</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 90 - Obesity</td>\n      <td>0.0</td>\n      <td>90</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>652</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 90 - DM</td>\n      <td>0.0</td>\n      <td>90</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>653</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 90 - PVD</td>\n      <td>0.0</td>\n      <td>90</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>654</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 90 - Rheumatic</td>\n      <td>0.0</td>\n      <td>90</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>655</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 90 - BloodLoss</td>\n      <td>0.0</td>\n      <td>90</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>656</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 90 - Depression</td>\n      <td>0.0</td>\n      <td>90</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>657</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 90 - Renal</td>\n      <td>0.0</td>\n      <td>90</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>658</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 90 - Paralysis</td>\n      <td>0.0</td>\n      <td>90</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>659</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 90 - NeuroOther</td>\n      <td>0.0</td>\n      <td>90</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>660</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 90 - Valvular</td>\n      <td>0.0</td>\n      <td>90</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>661</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 90 - HTNcx</td>\n      <td>0.0</td>\n      <td>90</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>662</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 90 - Coagulopathy</td>\n      <td>0.0</td>\n      <td>90</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>663</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 90 - DMcx</td>\n      <td>0.0</td>\n      <td>90</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>664</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 90 - Anemia</td>\n      <td>0.0</td>\n      <td>90</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>665</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 90 - Alcohol</td>\n      <td>0.0</td>\n      <td>90</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>666</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 90 - Tumor</td>\n      <td>0.0</td>\n      <td>90</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>667</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 90 - Psychoses</td>\n      <td>0.0</td>\n      <td>90</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>668</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 90 - WeightLoss</td>\n      <td>0.0</td>\n      <td>90</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>669</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 90 - Liver</td>\n      <td>0.0</td>\n      <td>90</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>670</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 90 - PHTN</td>\n      <td>0.0</td>\n      <td>90</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>671</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 90 - Drugs</td>\n      <td>0.0</td>\n      <td>90</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>672</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 90 - Mets</td>\n      <td>0.0</td>\n      <td>90</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>673</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 90 - PUD</td>\n      <td>0.0</td>\n      <td>90</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>674</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 90 - HIV</td>\n      <td>0.0</td>\n      <td>90</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>675</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 180 - Arrhythmia</td>\n      <td>0.0</td>\n      <td>180</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>676</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 180 - HTN</td>\n      <td>0.0</td>\n      <td>180</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>677</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 180 - Hypothyroid</td>\n      <td>0.0</td>\n      <td>180</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>678</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 180 - Pulmonary</td>\n      <td>0.0</td>\n      <td>180</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>679</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 180 - Depression</td>\n      <td>0.0</td>\n      <td>180</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>680</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 180 - CHF</td>\n      <td>0.0</td>\n      <td>180</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>681</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 180 - FluidsLytes</td>\n      <td>0.0</td>\n      <td>180</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>682</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 180 - Lymphoma</td>\n      <td>0.0</td>\n      <td>180</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>683</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 180 - Obesity</td>\n      <td>0.0</td>\n      <td>180</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>684</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 180 - DM</td>\n      <td>0.0</td>\n      <td>180</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>685</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 180 - PVD</td>\n      <td>0.0</td>\n      <td>180</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>686</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 180 - Rheumatic</td>\n      <td>0.0</td>\n      <td>180</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>687</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 180 - Anemia</td>\n      <td>0.0</td>\n      <td>180</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>688</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 180 - BloodLoss</td>\n      <td>0.0</td>\n      <td>180</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>689</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 180 - Renal</td>\n      <td>0.0</td>\n      <td>180</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>690</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 180 - Paralysis</td>\n      <td>0.0</td>\n      <td>180</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>691</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 180 - NeuroOther</td>\n      <td>0.0</td>\n      <td>180</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>692</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 180 - Valvular</td>\n      <td>0.0</td>\n      <td>180</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>693</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 180 - HTNcx</td>\n      <td>0.0</td>\n      <td>180</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>694</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 180 - Coagulopathy</td>\n      <td>0.0</td>\n      <td>180</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>695</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 180 - DMcx</td>\n      <td>0.0</td>\n      <td>180</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>696</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 180 - Alcohol</td>\n      <td>0.0</td>\n      <td>180</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>697</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 180 - Tumor</td>\n      <td>0.0</td>\n      <td>180</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>698</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 180 - Psychoses</td>\n      <td>0.0</td>\n      <td>180</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>699</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 180 - WeightLoss</td>\n      <td>0.0</td>\n      <td>180</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>700</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 180 - Liver</td>\n      <td>0.0</td>\n      <td>180</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>701</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 180 - PHTN</td>\n      <td>0.0</td>\n      <td>180</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>702</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 180 - Drugs</td>\n      <td>0.0</td>\n      <td>180</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>703</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 180 - Mets</td>\n      <td>0.0</td>\n      <td>180</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>704</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 180 - PUD</td>\n      <td>0.0</td>\n      <td>180</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>705</th>\n      <td>all_uti_features.csv</td>\n      <td>comorbidity 180 - HIV</td>\n      <td>0.0</td>\n      <td>180</td>\n      <td>Elixhauser Comorbidities</td>\n    </tr>\n    <tr>\n      <th>706</th>\n      <td>all_uti_features.csv</td>\n      <td>procedure 180 - had cvc</td>\n      <td>0.0</td>\n      <td>180</td>\n      <td>Prior central venous catheter (CVC)</td>\n    </tr>\n    <tr>\n      <th>707</th>\n      <td>all_uti_features.csv</td>\n      <td>procedure 180 - had surgery</td>\n      <td>0.0</td>\n      <td>180</td>\n      <td>Prior surgical procedure</td>\n    </tr>\n    <tr>\n      <th>708</th>\n      <td>all_uti_features.csv</td>\n      <td>procedure 180 - had mechanical ventilation</td>\n      <td>0.0</td>\n      <td>180</td>\n      <td>Prior mechanical ventilation</td>\n    </tr>\n    <tr>\n      <th>709</th>\n      <td>all_uti_features.csv</td>\n      <td>procedure 180 - had hemodialysis</td>\n      <td>0.0</td>\n      <td>180</td>\n      <td>Prior hemodialysis</td>\n    </tr>\n    <tr>\n      <th>710</th>\n      <td>all_uti_features.csv</td>\n      <td>procedure 180 - had parenteral nutrition</td>\n      <td>0.0</td>\n      <td>180</td>\n      <td>Prior parenteral nutrition</td>\n    </tr>\n    <tr>\n      <th>711</th>\n      <td>all_uti_features.csv</td>\n      <td>custom 7 - nursing home</td>\n      <td>0.0</td>\n      <td>7</td>\n      <td>Prior visit to skilled nursing facility</td>\n    </tr>\n    <tr>\n      <th>712</th>\n      <td>all_uti_features.csv</td>\n      <td>custom 14 - nursing home</td>\n      <td>0.0</td>\n      <td>14</td>\n      <td>Prior visit to skilled nursing facility</td>\n    </tr>\n    <tr>\n      <th>713</th>\n      <td>all_uti_features.csv</td>\n      <td>custom 30 - nursing home</td>\n      <td>0.0</td>\n      <td>30</td>\n      <td>Prior visit to skilled nursing facility</td>\n    </tr>\n    <tr>\n      <th>714</th>\n      <td>all_uti_features.csv</td>\n      <td>custom 90 - nursing home</td>\n      <td>0.0</td>\n      <td>90</td>\n      <td>Prior visit to skilled nursing facility</td>\n    </tr>\n    <tr>\n      <th>715</th>\n      <td>all_uti_features.csv</td>\n      <td>infection_sites - RESPIRATORY_TRACT</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>Other infection sites</td>\n    </tr>\n    <tr>\n      <th>716</th>\n      <td>all_uti_features.csv</td>\n      <td>infection_sites - BLOOD</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>Other infection sites</td>\n    </tr>\n    <tr>\n      <th>717</th>\n      <td>all_uti_features.csv</td>\n      <td>infection_sites - SKIN_SOFTTISSUE</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>Other infection sites</td>\n    </tr>\n    <tr>\n      <th>718</th>\n      <td>all_uti_features.csv</td>\n      <td>infection_sites - ABSCESS_OR_FLUID_NOS</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>Other infection sites</td>\n    </tr>\n    <tr>\n      <th>719</th>\n      <td>all_uti_features.csv</td>\n      <td>infection_sites - MUCOCUTANEOUS</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>Other infection sites</td>\n    </tr>\n    <tr>\n      <th>720</th>\n      <td>all_uti_features.csv</td>\n      <td>infection_sites - GENITOURINARY</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>Other infection sites</td>\n    </tr>\n    <tr>\n      <th>721</th>\n      <td>all_uti_features.csv</td>\n      <td>hosp ward - ER</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>Specimen collected in Emergency Room</td>\n    </tr>\n    <tr>\n      <th>722</th>\n      <td>all_uti_features.csv</td>\n      <td>hosp ward - ICU</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>Specimen collected in Intensive Care Unit</td>\n    </tr>\n    <tr>\n      <th>723</th>\n      <td>all_uti_features.csv</td>\n      <td>hosp ward - IP</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>Specimen collected in inpatient setting</td>\n    </tr>\n    <tr>\n      <th>724</th>\n      <td>all_uti_features.csv</td>\n      <td>hosp ward - OP</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>Specimen collected in outpatient setting</td>\n    </tr>\n    <tr>\n      <th>725</th>\n      <td>all_uti_features.csv</td>\n      <td>selected micro - colonization pressure AMC 90 ...</td>\n      <td>7.0</td>\n      <td>90</td>\n      <td>Resistance rate at same floor/ward/clinic</td>\n    </tr>\n    <tr>\n      <th>726</th>\n      <td>all_uti_features.csv</td>\n      <td>selected micro - colonization pressure AMP 90 ...</td>\n      <td>7.0</td>\n      <td>90</td>\n      <td>Resistance rate at same floor/ward/clinic</td>\n    </tr>\n    <tr>\n      <th>727</th>\n      <td>all_uti_features.csv</td>\n      <td>selected micro - colonization pressure ATM 90 ...</td>\n      <td>7.0</td>\n      <td>90</td>\n      <td>Resistance rate at same floor/ward/clinic</td>\n    </tr>\n    <tr>\n      <th>728</th>\n      <td>all_uti_features.csv</td>\n      <td>selected micro - colonization pressure CAZ 90 ...</td>\n      <td>7.0</td>\n      <td>90</td>\n      <td>Resistance rate at same floor/ward/clinic</td>\n    </tr>\n    <tr>\n      <th>729</th>\n      <td>all_uti_features.csv</td>\n      <td>selected micro - colonization pressure CIP 90 ...</td>\n      <td>7.0</td>\n      <td>90</td>\n      <td>Resistance rate at same floor/ward/clinic</td>\n    </tr>\n    <tr>\n      <th>730</th>\n      <td>all_uti_features.csv</td>\n      <td>selected micro - colonization pressure CLI 90 ...</td>\n      <td>7.0</td>\n      <td>90</td>\n      <td>Resistance rate at same floor/ward/clinic</td>\n    </tr>\n    <tr>\n      <th>731</th>\n      <td>all_uti_features.csv</td>\n      <td>selected micro - colonization pressure CRO 90 ...</td>\n      <td>7.0</td>\n      <td>90</td>\n      <td>Resistance rate at same floor/ward/clinic</td>\n    </tr>\n    <tr>\n      <th>732</th>\n      <td>all_uti_features.csv</td>\n      <td>selected micro - colonization pressure DOX 90 ...</td>\n      <td>7.0</td>\n      <td>90</td>\n      <td>Resistance rate at same floor/ward/clinic</td>\n    </tr>\n    <tr>\n      <th>733</th>\n      <td>all_uti_features.csv</td>\n      <td>selected micro - colonization pressure ERY 90 ...</td>\n      <td>7.0</td>\n      <td>90</td>\n      <td>Resistance rate at same floor/ward/clinic</td>\n    </tr>\n    <tr>\n      <th>734</th>\n      <td>all_uti_features.csv</td>\n      <td>selected micro - colonization pressure FEP 90 ...</td>\n      <td>7.0</td>\n      <td>90</td>\n      <td>Resistance rate at same floor/ward/clinic</td>\n    </tr>\n    <tr>\n      <th>735</th>\n      <td>all_uti_features.csv</td>\n      <td>selected micro - colonization pressure FOX 90 ...</td>\n      <td>7.0</td>\n      <td>90</td>\n      <td>Resistance rate at same floor/ward/clinic</td>\n    </tr>\n    <tr>\n      <th>736</th>\n      <td>all_uti_features.csv</td>\n      <td>selected micro - colonization pressure GEN 90 ...</td>\n      <td>7.0</td>\n      <td>90</td>\n      <td>Resistance rate at same floor/ward/clinic</td>\n    </tr>\n    <tr>\n      <th>737</th>\n      <td>all_uti_features.csv</td>\n      <td>selected micro - colonization pressure IPM 90 ...</td>\n      <td>7.0</td>\n      <td>90</td>\n      <td>Resistance rate at same floor/ward/clinic</td>\n    </tr>\n    <tr>\n      <th>738</th>\n      <td>all_uti_features.csv</td>\n      <td>selected micro - colonization pressure LVX 90 ...</td>\n      <td>7.0</td>\n      <td>90</td>\n      <td>Resistance rate at same floor/ward/clinic</td>\n    </tr>\n    <tr>\n      <th>739</th>\n      <td>all_uti_features.csv</td>\n      <td>selected micro - colonization pressure MEM 90 ...</td>\n      <td>7.0</td>\n      <td>90</td>\n      <td>Resistance rate at same floor/ward/clinic</td>\n    </tr>\n    <tr>\n      <th>740</th>\n      <td>all_uti_features.csv</td>\n      <td>selected micro - colonization pressure MXF 90 ...</td>\n      <td>7.0</td>\n      <td>90</td>\n      <td>Resistance rate at same floor/ward/clinic</td>\n    </tr>\n    <tr>\n      <th>741</th>\n      <td>all_uti_features.csv</td>\n      <td>selected micro - colonization pressure NIT 90 ...</td>\n      <td>7.0</td>\n      <td>90</td>\n      <td>Resistance rate at same floor/ward/clinic</td>\n    </tr>\n    <tr>\n      <th>742</th>\n      <td>all_uti_features.csv</td>\n      <td>selected micro - colonization pressure OXA 90 ...</td>\n      <td>7.0</td>\n      <td>90</td>\n      <td>Resistance rate at same floor/ward/clinic</td>\n    </tr>\n    <tr>\n      <th>743</th>\n      <td>all_uti_features.csv</td>\n      <td>selected micro - colonization pressure PEN 90 ...</td>\n      <td>7.0</td>\n      <td>90</td>\n      <td>Resistance rate at same floor/ward/clinic</td>\n    </tr>\n    <tr>\n      <th>744</th>\n      <td>all_uti_features.csv</td>\n      <td>selected micro - colonization pressure SAM 90 ...</td>\n      <td>7.0</td>\n      <td>90</td>\n      <td>Resistance rate at same floor/ward/clinic</td>\n    </tr>\n    <tr>\n      <th>745</th>\n      <td>all_uti_features.csv</td>\n      <td>selected micro - colonization pressure SXT 90 ...</td>\n      <td>7.0</td>\n      <td>90</td>\n      <td>Resistance rate at same floor/ward/clinic</td>\n    </tr>\n    <tr>\n      <th>746</th>\n      <td>all_uti_features.csv</td>\n      <td>selected micro - colonization pressure TET 90 ...</td>\n      <td>7.0</td>\n      <td>90</td>\n      <td>Resistance rate at same floor/ward/clinic</td>\n    </tr>\n    <tr>\n      <th>747</th>\n      <td>all_uti_features.csv</td>\n      <td>selected micro - colonization pressure TZP 90 ...</td>\n      <td>7.0</td>\n      <td>90</td>\n      <td>Resistance rate at same floor/ward/clinic</td>\n    </tr>\n    <tr>\n      <th>748</th>\n      <td>all_uti_features.csv</td>\n      <td>selected micro - colonization pressure VAN 90 ...</td>\n      <td>7.0</td>\n      <td>90</td>\n      <td>Resistance rate at same floor/ward/clinic</td>\n    </tr>\n    <tr>\n      <th>749</th>\n      <td>all_uti_features.csv</td>\n      <td>selected micro - colonization pressure AMC 90 ...</td>\n      <td>7.0</td>\n      <td>90</td>\n      <td>Resistance rate at same hospital / department ...</td>\n    </tr>\n    <tr>\n      <th>750</th>\n      <td>all_uti_features.csv</td>\n      <td>selected micro - colonization pressure AMP 90 ...</td>\n      <td>7.0</td>\n      <td>90</td>\n      <td>Resistance rate at same hospital / department ...</td>\n    </tr>\n    <tr>\n      <th>751</th>\n      <td>all_uti_features.csv</td>\n      <td>selected micro - colonization pressure ATM 90 ...</td>\n      <td>7.0</td>\n      <td>90</td>\n      <td>Resistance rate at same hospital / department ...</td>\n    </tr>\n    <tr>\n      <th>752</th>\n      <td>all_uti_features.csv</td>\n      <td>selected micro - colonization pressure CAZ 90 ...</td>\n      <td>7.0</td>\n      <td>90</td>\n      <td>Resistance rate at same hospital / department ...</td>\n    </tr>\n    <tr>\n      <th>753</th>\n      <td>all_uti_features.csv</td>\n      <td>selected micro - colonization pressure CIP 90 ...</td>\n      <td>7.0</td>\n      <td>90</td>\n      <td>Resistance rate at same hospital / department ...</td>\n    </tr>\n    <tr>\n      <th>754</th>\n      <td>all_uti_features.csv</td>\n      <td>selected micro - colonization pressure CLI 90 ...</td>\n      <td>7.0</td>\n      <td>90</td>\n      <td>Resistance rate at same hospital / department ...</td>\n    </tr>\n    <tr>\n      <th>755</th>\n      <td>all_uti_features.csv</td>\n      <td>selected micro - colonization pressure CRO 90 ...</td>\n      <td>7.0</td>\n      <td>90</td>\n      <td>Resistance rate at same hospital / department ...</td>\n    </tr>\n    <tr>\n      <th>756</th>\n      <td>all_uti_features.csv</td>\n      <td>selected micro - colonization pressure DOX 90 ...</td>\n      <td>7.0</td>\n      <td>90</td>\n      <td>Resistance rate at same hospital / department ...</td>\n    </tr>\n    <tr>\n      <th>757</th>\n      <td>all_uti_features.csv</td>\n      <td>selected micro - colonization pressure ERY 90 ...</td>\n      <td>7.0</td>\n      <td>90</td>\n      <td>Resistance rate at same hospital / department ...</td>\n    </tr>\n    <tr>\n      <th>758</th>\n      <td>all_uti_features.csv</td>\n      <td>selected micro - colonization pressure FEP 90 ...</td>\n      <td>7.0</td>\n      <td>90</td>\n      <td>Resistance rate at same hospital / department ...</td>\n    </tr>\n    <tr>\n      <th>759</th>\n      <td>all_uti_features.csv</td>\n      <td>selected micro - colonization pressure FOX 90 ...</td>\n      <td>7.0</td>\n      <td>90</td>\n      <td>Resistance rate at same hospital / department ...</td>\n    </tr>\n    <tr>\n      <th>760</th>\n      <td>all_uti_features.csv</td>\n      <td>selected micro - colonization pressure GEN 90 ...</td>\n      <td>7.0</td>\n      <td>90</td>\n      <td>Resistance rate at same hospital / department ...</td>\n    </tr>\n    <tr>\n      <th>761</th>\n      <td>all_uti_features.csv</td>\n      <td>selected micro - colonization pressure IPM 90 ...</td>\n      <td>7.0</td>\n      <td>90</td>\n      <td>Resistance rate at same hospital / department ...</td>\n    </tr>\n    <tr>\n      <th>762</th>\n      <td>all_uti_features.csv</td>\n      <td>selected micro - colonization pressure LVX 90 ...</td>\n      <td>7.0</td>\n      <td>90</td>\n      <td>Resistance rate at same hospital / department ...</td>\n    </tr>\n    <tr>\n      <th>763</th>\n      <td>all_uti_features.csv</td>\n      <td>selected micro - colonization pressure MEM 90 ...</td>\n      <td>7.0</td>\n      <td>90</td>\n      <td>Resistance rate at same hospital / department ...</td>\n    </tr>\n    <tr>\n      <th>764</th>\n      <td>all_uti_features.csv</td>\n      <td>selected micro - colonization pressure MIN 90 ...</td>\n      <td>7.0</td>\n      <td>90</td>\n      <td>Resistance rate at same hospital / department ...</td>\n    </tr>\n    <tr>\n      <th>765</th>\n      <td>all_uti_features.csv</td>\n      <td>selected micro - colonization pressure MXF 90 ...</td>\n      <td>7.0</td>\n      <td>90</td>\n      <td>Resistance rate at same hospital / department ...</td>\n    </tr>\n    <tr>\n      <th>766</th>\n      <td>all_uti_features.csv</td>\n      <td>selected micro - colonization pressure NIT 90 ...</td>\n      <td>7.0</td>\n      <td>90</td>\n      <td>Resistance rate at same hospital / department ...</td>\n    </tr>\n    <tr>\n      <th>767</th>\n      <td>all_uti_features.csv</td>\n      <td>selected micro - colonization pressure OXA 90 ...</td>\n      <td>7.0</td>\n      <td>90</td>\n      <td>Resistance rate at same hospital / department ...</td>\n    </tr>\n    <tr>\n      <th>768</th>\n      <td>all_uti_features.csv</td>\n      <td>selected micro - colonization pressure PEN 90 ...</td>\n      <td>7.0</td>\n      <td>90</td>\n      <td>Resistance rate at same hospital / department ...</td>\n    </tr>\n    <tr>\n      <th>769</th>\n      <td>all_uti_features.csv</td>\n      <td>selected micro - colonization pressure SAM 90 ...</td>\n      <td>7.0</td>\n      <td>90</td>\n      <td>Resistance rate at same hospital / department ...</td>\n    </tr>\n    <tr>\n      <th>770</th>\n      <td>all_uti_features.csv</td>\n      <td>selected micro - colonization pressure SXT 90 ...</td>\n      <td>7.0</td>\n      <td>90</td>\n      <td>Resistance rate at same hospital / department ...</td>\n    </tr>\n    <tr>\n      <th>771</th>\n      <td>all_uti_features.csv</td>\n      <td>selected micro - colonization pressure TET 90 ...</td>\n      <td>7.0</td>\n      <td>90</td>\n      <td>Resistance rate at same hospital / department ...</td>\n    </tr>\n    <tr>\n      <th>772</th>\n      <td>all_uti_features.csv</td>\n      <td>selected micro - colonization pressure TZP 90 ...</td>\n      <td>7.0</td>\n      <td>90</td>\n      <td>Resistance rate at same hospital / department ...</td>\n    </tr>\n    <tr>\n      <th>773</th>\n      <td>all_uti_features.csv</td>\n      <td>selected micro - colonization pressure VAN 90 ...</td>\n      <td>7.0</td>\n      <td>90</td>\n      <td>Resistance rate at same hospital / department ...</td>\n    </tr>\n    <tr>\n      <th>774</th>\n      <td>all_uti_features.csv</td>\n      <td>selected micro - colonization pressure AMC 90 ...</td>\n      <td>7.0</td>\n      <td>90</td>\n      <td>Resistance rate across all specimens</td>\n    </tr>\n    <tr>\n      <th>775</th>\n      <td>all_uti_features.csv</td>\n      <td>selected micro - colonization pressure AMP 90 ...</td>\n      <td>7.0</td>\n      <td>90</td>\n      <td>Resistance rate across all specimens</td>\n    </tr>\n    <tr>\n      <th>776</th>\n      <td>all_uti_features.csv</td>\n      <td>selected micro - colonization pressure ATM 90 ...</td>\n      <td>7.0</td>\n      <td>90</td>\n      <td>Resistance rate across all specimens</td>\n    </tr>\n    <tr>\n      <th>777</th>\n      <td>all_uti_features.csv</td>\n      <td>selected micro - colonization pressure CAZ 90 ...</td>\n      <td>7.0</td>\n      <td>90</td>\n      <td>Resistance rate across all specimens</td>\n    </tr>\n    <tr>\n      <th>778</th>\n      <td>all_uti_features.csv</td>\n      <td>selected micro - colonization pressure CIP 90 ...</td>\n      <td>7.0</td>\n      <td>90</td>\n      <td>Resistance rate across all specimens</td>\n    </tr>\n    <tr>\n      <th>779</th>\n      <td>all_uti_features.csv</td>\n      <td>selected micro - colonization pressure CLI 90 ...</td>\n      <td>7.0</td>\n      <td>90</td>\n      <td>Resistance rate across all specimens</td>\n    </tr>\n    <tr>\n      <th>780</th>\n      <td>all_uti_features.csv</td>\n      <td>selected micro - colonization pressure CRO 90 ...</td>\n      <td>7.0</td>\n      <td>90</td>\n      <td>Resistance rate across all specimens</td>\n    </tr>\n    <tr>\n      <th>781</th>\n      <td>all_uti_features.csv</td>\n      <td>selected micro - colonization pressure DOX 90 ...</td>\n      <td>7.0</td>\n      <td>90</td>\n      <td>Resistance rate across all specimens</td>\n    </tr>\n    <tr>\n      <th>782</th>\n      <td>all_uti_features.csv</td>\n      <td>selected micro - colonization pressure ERY 90 ...</td>\n      <td>7.0</td>\n      <td>90</td>\n      <td>Resistance rate across all specimens</td>\n    </tr>\n    <tr>\n      <th>783</th>\n      <td>all_uti_features.csv</td>\n      <td>selected micro - colonization pressure FEP 90 ...</td>\n      <td>7.0</td>\n      <td>90</td>\n      <td>Resistance rate across all specimens</td>\n    </tr>\n    <tr>\n      <th>784</th>\n      <td>all_uti_features.csv</td>\n      <td>selected micro - colonization pressure FOX 90 ...</td>\n      <td>7.0</td>\n      <td>90</td>\n      <td>Resistance rate across all specimens</td>\n    </tr>\n    <tr>\n      <th>785</th>\n      <td>all_uti_features.csv</td>\n      <td>selected micro - colonization pressure GEN 90 ...</td>\n      <td>7.0</td>\n      <td>90</td>\n      <td>Resistance rate across all specimens</td>\n    </tr>\n    <tr>\n      <th>786</th>\n      <td>all_uti_features.csv</td>\n      <td>selected micro - colonization pressure IPM 90 ...</td>\n      <td>7.0</td>\n      <td>90</td>\n      <td>Resistance rate across all specimens</td>\n    </tr>\n    <tr>\n      <th>787</th>\n      <td>all_uti_features.csv</td>\n      <td>selected micro - colonization pressure LVX 90 ...</td>\n      <td>7.0</td>\n      <td>90</td>\n      <td>Resistance rate across all specimens</td>\n    </tr>\n    <tr>\n      <th>788</th>\n      <td>all_uti_features.csv</td>\n      <td>selected micro - colonization pressure MEM 90 ...</td>\n      <td>7.0</td>\n      <td>90</td>\n      <td>Resistance rate across all specimens</td>\n    </tr>\n    <tr>\n      <th>789</th>\n      <td>all_uti_features.csv</td>\n      <td>selected micro - colonization pressure MIN 90 ...</td>\n      <td>7.0</td>\n      <td>90</td>\n      <td>Resistance rate across all specimens</td>\n    </tr>\n    <tr>\n      <th>790</th>\n      <td>all_uti_features.csv</td>\n      <td>selected micro - colonization pressure MXF 90 ...</td>\n      <td>7.0</td>\n      <td>90</td>\n      <td>Resistance rate across all specimens</td>\n    </tr>\n    <tr>\n      <th>791</th>\n      <td>all_uti_features.csv</td>\n      <td>selected micro - colonization pressure NIT 90 ...</td>\n      <td>7.0</td>\n      <td>90</td>\n      <td>Resistance rate across all specimens</td>\n    </tr>\n    <tr>\n      <th>792</th>\n      <td>all_uti_features.csv</td>\n      <td>selected micro - colonization pressure OXA 90 ...</td>\n      <td>7.0</td>\n      <td>90</td>\n      <td>Resistance rate across all specimens</td>\n    </tr>\n    <tr>\n      <th>793</th>\n      <td>all_uti_features.csv</td>\n      <td>selected micro - colonization pressure PEN 90 ...</td>\n      <td>7.0</td>\n      <td>90</td>\n      <td>Resistance rate across all specimens</td>\n    </tr>\n    <tr>\n      <th>794</th>\n      <td>all_uti_features.csv</td>\n      <td>selected micro - colonization pressure SAM 90 ...</td>\n      <td>7.0</td>\n      <td>90</td>\n      <td>Resistance rate across all specimens</td>\n    </tr>\n    <tr>\n      <th>795</th>\n      <td>all_uti_features.csv</td>\n      <td>selected micro - colonization pressure SXT 90 ...</td>\n      <td>7.0</td>\n      <td>90</td>\n      <td>Resistance rate across all specimens</td>\n    </tr>\n    <tr>\n      <th>796</th>\n      <td>all_uti_features.csv</td>\n      <td>selected micro - colonization pressure TET 90 ...</td>\n      <td>7.0</td>\n      <td>90</td>\n      <td>Resistance rate across all specimens</td>\n    </tr>\n    <tr>\n      <th>797</th>\n      <td>all_uti_features.csv</td>\n      <td>selected micro - colonization pressure TZP 90 ...</td>\n      <td>7.0</td>\n      <td>90</td>\n      <td>Resistance rate across all specimens</td>\n    </tr>\n    <tr>\n      <th>798</th>\n      <td>all_uti_features.csv</td>\n      <td>selected micro - colonization pressure VAN 90 ...</td>\n      <td>7.0</td>\n      <td>90</td>\n      <td>Resistance rate across all specimens</td>\n    </tr>\n    <tr>\n      <th>799</th>\n      <td>all_uti_features.csv</td>\n      <td>is_train</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>Used to denote membership in training set (200...</td>\n    </tr>\n    <tr>\n      <th>800</th>\n      <td>all_uti_features.csv</td>\n      <td>uncomplicated</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>Used to denote membership in uncomplicated UTI...</td>\n    </tr>\n  </tbody>\n</table>\n</div>"},"metadata":{}}]},{"cell_type":"code","metadata":{"deepnote_to_be_reexecuted":false,"source_hash":"c5ce2df","cell_id":"00013-f2176d12-eee1-4361-b321-ef751b8fa5c1","execution_millis":56,"execution_start":1611680891977,"deepnote_cell_type":"code"},"source":"all_proba = pd.read_csv(\"/work/amr-uti-stm/experiments/experiment_results/test_predictions.csv\")\ntest_proba = all_proba.query(\"is_train == 0\")\ntrain_proba = all_proba.query(\"is_train == 1\")\nprint(\"Test set size\", test_proba.shape)\nprint(\"Training set size\", train_proba.shape)\n\nis_white = (all_uncomp_uti_features['demographics - is_white'] == 1)\nis_nonwhite = (all_uncomp_uti_features['demographics - is_white'] == 0)\n\nis_white_tr = (train_uncomp_uti_features['demographics - is_white'] == 1)\nis_nonwhite_tr = (train_uncomp_uti_features['demographics - is_white'] == 0)\nprint('Training', 'White:', sum(is_white_tr),'Non-white:', sum(is_nonwhite_tr))\nis_white_te = (test_uncomp_uti_features['demographics - is_white'] == 1)\nis_nonwhite_te = (test_uncomp_uti_features['demographics - is_white'] == 0)\nprint('Test', 'White:', sum(is_white_te),'Non-white:', sum(is_nonwhite_te))\n\n\nwhite_proba = all_proba[is_white.reset_index()['demographics - is_white']] \nnonwhite_proba = all_proba[is_nonwhite.reset_index()['demographics - is_white']] \n\n\nprint(white_proba.shape)\nprint(nonwhite_proba.shape)\n# %%\nwhite_proba.head()","execution_count":18,"outputs":[{"name":"stdout","text":"Test set size (3941, 6)\nTraining set size (11865, 6)\nTraining White: 7599 Non-white: 4266\nTest White: 2455 Non-white: 1486\n(10054, 6)\n(5752, 6)\n","output_type":"stream"},{"output_type":"execute_result","execution_count":18,"data":{"application/vnd.deepnote.dataframe.v2+json":{"row_count":5,"column_count":6,"columns":[{"name":"example_id","dtype":"int64","stats":{"unique_count":5,"nan_count":0,"min":4,"max":177,"histogram":[{"bin_start":4,"bin_end":21.3,"count":1},{"bin_start":21.3,"bin_end":38.6,"count":0},{"bin_start":38.6,"bin_end":55.900000000000006,"count":0},{"bin_start":55.900000000000006,"bin_end":73.2,"count":1},{"bin_start":73.2,"bin_end":90.5,"count":0},{"bin_start":90.5,"bin_end":107.80000000000001,"count":0},{"bin_start":107.80000000000001,"bin_end":125.10000000000001,"count":0},{"bin_start":125.10000000000001,"bin_end":142.4,"count":2},{"bin_start":142.4,"bin_end":159.70000000000002,"count":0},{"bin_start":159.70000000000002,"bin_end":177,"count":1}]}},{"name":"is_train","dtype":"int64","stats":{"unique_count":1,"nan_count":0,"min":1,"max":1,"histogram":[{"bin_start":0.5,"bin_end":0.6,"count":0},{"bin_start":0.6,"bin_end":0.7,"count":0},{"bin_start":0.7,"bin_end":0.8,"count":0},{"bin_start":0.8,"bin_end":0.9,"count":0},{"bin_start":0.9,"bin_end":1,"count":0},{"bin_start":1,"bin_end":1.1,"count":5},{"bin_start":1.1,"bin_end":1.2000000000000002,"count":0},{"bin_start":1.2000000000000002,"bin_end":1.3,"count":0},{"bin_start":1.3,"bin_end":1.4,"count":0},{"bin_start":1.4,"bin_end":1.5,"count":0}]}},{"name":"predicted_prob_NIT","dtype":"float64","stats":{"unique_count":5,"nan_count":0,"min":0.0982304043610507,"max":0.2092926685825408,"histogram":[{"bin_start":0.0982304043610507,"bin_end":0.1093366307831997,"count":3},{"bin_start":0.1093366307831997,"bin_end":0.12044285720534872,"count":0},{"bin_start":0.12044285720534872,"bin_end":0.13154908362749773,"count":0},{"bin_start":0.13154908362749773,"bin_end":0.14265531004964674,"count":1},{"bin_start":0.14265531004964674,"bin_end":0.15376153647179575,"count":0},{"bin_start":0.15376153647179575,"bin_end":0.16486776289394478,"count":0},{"bin_start":0.16486776289394478,"bin_end":0.17597398931609376,"count":0},{"bin_start":0.17597398931609376,"bin_end":0.1870802157382428,"count":0},{"bin_start":0.1870802157382428,"bin_end":0.19818644216039177,"count":0},{"bin_start":0.19818644216039177,"bin_end":0.2092926685825408,"count":1}]}},{"name":"predicted_prob_SXT","dtype":"float64","stats":{"unique_count":5,"nan_count":0,"min":0.1161036452966195,"max":0.2128181321460583,"histogram":[{"bin_start":0.1161036452966195,"bin_end":0.1257750939815634,"count":1},{"bin_start":0.1257750939815634,"bin_end":0.13544654266650727,"count":0},{"bin_start":0.13544654266650727,"bin_end":0.14511799135145115,"count":0},{"bin_start":0.14511799135145115,"bin_end":0.15478944003639503,"count":3},{"bin_start":0.15478944003639503,"bin_end":0.1644608887213389,"count":0},{"bin_start":0.1644608887213389,"bin_end":0.17413233740628278,"count":0},{"bin_start":0.17413233740628278,"bin_end":0.18380378609122666,"count":0},{"bin_start":0.18380378609122666,"bin_end":0.19347523477617054,"count":0},{"bin_start":0.19347523477617054,"bin_end":0.20314668346111442,"count":0},{"bin_start":0.20314668346111442,"bin_end":0.2128181321460583,"count":1}]}},{"name":"predicted_prob_CIP","dtype":"float64","stats":{"unique_count":5,"nan_count":0,"min":0.0349560482649903,"max":0.0437979002911416,"histogram":[{"bin_start":0.0349560482649903,"bin_end":0.035840233467605426,"count":1},{"bin_start":0.035840233467605426,"bin_end":0.036724418670220554,"count":0},{"bin_start":0.036724418670220554,"bin_end":0.03760860387283569,"count":0},{"bin_start":0.03760860387283569,"bin_end":0.03849278907545082,"count":0},{"bin_start":0.03849278907545082,"bin_end":0.03937697427806595,"count":0},{"bin_start":0.03937697427806595,"bin_end":0.040261159480681076,"count":1},{"bin_start":0.040261159480681076,"bin_end":0.041145344683296205,"count":1},{"bin_start":0.041145344683296205,"bin_end":0.04202952988591134,"count":0},{"bin_start":0.04202952988591134,"bin_end":0.04291371508852647,"count":1},{"bin_start":0.04291371508852647,"bin_end":0.0437979002911416,"count":1}]}},{"name":"predicted_prob_LVX","dtype":"float64","stats":{"unique_count":5,"nan_count":0,"min":0.0348576149779545,"max":0.0424600986286186,"histogram":[{"bin_start":0.0348576149779545,"bin_end":0.03561786334302091,"count":3},{"bin_start":0.03561786334302091,"bin_end":0.036378111708087316,"count":0},{"bin_start":0.036378111708087316,"bin_end":0.03713836007315373,"count":0},{"bin_start":0.03713836007315373,"bin_end":0.03789860843822014,"count":1},{"bin_start":0.03789860843822014,"bin_end":0.038658856803286554,"count":0},{"bin_start":0.038658856803286554,"bin_end":0.03941910516835296,"count":0},{"bin_start":0.03941910516835296,"bin_end":0.04017935353341937,"count":0},{"bin_start":0.04017935353341937,"bin_end":0.040939601898485785,"count":0},{"bin_start":0.040939601898485785,"bin_end":0.04169985026355219,"count":0},{"bin_start":0.04169985026355219,"bin_end":0.0424600986286186,"count":1}]}},{"name":"_deepnote_index_column","dtype":"int64"}],"rows_top":[{"example_id":4,"is_train":1,"predicted_prob_NIT":0.1047608781278122,"predicted_prob_SXT":0.1524550763605345,"predicted_prob_CIP":0.0408294033326525,"predicted_prob_LVX":0.0350460960710743,"_deepnote_index_column":0},{"example_id":68,"is_train":1,"predicted_prob_NIT":0.1386362966685579,"predicted_prob_SXT":0.1479243192407667,"predicted_prob_CIP":0.0422329438150143,"predicted_prob_LVX":0.0424600986286186,"_deepnote_index_column":5},{"example_id":129,"is_train":1,"predicted_prob_NIT":0.0999241311868748,"predicted_prob_SXT":0.2128181321460583,"predicted_prob_CIP":0.0399021193187184,"predicted_prob_LVX":0.0348576149779545,"_deepnote_index_column":11},{"example_id":132,"is_train":1,"predicted_prob_NIT":0.2092926685825408,"predicted_prob_SXT":0.1161036452966195,"predicted_prob_CIP":0.0437979002911416,"predicted_prob_LVX":0.0378592578328676,"_deepnote_index_column":12},{"example_id":177,"is_train":1,"predicted_prob_NIT":0.0982304043610507,"predicted_prob_SXT":0.1517111295100886,"predicted_prob_CIP":0.0349560482649903,"predicted_prob_LVX":0.0354677362442385,"_deepnote_index_column":16}],"rows_bottom":null},"text/plain":"    example_id  is_train  predicted_prob_NIT  predicted_prob_SXT  \\\n0            4         1            0.104761            0.152455   \n5           68         1            0.138636            0.147924   \n11         129         1            0.099924            0.212818   \n12         132         1            0.209293            0.116104   \n16         177         1            0.098230            0.151711   \n\n    predicted_prob_CIP  predicted_prob_LVX  \n0             0.040829            0.035046  \n5             0.042233            0.042460  \n11            0.039902            0.034858  \n12            0.043798            0.037859  \n16            0.034956            0.035468  ","text/html":"<div>\n<style scoped>\n    .dataframe tbody tr th:only-of-type {\n        vertical-align: middle;\n    }\n\n    .dataframe tbody tr th {\n        vertical-align: top;\n    }\n\n    .dataframe thead th {\n        text-align: right;\n    }\n</style>\n<table border=\"1\" class=\"dataframe\">\n  <thead>\n    <tr style=\"text-align: right;\">\n      <th></th>\n      <th>example_id</th>\n      <th>is_train</th>\n      <th>predicted_prob_NIT</th>\n      <th>predicted_prob_SXT</th>\n      <th>predicted_prob_CIP</th>\n      <th>predicted_prob_LVX</th>\n    </tr>\n  </thead>\n  <tbody>\n    <tr>\n      <th>0</th>\n      <td>4</td>\n      <td>1</td>\n      <td>0.104761</td>\n      <td>0.152455</td>\n      <td>0.040829</td>\n      <td>0.035046</td>\n    </tr>\n    <tr>\n      <th>5</th>\n      <td>68</td>\n      <td>1</td>\n      <td>0.138636</td>\n      <td>0.147924</td>\n      <td>0.042233</td>\n      <td>0.042460</td>\n    </tr>\n    <tr>\n      <th>11</th>\n      <td>129</td>\n      <td>1</td>\n      <td>0.099924</td>\n      <td>0.212818</td>\n      <td>0.039902</td>\n      <td>0.034858</td>\n    </tr>\n    <tr>\n      <th>12</th>\n      <td>132</td>\n      <td>1</td>\n      <td>0.209293</td>\n      <td>0.116104</td>\n      <td>0.043798</td>\n      <td>0.037859</td>\n    </tr>\n    <tr>\n      <th>16</th>\n      <td>177</td>\n      <td>1</td>\n      <td>0.098230</td>\n      <td>0.151711</td>\n      <td>0.034956</td>\n      <td>0.035468</td>\n    </tr>\n  </tbody>\n</table>\n</div>"},"metadata":{}}]},{"cell_type":"code","source":"white_proba.to_csv('white_proba.csv')\nnonwhite_proba.to_csv('non_whiteproba.csv')","metadata":{"tags":[],"cell_id":"00014-23e7584b-c62e-4979-ae31-8205e201080c","deepnote_to_be_reexecuted":false,"source_hash":"eb5f5ece","execution_millis":120,"execution_start":1611682134048,"deepnote_cell_type":"code"},"outputs":[],"execution_count":58},{"cell_type":"code","metadata":{"tags":[],"cell_id":"00014-19550dcd-444e-4086-8484-b0e6c13fde77","deepnote_to_be_reexecuted":false,"source_hash":"ab5da1a7","execution_millis":5,"execution_start":1611680961067,"deepnote_cell_type":"code"},"source":"white_proba.columns","execution_count":20,"outputs":[{"output_type":"execute_result","execution_count":20,"data":{"text/plain":"Index(['example_id', 'is_train', 'predicted_prob_NIT', 'predicted_prob_SXT',\n       'predicted_prob_CIP', 'predicted_prob_LVX'],\n      dtype='object')"},"metadata":{}}]},{"cell_type":"code","metadata":{"tags":[],"cell_id":"00015-01c2f292-3195-40aa-81a3-133aec8831ec","deepnote_to_be_reexecuted":false,"source_hash":"c31895e6","execution_millis":263,"execution_start":1611681694573,"deepnote_cell_type":"code"},"source":"ecdf_white = ECDF(white_proba['predicted_prob_CIP'])\necdf_nonwhite = ECDF(nonwhite_proba['predicted_prob_CIP'])\rfig, (ax1, ax2) = plt.subplots(1, 2)\nax1.plot(ecdf_white.x, ecdf_white.y, color='r')\nax2.plot(ecdf_nonwhite.x, ecdf_nonwhite.y, color='g')\n","execution_count":47,"outputs":[{"output_type":"execute_result","execution_count":47,"data":{"text/plain":"[<matplotlib.lines.Line2D at 0x7ffaa6086210>]"},"metadata":{}},{"data":{"text/plain":"<Figure size 432x288 with 2 Axes>","image/png":"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\n"},"metadata":{},"output_type":"display_data"}]},{"cell_type":"code","source":"ecdf_white = ECDF(white_proba['predicted_prob_NIT'])\necdf_nonwhite = ECDF(nonwhite_proba['predicted_prob_NIT'])\nfig, (ax1, ax2) = plt.subplots(1, 2)\nplt.suptitle('NIT')\nax1.plot(ecdf_white.x, ecdf_white.y, color='r')\nax2.plot(ecdf_nonwhite.x, ecdf_nonwhite.y, color='g')\n","metadata":{"tags":[],"cell_id":"00016-06a94180-872d-47d3-b76b-4a0c466761e4","deepnote_to_be_reexecuted":false,"source_hash":"a90a586b","execution_millis":253,"execution_start":1611681996680,"deepnote_cell_type":"code"},"outputs":[{"output_type":"execute_result","execution_count":52,"data":{"text/plain":"[<matplotlib.lines.Line2D at 0x7ffaa866cb10>]"},"metadata":{}},{"data":{"text/plain":"<Figure size 432x288 with 2 Axes>","image/png":"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\n"},"metadata":{},"output_type":"display_data"}],"execution_count":52},{"cell_type":"code","source":"ecdf_white = ECDF(white_proba['predicted_prob_SXT'])\necdf_nonwhite = ECDF(nonwhite_proba['predicted_prob_SXT'])\nfig, (ax1, ax2) = plt.subplots(1, 2)\nplt.suptitle('SXT')\nax1.plot(ecdf_white.x, ecdf_white.y, color='r')\nax2.plot(ecdf_nonwhite.x, ecdf_nonwhite.y, color='g')\n","metadata":{"tags":[],"cell_id":"00017-a21deba2-dced-4215-b80b-d1fec3ee8a51","deepnote_to_be_reexecuted":false,"source_hash":"d624dd4d","execution_millis":275,"execution_start":1611682034419,"deepnote_cell_type":"code"},"outputs":[{"output_type":"execute_result","execution_count":55,"data":{"text/plain":"[<matplotlib.lines.Line2D at 0x7ffaa53fc350>]"},"metadata":{}},{"data":{"text/plain":"<Figure size 432x288 with 2 Axes>","image/png":"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\n"},"metadata":{},"output_type":"display_data"}],"execution_count":55},{"cell_type":"code","source":"ecdf_white = ECDF(white_proba['predicted_prob_LVX'])\necdf_nonwhite = ECDF(nonwhite_proba['predicted_prob_LVX'])\nfig, (ax1, ax2) = plt.subplots(1, 2)\nplt.suptitle('LVX')\nax1.plot(ecdf_white.x, ecdf_white.y, color='r')\nax2.plot(ecdf_nonwhite.x, ecdf_nonwhite.y, color='g')\n","metadata":{"tags":[],"cell_id":"00018-18fcc9b9-7c1c-4bdd-8a54-94aad2e9c3bc","deepnote_to_be_reexecuted":false,"source_hash":"f8423668","execution_millis":222,"execution_start":1611682263583,"deepnote_cell_type":"code"},"outputs":[{"output_type":"execute_result","execution_count":59,"data":{"text/plain":"[<matplotlib.lines.Line2D at 0x7ffaa521d4d0>]"},"metadata":{}},{"data":{"text/plain":"<Figure size 432x288 with 2 Axes>","image/png":"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\n"},"metadata":{},"output_type":"display_data"}],"execution_count":59},{"cell_type":"code","source":"","metadata":{"tags":[],"cell_id":"00019-a8fe112b-b13d-4580-86ae-05f919f4453d","deepnote_cell_type":"code"},"outputs":[],"execution_count":null}],"nbformat":4,"nbformat_minor":2,"metadata":{"language_info":{"codemirror_mode":{"name":"ipython","version":3},"file_extension":".py","mimetype":"text/x-python","name":"python","nbconvert_exporter":"python","pygments_lexer":"ipython3","version":"3.8.3-final"},"orig_nbformat":2,"kernelspec":{"name":"python3","display_name":"Python 3","language":"python"},"deepnote_notebook_id":"7511683b-3f93-4554-a56b-348f49712bd6","deepnote_execution_queue":[]}}